<SEC-DOCUMENT>0001437749-23-016284.txt : 20230531
<SEC-HEADER>0001437749-23-016284.hdr.sgml : 20230531
<ACCEPTANCE-DATETIME>20230531164939
ACCESSION NUMBER:		0001437749-23-016284
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20230531
DATE AS OF CHANGE:		20230531

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-272304
		FILM NUMBER:		23981701

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>nby20230525_s1.htm
<DESCRIPTION>FORM S-1
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:nby="http://www.nby.com/20230531"><head>
	<title>nby20230525_s1.htm</title>

	<!-- Generated by ThunderDome Portal - 5/31/2023 8:44:03 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d202310K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d202310K" name="dei:EntityCentralIndexKey">0001389545</ix:nonNumeric>
<ix:nonNumeric contextRef="d202310K" name="dei:EntitySmallBusiness">true</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="nby-20230531.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d202310K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001389545</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-05-31</xbrli:startDate>
<xbrli:endDate>2023-05-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>As filed with the Securities and Exchange Commission on May 31, 2023</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">Registration No. 333-&#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0; &#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b><br />
<b>SECURITIES AND EXCHANGE COMMISSION</b><br />
<b>WASHINGTON, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM</b>&#xa0;<ix:nonNumeric contextRef="d202310K" name="dei:DocumentType"><b>S-1</b></ix:nonNumeric><br />
<b>REGISTRATION STATEMENT</b><br />
<b>UNDER THE SECURITIES ACT OF 1933</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d202310K" name="dei:EntityRegistrantName"><b>NOVABAY PHARMACEUTICALS, INC.</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact name of registrant as specified in its charter)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d202310K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b>Delaware</b></ix:nonNumeric></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or other jurisdiction of</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">incorporation or organization)</div>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2834</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Primary Standard Industrial</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Classification Code Number)</div>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d202310K" name="dei:EntityTaxIdentificationNumber"><b>68-0454536</b></ix:nonNumeric></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(I.R.S. Employer</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d202310K" name="dei:EntityAddressAddressLine1"><b>2000 Powell Street, Suite 1150</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d202310K" name="dei:EntityAddressCityOrTown"><b>Emeryville</b></ix:nonNumeric><b>,</b>&#xa0;<ix:nonNumeric contextRef="d202310K" name="dei:EntityAddressStateOrProvince"><b>CA</b></ix:nonNumeric>&#xa0;<ix:nonNumeric contextRef="d202310K" name="dei:EntityAddressPostalZipCode"><b>94608</b></ix:nonNumeric></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d202310K" name="dei:CityAreaCode"><b>510</b></ix:nonNumeric>)</b>&#xa0;<ix:nonNumeric contextRef="d202310K" name="dei:LocalPhoneNumber"><b>899-8800</b></ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address, including zip code, and telephone number,</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">including area code, of registrant&#8217;s principal executive offices)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Justin M. Hall, Esq.</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Chief Executive Officer and General Counsel</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2000 Powell Street, Suite 1150</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Emeryville, CA 94608</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(510) 899-8800</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Name, address, including zip code, and telephone number,</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">including area code, of agent for service)</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Copy to:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Abby E. Brown, Esq.</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Squire Patton Boggs (US) LLP</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2550 M Street, NW</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, DC 20037</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(202) 457-6000</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Approximate date of commencement of proposed sale to the public</b>: From time to time after the effective date of this Registration Statement.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. &#9746;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:9.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Large Accelerated Filer</div>
			</td>
			<td style="vertical-align:middle;width:9.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</div>
			</td>
			<td style="vertical-align:middle;width:9.3%;">&#xa0;</td>
			<td style="vertical-align:middle;width:9.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accelerated Filer</div>
			</td>
			<td style="vertical-align:middle;width:9.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:9.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d202310K" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-Accelerated Filer</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:9.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9746;</div>
			</td>
			<td style="vertical-align:middle;width:9.3%;">&#xa0;</td>
			<td style="vertical-align:middle;width:9.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Smaller Reporting Company</div>
			</td>
			<td style="vertical-align:middle;width:9.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d202310K" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:9.3%;">&#xa0;</td>
			<td style="vertical-align:middle;width:9.3%;">&#xa0;</td>
			<td style="vertical-align:middle;width:9.3%;">&#xa0;</td>
			<td style="vertical-align:middle;width:9.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Emerging Growth Company</div>
			</td>
			<td style="vertical-align:middle;width:9.3%;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d202310K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. &#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with section 8(A) of the Securities Act or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said section 8(A), may determine.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="color:#ff0000;">The information in this prospectus is not complete and may be changed. The selling stockholders named in this prospectus may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</span></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><span style="color:#ff0000;">SUBJECT TO COMPLETION, DATED MAY 31, 2023</span></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>PROSPECTUS</b></div>

<div style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="nby20230525_s1img001.jpg" src="nby20230525_s1img001.jpg" style="width:308;height:69;" /></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>7,615,392 Shares of Common Stock</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This prospectus relates to the resale, from time to time, by the selling stockholders identified in the section of this prospectus entitled &#8220;Selling Stockholders&#8221; (the &#8220;<b><i>Selling Stockholders</i></b>&#8221;) of up to 7,615,392 shares (the &#8220;<b><i>Shares</i></b>&#8221;) of NovaBay Pharmaceuticals, Inc.&#8217;s (&#8220;<b><i>us</i></b>&#8221;, &#8220;<b><i>we</i></b>&#8221;, &#8220;<b><i>our</i></b>&#8221;, &#8220;<b><i>NovaBay</i></b>&#8221;, or the &#8220;<b><i>Company</i></b>&#8221;) common stock, par value $0.01 per share (the &#8220;<b><i>Common</i></b>&#xa0;<b><i>Stock</i></b>&#8221;), issuable upon: (i) conversion of our Original Issue Discount Senior Secured Convertible Debentures Due November 1, 2024 (the &#8220;<b><i>Debentures</i></b>&#8221;), (ii) the exercise of our outstanding long-term Series B-1 warrants to purchase Common Stock exercisable for a five-year period (&#8220;<b><i>Long-Term Warrants</i></b>&#8221;), and (iii) the exercise of our outstanding short-term Series B-2 warrants to purchase Common Stock exercisable for a two-year period (&#8220;<b><i>Short-Term Warrants</i></b>&#8221; and, together with the Long-Term Warrants, the &#8220;<b><i>2023 Warrants</i></b>&#8221;). The Debentures and the 2023 Warrants are collectively referred to herein as the &#8220;<b><i>2023 Securities</i></b>&#8221;.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The 2023 Securities were originally sold to accredited investors in a private placement offering that was consummated on May&#xa0;1, 2023 (the &#8220;<b><i>2023 Private Placement</i></b>&#8221;), pursuant to a Securities Purchase Agreement, dated April 27, 2023, by and between the Company and each of the Selling Stockholders (the&#xa0;&#8220;<b><i>2023 Securities Purchase Agreement</i></b>&#8221;). We are registering the resale of the Shares by the Selling Stockholders pursuant to the terms and conditions of the Registration Rights Agreement, dated as of April 27, 2023 (the &#8220;<b><i>2023</i></b>&#xa0;<b><i>Registration Rights Agreement</i></b>&#8221;), which we entered into with the Selling Stockholders in connection with the 2023 Private Placement.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our registration of the Shares covered by this prospectus does not mean that the Selling Stockholders will offer or sell any of the Shares.&#xa0;The Selling Stockholders may sell all or a portion of the additional Shares being offered pursuant to this prospectus at the prevailing market prices at the time of sale or at negotiated prices. For additional information, see the section entitled &#8220;Selling Stockholders&#8221;.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will not receive any proceeds from the sale of the Shares by the Selling Stockholders. However, upon any cash exercise of the 2023 Warrants by the Selling Stockholders, we will receive cash proceeds per share equal to the exercise price of the 2023 Warrants. If the 2023 Warrants are exercised in a cashless exercise, we will not receive any proceeds from the exercise of the 2023 Warrants. The Selling Stockholders will each bear all commissions and discounts, if any, attributable to their respective sales of the Shares. We will bear the costs, expenses and fees in connection with the registration of the Shares.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Common Stock is listed on the NYSE American under the symbol &#8220;NBY.&#8221; The last reported sale price of our Common Stock on May 30, 2023 was $0.65 per share.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">You should read this prospectus, any applicable prospectus supplement and any related free writing prospectus carefully before you invest. <b>Investing in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should carefully consider the risks that we have described under the caption </b>&#8220;<b>Risk Factors</b>&#8221;<b> on page 6 of this prospectus.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The date of this prospectus is &#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;, 2023.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TABLE OF CONTENTS</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:22.5%;">&#xa0;</td>
			<td style="vertical-align:top;width:2.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Page</b></div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">About this Prospectus</div>
			</td>
			<td style="vertical-align:top;width:2.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2</div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Prospectus Summary</div>
			</td>
			<td style="vertical-align:top;width:2.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3</div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Risk Factors</div>
			</td>
			<td style="vertical-align:top;width:2.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">6</div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Special Note Regarding Forward-Looking Statements</div>
			</td>
			<td style="vertical-align: top; width: 2.1%; text-align: center;">7</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Use of Proceeds</div>
			</td>
			<td style="vertical-align: top; width: 2.1%; text-align: center;">8</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Market for our Common Stock</div>
			</td>
			<td style="vertical-align: top; width: 2.1%; text-align: center;">9</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dividend Policy</div>
			</td>
			<td style="vertical-align: top; width: 2.1%; text-align: center;">9</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Principal Stockholders</div>
			</td>
			<td style="vertical-align: top; width: 2.1%; text-align: center;">10</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Description of Capital Stock</div>
			</td>
			<td style="vertical-align: top; width: 2.1%; text-align: center;">12</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Selling Stockholders</div>
			</td>
			<td style="vertical-align: top; width: 2.1%; text-align: center;">19</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plan of Distribution</div>
			</td>
			<td style="vertical-align: top; width: 2.1%; text-align: center;">22</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Legal Matters</div>
			</td>
			<td style="vertical-align: top; width: 2.1%; text-align: center;">23</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Experts</div>
			</td>
			<td style="vertical-align: top; width: 2.1%; text-align: center;">23</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Where You Can Find More Information</div>
			</td>
			<td style="vertical-align: top; width: 2.1%; text-align: center;">23</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:22.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Incorporation of Certain Documents by Reference</div>
			</td>
			<td style="vertical-align: top; width: 2.1%; text-align: center;">23</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ABOUT THIS PROSPECTUS</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This prospectus is part of a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (the &#8220;<b><i>SEC</i></b>&#8221;), using a &#8220;shelf&#8221; registration process. By using a shelf registration statement, the Selling Stockholders may sell up to 7,615,392 shares of Common Stock received upon conversion or exercise (as the case may be) of the Debentures and the 2023 Warrants, from time to time in one or more offerings as described in this prospectus. We will not receive any proceeds from the sale of the Shares by the Selling Stockholders. However, upon any cash exercise of the 2023 Warrants by the Selling Stockholders, we will receive cash proceeds per share equal to the exercise price of the 2023 Warrants. If the 2023 Warrants are exercised in a cashless exercise, we will not receive any proceeds from the exercise of the 2023 Warrants.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We may also file a prospectus supplement or post-effective amendment to the registration statement of which this prospectus forms a part, which may contain material information relating to this offering. The prospectus supplement or post-effective amendment may also add, update or change information contained in this prospectus with respect to the offering. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or post-effective amendment, you should rely on the prospectus supplement or post-effective amendment, as applicable. As permitted by the rules and regulations of the SEC, the registration statement filed by us includes additional information that has been incorporated by reference, including reports we file with the SEC, that are not contained in this prospectus. Before purchasing any securities, you should carefully read this prospectus, any post-effective amendment, and any applicable prospectus supplement, together with the documents incorporated by reference and other additional information that we file with the SEC described in the &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation of Certain Documents by Reference&#8221; sections of this prospectus.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>This prospectus includes important information about us and the securities being offered. You should rely only on this prospectus, any post-effective amendment, and any applicable prospectus supplement, and the information incorporated or deemed to be incorporated by reference in this prospectus. We have not, and the Selling Stockholders have not, authorized anyone to provide you with information that is in addition to, or different from, the information that is contained, or incorporated by reference, in this prospectus prepared by or on behalf of us or to which we have referred you. If anyone provides you with different or inconsistent information, you should not rely on it. We and the Selling Stockholders take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus does not constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The documents entered into in connection with the 2023 Private Placement that are described herein and/or in our filings with the SEC (collectively, the &#8220;<b><i>Transaction Documents</i></b>&#8221;) contain representations and warranties of the parties to such agreements that may be subject to limitations, qualifications or exceptions agreed upon by the parties, and may be subject to a contractual standard of materiality that differs from the materiality standard that applies to reports and documents filed with the SEC. In particular, in your review of the representations and warranties contained in the Transaction Documents and described in the foregoing summary, it is important to bear in mind that the representations and warranties were negotiated in connection with separate transactions and with the principal purpose of allocating contractual risk between the parties in such transactions. The representations and warranties, other provisions of the Transaction Documents or any description of these provisions should not be read alone, but instead should be read only in conjunction with the information provided elsewhere in this prospectus, any post-effective amendment and any applicable prospectus supplement, as well as in the other reports, statements and filings that the Company publicly files with the SEC.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This prospectus contains market data and industry statistics and forecasts that are based on our internal estimates and independent industry publications and other sources that we believe to be reliable sources. In some cases, we do not expressly refer to the sources from which this data is derived. Industry publications and third-party research, surveys and studies generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. Our internal estimates are based upon information obtained from trade and business organizations and other contacts in the industry in which we operate, and our management&#8217;s understanding of industry conditions. While we believe our internal estimates are reliable, they has not been verified by an independent source. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. We are responsible for all of the disclosure contained in this prospectus, and we believe these industry publications and third-party research, surveys and studies are reliable. While we are not aware of any misstatements regarding any third-party information presented in this prospectus, their estimates, in particular, as they relate to projections, involve numerous assumptions, are subject to risks and uncertainties, and are subject to change based on various factors, including those discussed under the section entitled &#8220;Risk Factors&#8221; and elsewhere in this prospectus or otherwise incorporated by reference into this prospectus.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Unless otherwise specifically indicated, references to &#8220;prospectus&#8221; herein shall include any post-effective amendment, applicable prospectus supplement, and the information incorporation or deemed to be incorporated by reference in this prospectus. This prospectus contains summaries of certain provisions contained in some of the documents described herein or therein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, and you may obtain copies of those documents as described below under the section entitled &#8220;Where You Can Find More Information.&#8221;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On November 15, 2022, we effected a 1-for-35 reverse stock split of our outstanding Common Stock (the &#8220;<b><i>Reverse Stock Split</i></b>&#8221;) as more fully described in the prospectus. Unless the context indicates or otherwise requires, all share numbers and share price data included in this prospectus have been adjusted to give effect to the Reverse Stock Split.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This prospectus includes trademarks, service marks and trade names owned by us, our subsidiary DERMAdoctor, LLC, or other companies. All trademarks, service marks and trade names included or incorporated by reference into this prospectus are the property of their respective owners.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Unless the context indicates otherwise in this prospectus, the terms &#8220;NovaBay,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221; in this prospectus refer to NovaBay Pharmaceuticals, Inc.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
2

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PROSPECTUS SUMMARY</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>This summary highlights, and is qualified in its entirety by, the selected information contained elsewhere in this prospectus or incorporated by reference in this prospectus. This summary does not contain all of the information that may be important to you or that you need to consider in making your investment decision. You should carefully read the entire prospectus, including any applicable prospectus supplement, especially the </i>&#8220;<i>Risk Factors</i>&#8221;<i> section beginning on page 6 of this prospectus and the risks under similar headings in other documents and filings that are incorporated by referenced into this prospectus, our financial statements, the exhibits to the registration statement of which this prospectus forms a part and other information incorporated by reference in this prospectus before deciding to invest in our Common Stock. Each of the risk factors could adversely affect our business, operating results and financial condition, as well as adversely affect the value of an investment in our securities.</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>About NovaBay</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NovaBay develops and sells scientifically-created and clinically proven eyecare, skincare and wound care products.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Eyecare:</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our leading product, Avenova&#174; Antimicrobial Lid and Lash Solution (&#8220;Avenova Spray&#8221;), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is formulated with our proprietary, stable and pure form of hypochlorous acid and is cleared by the U.S. Food and Drug Administration for sale in the United States. Avenova Spray is available direct to consumers primarily through online distribution channels and is also available by prescription and dispensed by eyecare professionals for blepharitis and dry-eye disease. Other eyecare products offered under the Avenova eyecare brand include Novawipes by Avenova, Avenova Lubricant Eye Drops, Avenova Moist Heating Eye Compress, the i-Chek eyelid and eyelash mirror by Avenova, and the Eye Health Support Oral Supplement with MaquiBright.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Skincare:</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Through our subsidiary DERMAdoctor, LLC (&#8220;DERMAdoctor&#8221;), we offer over 30 dermatologist-developed products targeting common skin concerns, ranging from aging and blemishes to dry skin, perspiration and keratosis pilaris. DERMAdoctor branded products are marketed and sold through the DERMAdoctor website, well-known traditional and digital beauty retailers, and a network of international distributors. We acquired DERMAdoctor in November 2021, and since completing the DERMAdoctor Acquisition we have been working to integrate and expand the DERMAdoctor business in order to achieve strategic objectives that we expected by completing this acquisition, including revenue growth, cost reductions and achieving overall profitability. We did not achieve these objectives in fiscal 2022, as DERMAdoctor&#8217;s product revenue declined in 2022 compared to 2021, while operating costs relating to these products remained substantially the same. We are working to achieve our overall objectives, as well as continuing to evaluate additional strategies for our Company and its business to address our capital and liquidity needs.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Wound Care:</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We also manufacture and sell our proprietary form of hypochlorous acid for the wound care market through our NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers and other injuries. We currently sell these products through distributors.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>The 2023 Private Placement and the Shares</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On&#xa0;April 27, 2023<i>,</i>&#xa0;we entered into the 2023 Securities Purchase Agreement with each of the Selling Stockholders that provided for the issuance and sale of: (i) $3.3 million aggregate principal amount of the Debentures that&#xa0;may&#xa0;be converted or redeemed into up to an aggregate of&#xa0;2,538,464&#xa0;shares of Common Stock (the &#8220;<b><i>Conversion Shares</i></b>&#8221;), (ii) the new Long-Term Warrants exercisable for up to an aggregate of&#xa0;2,538,464&#xa0;shares of Common Stock for a five year period (the &#8220;<b><i>Long-Term Warrant Shares</i></b>&#8221;), and (iii) the new Short-Term Warrants exercisable for up to an aggregate of&#xa0;2,538,464&#xa0;shares of Common Stock for a&#xa0;two&#xa0;year period (the &#8220;<b><i>Short-Term Warrant Shares</i></b>&#8221;, and together with the Long-Term Warrants, the &#8220;<b><i>Warrant Shares</i></b>&#8221;). The&#xa0;2023&#xa0;Private Placement closed on&#xa0;May 1, 2023<i> (</i>the &#8220;<b><i>2023 Private Placement Closing</i></b>&#8221;) and we received gross proceeds of $3.0&#xa0;million, before deducting placement agent fees and other offering expenses.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Since the Common Stock is currently listed on the NYSE American and due to the number of shares of Common Stock that&#xa0;may&#xa0;be issued upon conversion or redemption of the Debentures and the exercise of the&#xa0;2023&#xa0;Warrants, we are required to comply with the continued listing rules of the NYSE American Company Guide, and among these requirements are Section 713(a) and (b) of the NYSE American Company Guide (the &#8220;<b><i>Stockholder Approval</i></b>&#8221;). Section 713(a) of the NYSE American Company Guide requires stockholder approval in connection with a private transaction involving the sale, issuance, or potential issuance, of common stock or securities convertible into common stock, equal to 20.0% or more of presently outstanding stock for less than the greater of book or market value. Section 713(b) of the NYSE American Company Guide requires stockholder approval of a private transaction involving the sale, issuance or potential issuance by an issuer of common stock (or securities convertible into or exercisable for common stock) when the issuance or potential issuance of additional shares may result in a change of control of the issuer. Pursuant to the 2023 Purchase Agreement, we are required to promptly hold a meeting of stockholders within sixty (60) days following the 2023 Private Placement Closing to seek the Stockholder Approval. To the extent that the Stockholder Approval is not obtained, then the Company will be required to call a meeting of stockholders every two (2) months until Stockholder Approval is obtained or until the Debentures are no longer outstanding. The Company is seeking Stockholder Approval at its 2023 Annual Meeting of Stockholders. Until the Stockholder Approval is obtained, the conversion of the Debentures by the holders into shares of Common Stock is currently limited to a holder&#8217;s pro rata share of 19.99% of our Common Stock, or into an aggregate of 438,669 shares of Common Stock (the &#8220;<b><i>Issuable</i></b> <b><i>Maximum</i></b>&#8221;).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
3
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In connection with the 2023 Private Placement Closing, Common Stock purchase warrants that the Company previously issued to the Selling Stockholders and to other existing investors in prior private placements and warrant reprice transactions were amended to lower the exercise price of the previously issued warrants exercisable for an aggregate of 1,647,310 shares of Common Stock from $6.30 to $1.50 per share. The underlying shares of Common Stock that are issuable upon exercise for these previously issued Common Stock purchase warrants are not being offered by this prospectus. See &#8220;Description of Capital Stock &#8212; Common Stock Warrants.&#8221;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>The Debentures</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Debentures issued in the 2023 Private Placement have a term of 18 months from the date of the 2023 Private Placement Closing with a maturity date of November 1, 2024. The Debentures were issued at a 10% discount to the Selling Stockholders in the 2023 Private Placement, which resulted in us receiving in gross proceeds of $3.0 million.</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Debentures are convertible by the holder, in whole or in part, into the Conversion Shares at a conversion price equal to $1.30 per share (&#8220;<b><i>Conversion Price</i></b>&#8221;), subject to limitations upon conversion, including until such time as the Stockholder Approval is obtained by the Company. As of the date of this prospectus, the aggregate number of Conversion Shares is 2,538,464 shares of Common Stock, which number of shares will be subject to reduction for conversions and redemptions of the Debentures, as well as customary antidilution adjustments. Until Stockholder Approval occurs, the holders of the Debentures may convert their Debentures only up to their pro rata share of the Issuable Maximum. The Debentures are subject to another limitation upon conversion into shares of Common Stock to the extent that, after giving effect to such conversion, the holder of a Debenture (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates), would beneficially own in excess of 4.99% or 9.99% of the outstanding Common Stock.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under the terms of the Debentures, we are required to make a monthly redemption of the Debentures (&#8220;<b><i>Monthly Redemption</i></b>&#8221;) beginning on&#xa0;June 1, 2023&#xa0;equal to&#xa0;1/18<sup style="vertical-align:top;line-height:120%;">th</sup>&#xa0;of the Aggregate Principal Amount multiplied by&#xa0;1.10&#xa0;in cash; or, as provided in the Debenture, in shares of Common Stock at our election with a conversion rate equal to the lower of (i) the Conversion Price or (ii)&#xa0;90% of the average volume-weighted average price of our Common Stock over&#xa0;ten (10)&#xa0;trading days.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Additionally, under the terms of the Debentures, our Company and our subsidiaries are subject to financial and other restrictive covenants for as long as any portion of the Debentures remain outstanding, unless the holders of at least 67% of the then outstanding principal amount of the Debentures shall have otherwise given prior written consent. If any event of default occurs as provided for in the Debentures, the outstanding principal amount of the Debentures, plus accrued but unpaid interest, liquidated damages and other amounts owing in respect thereof through the date of acceleration, shall become, at the holder&#8217;s election, immediately due and payable in cash. Commencing&#xa0;five&#xa0;(5) days after the occurrence of any event of default that results in the eventual acceleration of the Debentures, the interest rate on the Debentures shall accrue at an interest rate equal to the lesser of&#xa0;18% per annum and the maximum rate permitted under applicable law.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Debentures are secured obligations of our Company and DERMAdoctor pursuant to the terms of the Security Agreement, dated&#xa0;April 27, 2023<i> (</i>the &#8220;<b><i>Security Agreement</i></b>&#8221;). Under the terms of the Security Agreement, the holders of the Debentures were granted a security interest, a lien upon and a right of set-off against all of our Company&#8217;s and DERMAdoctor&#8217;s assets as collateral security for the complete, timely payment, performance and discharge of the obligations under the Debentures. To further secure our obligations under the Debentures, DERMAdoctor also executed a Subsidiary Guarantee, pursuant to which DERMAdoctor is a guarantor of the Company&#8217;s obligations owed to the Debenture holders.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>The 2023 Warrants</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The 2023 Warrants have an exercise price equal to $1.30, subject to customary anti-dilution adjustments as provided in the 2023 Warrants. The 2023 Warrants, however, will not be exercisable into the 5,076,928 Warrant Shares unless and until Stockholder Approval has been obtained by us. After Stockholder Approval is obtained, the Long-Term Warrants will be exercisable for a period of five (5) years thereafter and the Short-Term Warrants will be exercisable for a period of two (2) years thereafter. The 2023 Warrants prohibit the exercise of such 2023 Warrants to the extent that, after giving effect to such exercise, the holder of such 2023 Warrant (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates), would beneficially own in excess of 4.99% or 9.99% of the outstanding Common Stock. The 2023 Warrants do not have any preemptive rights or a preference upon any liquidation, dissolution or winding-up of the Company.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Registration Rights</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In connection with the 2023 Private Placement, the Company entered into the 2023 Registration Rights Agreement with the Selling Stockholders&#xa0;to register the Conversion Shares and the Warrant Shares. Accordingly, we are registering the offer and sale of the Shares by the Selling Stockholders pursuant to the terms and conditions of the 2023 Registration Rights Agreement. For additional information regarding the 2023 Registration Rights Agreement, see &#8220;Description of Capital Stock&#8221; in this prospectus.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
4
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will not receive any proceeds from the sale of the Shares by the Selling Stockholders. However, upon any cash exercise of the 2023 Warrants by the Selling Stockholders, we will receive cash proceeds per share equal to the exercise price of the 2023 Warrants. If the 2023 Warrants are exercised in a cashless exercise, we will not receive any proceeds from the exercise of the 2023 Warrants. We will bear the costs, expenses and fees in connection with the registration of the Shares. The Selling Stockholders will each bear all commissions and discounts, if any, attributable to their respective sales of the Shares. For additional information, see the section entitled &#8220;Plan of Distribution&#8221;.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Recent Developments</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Financial Outlook</i></b>&#8212;<b><i>Going Concern</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In our Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, filed with the SEC on May 11, 2023 (the &#8220;<b><i>First</i></b> <b><i>Quarter Form 10-Q</i></b>&#8221;), as well in our previous periodic reports filed with the SEC, we reported, based primarily on the funds available on March 31, 2023 and the 2023 Private Placement, the Company believes that the its existing cash and cash equivalents and cash flows generated from product sales will be sufficient to fund its existing operations and meet its planned operating expenses into at least the second quarter of 2024. We also reported that we sustained operating losses for the majority of our corporate history and expect that our 2023 expenses will exceed our 2023 revenues, as we continue to invest in both Avenova and DERMAdoctor commercialization efforts. Additionally, we expect to continue incurring operating losses and negative cash flows until revenues reach a level sufficient to support ongoing growth and operations. Accordingly, as reported in the First Quarter Form 10-Q, we have determined that our planned operations raise substantial doubt about our ability to continue as a going concern. In addition, we also noted that changing circumstances may cause us to expend cash significantly faster than currently anticipated, and we may need to spend more cash than currently expected because of circumstances beyond our control that impact the broader economy such as periods of inflation, supply chain issues, the continuation of the COVID-19 pandemic and international conflicts.<b> </b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Anti-Dilution Adjustment to Series B Preferred Stock and the Series C Preferred Stock</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Certificate of Designation of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock (the&#xa0;&#8220;<b><i>Series B Certificate of Designation</i></b>&#8221;) and the Certificate of Designation of Preferences, Rights and Limitations of Series C Non-Voting Convertible Preferred Stock (the&#xa0;&#8220;<b><i>Series C Certificate of Designation</i></b>&#8221;) provides for anti-dilution protections in the event that the Company grants any right to reprice any Company security or issue a new Company security that would entitle the holder to acquire Common Stock at an effective price per share that is lower than the conversion price of the Series B Non-Voting Convertible Preferred Stock, par value $0.01 per share (&#8220;<b><i>Series B Preferred Stock</i></b>&#8221;) and the Series C Non-Voting Convertible Preferred Stock, par value $0.01 per share (&#8220;<b><i>Series C Preferred Stock</i></b>&#8221;), which is referred to as &#8220;full-ratchet&#8221; anti-dilution protection. As a result of the issuance of the Debentures at the Conversion Price of $1.30 and the 2023 Warrants having an exercise price at $1.30 per share, such anti-dilution protections were triggered resulting in the conversion price of each share of Series B Preferred Stock and Series C Preferred Stock, which were both convertible at a conversion price of $6.30 into 159 shares of Common Stock, being automatically adjusted downward to now be convertible at a conversion price of $1.30 into 770 shares of Common Stock. As a result of this conversion price adjustment, an additional 7,863,570 shares of Common Stock are issuable upon conversion of the outstanding Series B Preferred Stock and Series C Preferred Stock.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Additional Information</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:9pt;">For additional information related to and a more complete description of our business and operations, financial condition, results of operations and other important information about our Company, including the recent developments, please refer to the reports and other filings incorporated by reference in this prospectus, including our most recent Annual Report on Form 10-K for the year ended December 31, 2022 (the &#8220;<i><b>Annual Report</b></i>&#8221;), the First Quarter Form 10-Q and our other Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K, as described in this prospectus under the caption &#8220;Incorporation of Certain Documents by Reference&#8221;.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Company Information</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NovaBay was incorporated under the laws of the State of California on January 19, 2000, as NovaCal Pharmaceuticals, Inc. It had no operations until July 1, 2002, on which date it acquired all of the operating assets of NovaCal Pharmaceuticals, LLC, a California limited liability company. In February 2007, it changed its name from NovaCal Pharmaceuticals, Inc. to NovaBay Pharmaceuticals, Inc. In June 2010, the Company changed the state in which it was incorporated and is now incorporated under the laws of the State of Delaware.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our corporate address is 2000 Powell Street, Suite 1150, Emeryville, California 94608, and our telephone number is (510) 899-8800. Our website address is www.novabay.com. Information found on, or accessible through, our website is not a part of, and is not incorporated into, this prospectus, and you should not consider it part of this prospectus. Our website address is included in this document as an inactive textual reference only.</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
5

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>RISK FACTORS</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Investing in our Common Stock involves a high degree of risk. You should consider carefully the risk factors described below, and all other information and documents contained in or incorporated by reference in this prospectus (as supplemented and amended), including the risks described under the caption &#8220;Risk Factors&#8221; in the Annual Report the First Quarter Form 10-Q and any future Quarterly Reports on Form 10-Q and other filings that we make with the SEC, including those incorporated by reference herein, before deciding whether to buy our Common Stock. The risks described in this prospectus or incorporated by reference into this prospectus are not the only ones we face, but those that we consider to be material. Additional risks not presently known to us or that we currently believe are immaterial may also significantly impair our business operations and could result in a complete loss of your investment. Past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results or trends in future periods. If any of the following risks actually occur, our business, financial condition, results of operations or cash flow could be seriously harmed. This could cause the market price of our Common Stock to decline, and you could lose all or part of your investment. Please also read carefully the section below entitled &#8220;Special Note Regarding Forward-Looking Statements.&#8221;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
6

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This prospectus and the documents we have filed with the SEC that are incorporated by reference contain &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;<b><i>Securities Act</i></b>&#8221;), and Section 21E of the Securities Exchange Act of 1934 (the &#8220;<b><i>Exchange Act</i></b>&#8221;), including, but not limited to, statements that are based upon management&#8217;s current expectations, assumptions, estimates, projections and beliefs, including statements about the commercial progress and future financial performance of the Company. These statements relate to future events or to our future operating or financial performance and involve risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The use of words such as, but not limited to, &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; or &#8220;would&#8221; and similar words or expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding our ability to comply with the continued listing standards of the NYSE American, the financial and business impact and effect of our recent financing transactions, and any future revenue that may result from selling the Company&#8217;s products, as well as the Company&#8217;s expected future financial results and ability to continue as a going concern. These statements involve risks, uncertainties and other factors that may cause actual results or achievements to be materially different and adverse from those expressed in or implied by these forward-looking statements.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We discuss in greater detail many of these risks under the heading &#8220;Risk Factors&#8221; contained in this prospectus or otherwise described in our filings with the SEC, including our Annual Report on Form 10-K, in our subsequently filed Quarterly Reports on Form 10-Q, as well as any amendments thereto reflected in subsequent filings with the SEC, which are incorporated by reference into this prospectus in their entirety. Also, these forward-looking statements represent our estimates and assumptions only as of the date of the document containing the applicable statement. Unless required by law, we undertake no obligation to update or revise any forward-looking statements to reflect new information or future events or developments. Thus, you should not assume that our silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. You should read this prospectus together with the documents we have filed with the SEC that are incorporated by reference completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of the forward-looking statements in the foregoing documents by these cautionary statements.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
7

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>USE OF PROCEEDS</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will not receive any proceeds from the sale of the Shares by the Selling Stockholders. However, upon any cash exercise of the 2023 Warrants by the Selling Stockholders, we will receive cash proceeds per share equal to the exercise price of the 2023 Warrants. If the 2023 Warrants are exercised in a cashless exercise, we will not receive any proceeds from the exercise of the 2023 Warrants. We will bear the costs, expenses and fees in connection with the registration of the Shares. The Selling Stockholders will each bear all commissions and discounts, if any, attributable to their respective sales of the Shares.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
8

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>MARKET FOR OUR COMMON STOCK</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Market Information</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Common Stock is listed on the NYSE American, under the symbol &#8220;NBY.&#8221;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Holders</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">As of May 24, 2023, we had 4,209,534 shares of Common Stock outstanding and there were approximately 116 holders of record of our Common Stock. This figure does not reflect persons or entities that hold their stock in nominee or &#8220;street&#8221; name through various brokerage firms. As of May 24, 2023, we have 9,156 shares of Series B Preferred Stock that are outstanding and were issued in a private placement offering that was consummated on November 2, 2021 (the &#8220;<b><i>2021 Private Placement</i></b>&#8221;), 1,097 shares of Series C Preferred Stock that are outstanding and were issued in a private placement offering that was consummated on November 18, 2022 (the &#8220;<b><i>2022 Private Placement</i></b>&#8221;), and no other preferred stock outstanding as of the date of this prospectus.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DIVIDEND POLICY</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have not paid cash dividends on our Common Stock since our inception. We currently expect to retain earnings primarily for use in the operation and expansion of our business; therefore, we do not anticipate paying any cash dividends in the foreseeable future. Any future determination to pay cash dividends will be at the discretion of our Board of Directors and will be dependent upon our financial condition, results of operations, capital requirements, restrictions under any existing indebtedness and other factors the Board of Directors deems relevant.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
9

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PRINCIPAL STOCKHOLDERS</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table indicates information as of May 24, 2023 regarding the beneficial ownership of our Common Stock by:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">each person who is known by us to beneficially own more than five percent (5%) of our securities;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">our current executive officers;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">each of our directors; and</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">all of our directors and executive officers as a group.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The percentage of shares beneficially owned is based on 4,209,534 shares of Common Stock outstanding as of May 24, 2023. Except as indicated in the footnotes to this table, and as affected by applicable community property laws, all persons listed have sole voting and investment power for all shares shown as beneficially owned by them and no shares are pledged.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 32.4%; border-top: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name and Address of Beneficial Owner (1)</b></div>
			</td>
			<td colspan="1" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; text-align: center; border-top: 1px solid rgb(0, 0, 0);"><b>Number of</b><br />
			<b>Shares</b><br />
			<b>Beneficially</b><br />
			<b>Owned</b></td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; text-align: center; border-top: 1px solid rgb(0, 0, 0);"><b>Percent</b><br />
			<b>of Class</b></td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Beneficial Owners Holding More Than 5%</div>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Hudson Bay Master Fund Ltd. (2)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">225,909</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">5.1%</div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">c/o Hudson Bay Capital Management LP</div>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">28 Havemeyer Place, 2nd Floor</div>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Greenwich, CT 06830</div>
			</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Armistice Capital, LLC (3)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">191,826</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">4.6%</div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">510 Madison Avenue, 7th Floor</div>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">New York, New York 10022</div>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pioneer Pharma (Hong Kong) Company Ltd. (&#8220;<b><i>Pioneer Hong Kong</i></b>&#8221;) (4)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">148,241</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">3.5%</div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">682 Castle Peak Road</div>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Lai Chi Kok, Kowloon, Hong Kong</div>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline;">Executive Officers and Directors</span></div>
			</td>
			<td style="vertical-align: bottom; width: auto; text-align: center;">&#xa0;</td>
			<td style="vertical-align:bottom;width:auto;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Justin M. Hall, Esq. (5)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">17,193</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">*</div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tommy Law (6)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">599</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">*</div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Audrey Kunin, M.D. (7)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2,143</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">*</div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jeff Kunin, M.D. (8)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2,143</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">*</div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Paul E. Freiman, Ph.D. (9)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">5,182</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">*</div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Julie Garlikov (10)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">858</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">*</div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Swan Sit (11)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2,288</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">*</div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mijia (Bob) Wu, M.B.A. (12)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">3,296</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">*</div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Yenyou (Jeff) Zheng, Ph.D. (13)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">2,288</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">*</div>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Yongxiang (Sean) Zheng (14)</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">858</div>
			</td>
			<td style="vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">*</div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">All directors and executive officers as a group (10 persons)</div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">34,705</div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">*</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="text-align: left; height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 3pt auto 3pt 0" />
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">*</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Less than one percent (1%).</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
10
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The address for each director and officer of NovaBay listed is c/o NovaBay Pharmaceuticals, Inc., 2000 Powell Street, Suite 1150, Emeryville, CA 94608. Number of shares beneficially owned and percent of class is calculated in accordance with SEC rules. A beneficial owner is deemed to beneficially own shares the beneficial owner has the right to acquire within 60 days of May 24, 2023. For purposes of calculating the percent of class held by a single beneficial owner, the shares that such beneficial owner has the right to acquire within 60 days of May 24, 2023 are also deemed to be outstanding; however, such shares are not deemed to be outstanding for purposes of calculating the percentage ownership of any other beneficial owner.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(2)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Based upon information contained in Amendment No. 1 to the Schedule 13G filed by Hudson Bay Capital Management LP and Sander Gerber with the SEC on February 10, 2023, Hudson Bay Capital Management LP beneficially owned 225,909 shares of Common Stock issuable upon the exercise of certain warrants and/or conversion of shares of convertible preferred stock as of December 31, 2022, with shared voting and dispositive power of all shares and sole voting and dispositive power of no shares.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(3)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Based upon information contained in the Schedule 13G filed by Armistice Capital, LLC and Steven Boyd with the SEC on February 14, 2023, Armistice Capital, LLC beneficially owned 191,826 shares of Common Stock as of December 31, 2022, with shared voting and dispositive power of all shares and sole voting and dispositive power of no shares.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(4)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Based upon information contained in the Schedule 13D/A filed by Pioneer Hong Kong and China Pioneer Pharma Holdings Limited, the parent company of Pioneer Hong Kong, with the SEC on January 13, 2017, Pioneer Hong Kong beneficially owned 148,241 shares of Common Stock (as adjusted for the Reverse Stock Split) as of December 9, 2016, with shared voting and dispositive power of all shares and sole voting and dispositive power of no shares.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(5)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (i) 2,377 shares of Common Stock held directly by Mr. Hall and (ii) 14,816 shares issuable upon the exercise of outstanding options which are exercisable as of May 24, 2023 or within 60 days after such date. Does not include 14,286 performance restricted stock units granted to Mr. Hall on May 4, 2021 that will vest based on the achievement of three performance goals at the end of a three-year performance period ending December 31, 2023.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(6)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of 599 shares of Common Stock issuable upon exercise of outstanding options which are exercisable as of May 24, 2023 or within 60 days after such date.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(7)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of 2,143 shares of Common Stock issuable upon exercise of outstanding options which are exercisable as of May 24, 2023 or within 60 days after such date. Does not include 8,572 performance restricted stock units granted to Dr. Audrey Kunin on November 8, 2021 that will vest based on the achievement of three performance goals at the end of a three year performance period ending December 31, 2023.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(8)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of 2,143 shares of Common Stock issuable upon exercise of outstanding options which are held by Dr. Jeff Kunin&#8217;s spouse, Dr. Audrey Kunin, and exercisable as of May 24, 2023 or within 60 days after such date.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(9)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (i) 67 shares of Common Stock held by the Paul Freiman and Anna Mazzuchi Freiman Trust, of which Dr. Freiman and his spouse are trustees (with sole voting power over 18 shares, shared voting power over 31 shares, sole investment power over no shares and shared investment power over 49 shares); (ii) 1,716 shares of Common Stock held directly by Dr. Freiman; and (iii) 3,399 shares of Common Stock issuable upon exercise of outstanding options which are exercisable as of May 24, 2023 or within 60 days after such date.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(10)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of 858 shares of Common Stock held directly by Ms. Garlikov.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(11)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (i) 1,716 shares of Common Stock held directly by Ms. Sit and (ii) 572 shares issuable upon exercise of outstanding options which are exercisable as of May 24, 2023 or within 60 days after such date.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(12)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (i) 1,716 shares of Common Stock held directly by Mr. Wu and (ii) 1,580 shares of Common Stock issuable upon exercise of outstanding options which are exercisable as of May 24, 2023 or within 60 days after such date. As Non-Executive Director of China Pioneer, the parent company of Pioneer Hong Kong, Mr. Wu disclaims beneficial ownership of the shares of the Common Stock held by China Pioneer Pharma and Pioneer Hong Kong.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(13)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of (i) 1,716 shares of Common Stock held directly by Dr. Jeff Zheng and (ii) 572 shares of Common Stock issuable upon exercise of outstanding options which are exercisable as of May 24, 2023 or within 60 days after such date.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(14)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of 858 shares of Common Stock held directly by Mr. Sean Zheng.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
11
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DESCRIPTION OF CAPITAL STOCK</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Overview</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Our authorized capital stock currently consists of 150,000,000 shares of Common Stock with a $0.01 par value per share, and 5,000,000 shares of preferred stock with a $0.01 par value per share. A description of material terms and provisions of the Amended and Restated Certificate of Incorporation, as amended (&#8220;<b><i>Certificate of Incorporation</i></b>&#8221;) and our Bylaws, as amended and restated (&#8220;<b><i>Bylaws</i></b>&#8221;), affecting the rights of holders of the Company&#8217;s capital stock is set forth below. The description is intended as a summary, and is qualified in its entirety by reference to the Certificate of Incorporation and the Bylaws, which are available in our filings with the SEC. As of May&#xa0;24, 2023, there were (i) 4,209,534 shares of Common Stock outstanding; (ii) of the 15,000 shares of Series B Preferred Stock initially issued in the 2021 Private Placement, there are 9,156&#xa0;shares of Series B Preferred Stock that have not been converted and are outstanding; and (iii) of the 3,250 shares of Series C Preferred Stock initially issued in the 2022 Private Placement, there are 1,097&#xa0;shares of Series C Preferred Stock that have not been converted and remain outstanding.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">On November 15, 2022, we effected the Reverse Stock Split. The Reverse Stock Split resulted in combining every thirty-five (35) shares of Common Stock outstanding or held in treasury into one (1) share of Common Stock. The Reverse Stock Split did not reduce the number of authorized shares of Common Stock or authorized shares of preferred stock or change the par values of our Common Stock or preferred stock, both of which remain at&#xa0;$0.01&#xa0;per share. The Company did not issue fractional shares of Common Stock and instead issued an additional whole share of Common Stock to all holders that would otherwise have received a fractional share. Except for adjustments resulting from the treatment of fractional shares, each stockholder continued to hold the same percentage of our outstanding Common Stock immediately following the Reverse Stock Split becoming effective as such stockholder held immediately prior to the Reverse Stock Split.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Common Stock</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i>Dividend rights</i>. Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of our Common Stock are entitled to receive dividends out of funds legally available if the Board of Directors, in its discretion, determines to issue dividends and then only at the times and in the amounts that the Board of Directors may determine.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i>Voting rights</i>. Each holder of Common Stock is entitled to one vote for each share of Common Stock held on all matters submitted to a vote of stockholders. Our Certificate of Incorporation does not provide for the right of stockholders to cumulate votes for the election of directors. Our Certificate of Incorporation establishes a classified Board of Directors, divided into three classes with staggered three-year terms. Only one class of directors is elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i>No preemptive or similar rights</i>. Our Common Stock is not entitled to preemptive rights and is not subject to conversion, redemption or sinking fund provisions. The rights, preferences and privileges of the holders of our Common Stock are subject to, and may be adversely affected by, the rights of the holders of any series of our preferred stock that NovaBay may designate and issue in the future.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><i>Right to receive liquidation distributions</i>. Upon our dissolution, liquidation or winding-up, the assets legally available for distribution to holders of our Common Stock are distributable ratably among the holders of our Common Stock, subject to prior satisfaction of all outstanding debt and liabilities and the preferential or pari passu rights and payment of liquidation preferences, if any, on any outstanding shares of our preferred stock, including the Series B Preferred Stock and the Series C Preferred Stock.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The rights of the holders of Common Stock are subject to, and may be adversely affected by, the rights of holders of shares of the Series B Preferred Stock and the Series C Preferred Stock, as described below, and any other preferred stock that we may designate and issue in the future.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b>Preferred Stock</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Under the terms of the Certificate of Incorporation, the Board of Directors is authorized to issue up to 5,000,000 shares of preferred stock in one or more series without stockholder approval. Other than the Series B Preferred Stock and the Series C Preferred Stock, we do not currently have any shares of preferred stock issued and outstanding.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Our Certificate of Incorporation authorized the Board of Directors, subject to limitations prescribed by Delaware law, to issue preferred stock in one or more series, to establish from time to time the number of shares to be included in each series and to fix the designation, powers, preferences and rights of the shares of each series and any of its qualifications, limitations or restrictions. The Board of Directors can also increase or decrease the number of shares of any series, but not below the number of shares of that series then outstanding, without any further vote or action by our stockholders. The Board of Directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of the Common Stock. The issuance of preferred stock, while providing flexibility in connection with financings, possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring, discouraging or preventing a change in control of the Company, may adversely affect the market price of our Common Stock and the voting and other rights of the holders of Common Stock, and may reduce the likelihood that stockholders will receive dividend payments and payments upon liquidation.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
12
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Series B Non-Voting Convertible Preferred Stock</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On November 2, 2021, we closed the 2021 Private Placement and we issued and sold 15,000 shares of the Series B Preferred Stock, all of which were convertible into shares of Common Stock at the election of the holders of the Series B Preferred Stock, subject to the beneficial ownership limitation described below. Of the 15,000 shares of Series B Preferred Stock originally issued and sold in the 2021 Private Placement, 9,156 shares of Series B Preferred Stock have not been converted and remain outstanding. In accordance with the Series B Certificate of Designation, the stated value of each share of the Series B Preferred Stock is $1,000 with a current per share conversion price of $1.30 into 770 shares of Common Stock, or an aggregate of 7,050,120 shares of Common Stock upon conversion of all outstanding Series B Preferred Stock.&#xa0;The current conversion price of the Series B Preferred Stock reflects adjustments since its initial issuance as a result of the Reverse Stock Split and the anti-dilution adjustments that have occurred pursuant to the Series B Certificate of Designation as a result of (i) the lower conversion price of the Series C Preferred Stock and exercise price of the short-term Series A-1 Common Stock purchase warrants and the long-term Series A-2 Common Stock purchase warrants (collectively, the &#8220;<b><i>2022 Warrants</i></b>&#8221;) that were issued in the 2022 Private Placement, which Series C Preferred Stock conversion price and exercise price of the 2022 Warrants were the same as the amended exercise prices of certain previously issued Common Stock purchase warrants and the Reprice Warrants (defined and discussed below) that were issued in connection with the 2022 Warrant Reprice Transaction (as defined and discussed below), and (ii) the lower conversion price of the Debentures and the exercise price of the 2023 Warrants that were issued in the 2023 Private Placement. The following is a summary of the terms of the Series B Preferred Stock, which is qualified in its entirety by the Series B Certificate of Designation that is filed as an exhibit to our Annual Report and which is incorporated into this prospectus by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Rank</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Series B Preferred Stock ranks as to dividends or distributions of assets upon our liquidation, dissolution or winding up, whether voluntarily or involuntarily, as follows:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">on par with our Common Stock and our Series C Preferred Stock;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">senior to any class or series of our capital stock hereafter created specifically ranking by its terms junior to the Series B Preferred Stock; and</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">junior to any class or series of our capital stock hereafter created specifically ranking by its terms senior to the Series B Preferred Stock.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Conversion Limitation</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Series B Preferred Stock is subject to a limitation upon conversion of the Series B Preferred Stock to the extent that, after giving effect to such conversion, the holder of such Series B Preferred Stock (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates), would beneficially own Common Stock in excess of the Beneficial Ownership Limitation (or 4.99% or 9.99% of the outstanding Common Stock) as set forth in the Series B Certificate of Designation. Any holder may increase or decrease such percentage to any other percentage not in excess of 9.99% of the total number of shares of Common Stock then issued and outstanding provided that such increase in percentage shall not be effective until sixty-one days after notice to us.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Liquidation Preference</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the event of our liquidation, dissolution or winding up, holders of Series B Preferred Stock are entitled to receive the same amount as a holder of Common Stock.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Voting Rights</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Shares of Series B Preferred Stock generally have no voting rights, except as required by law and except that the consent of the majority of holders of the outstanding Series B Preferred Stock is required to: (i) alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock or alter or amend the Series B Certificate of Designation, (ii) amend our Certificate of Incorporation or other charter documents in any manner that adversely affects any rights of the holders of Preferred Stock, (iii) increase the number of authorized shares of Preferred Stock, and (iv) enter into any agreement with respect to any of the foregoing.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Dividends</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Holders of Series B Preferred Stock are entitled to receive, and we are required to pay, dividends on shares of the Series B Preferred Stock equal (on an as if converted to Common Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. The Series B Preferred Stock is not entitled to any other dividends.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
13
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Redemption</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We are not obligated to redeem or repurchase any shares of Series B Preferred Stock. Shares of Series B Preferred Stock are not otherwise entitled to any redemption rights, or mandatory sinking fund or analogous fund provisions.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Listing</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There is no established public trading market for the Series B Preferred Stock, and the Series B Preferred Stock has not been listed on any national securities exchange or trading system.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Dilution Protection</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the event we, at any time after the first date of issue of the Series B Preferred Stock and while at least one share of Series B Preferred Stock is outstanding: (i) pays a dividend or otherwise make a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by us upon conversion of the Series B Preferred Stock or any debt securities), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of Common Stock any shares of our capital stock, then, in each case, the conversion price of the Series B Preferred Stock shall be adjusted as provided in the Series B Certificate of Designation. Any adjustment made pursuant to the Series B Certificate of Designation shall become effective immediately after the effective date of the applicable event described in subsections (i) through (iv) above. In addition, in the event that we or any of our subsidiaries, as applicable, at any time while the Series B Preferred Stock is outstanding sells or grants any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other disposition), any Common Stock or any of our securities or any of our subsidiaries which would entitle the holder thereof to acquire at any time Common Stock at an effective price per share that is lower than the then conversion price of the Series B Preferred Stock, then the conversion price of the Series B Preferred Stock will be reduced to such lower price; this protection afforded the holder of the Series B Preferred Stock is referred to as a &#8220;full-ratchet&#8221; anti-dilution protection. This full-ratchet anti-dilution protection is subject to termination as provided in the Series B Certificate of Designation upon the earlier of: (x) our Common Stock achieving an average trading price during any 10 days during a 30-consecutive trading day period that&#xa0;exceeds $35.00 (such dollar amount having been adjusted to reflect the Reverse Stock Split, and which is subject to further adjustment for future stock splits, recapitalizations, stock dividends and other similar adjustments) and the trading volume during such period exceeds $500,000 per trading day; provided that the Initial Series B Registration Statement (as defined below) and the registration statement registering the resale of the Common Stock underlying the warrants issued in the 2021 Private Placement both remain effective during this measurement period; or (y) 75% of the Series B Preferred Stock issued having been converted. The holders of Series B Preferred Stock do not have any preemptive rights as a result of their ownership of Series B Preferred Stock.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Fundamental Transactions</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If, at any time that shares of Series B Preferred Stock were outstanding, we effected a merger, a sale of substantially all assets or engage in another type of change of control transaction, as described in the Series B Certificate of Designation and referred to as a &#8220;Fundamental Transaction&#8221;, then a holder of Series B Preferred Stock would have the right to receive, upon any subsequent conversion of a share of Series B Preferred Stock (in lieu of shares of Common Stock) for each issuable conversion share, the same kind and amount of securities, cash or property as such holder would have been entitled to receive upon the occurrence of such fundamental transaction if such holder had been, immediately prior to such fundamental transaction, the holder of Common Stock. In connection with a Fundamental Transaction, the holders of Series B Preferred Stock may instead receive in exchange for their shares of Series B Preferred Stock a security of the successor entity evidenced by a written instrument substantially similar in form and substance to the Series B Preferred Stock, which is convertible for a corresponding number of shares of capital stock of such successor entity equivalent to the shares of Common Stock upon conversion of the Series B Preferred Stock and with a conversion price consistent with the conversion price of the Series B Preferred Stock then currently in effect. If we are not the surviving entity in any such fundamental transaction, then it shall cause any successor entity to assume in writing all of the obligations of the Company under the Series B Certificate of Designation, the 2021 Securities Purchase Agreement, the Series B Registration Rights Agreement and the 2021 Warrants in accordance with the provisions of the Series B Certificate of Designation.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
14
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Series B Registration Rights Agreement</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In connection with the 2021 Private Placement, we entered into a Registration Rights Agreement, dated October 29, 2021 (the&#xa0;&#8220;<b><i>Series B Registration Rights Agreement</i></b>&#8221;), with investors (the &#8220;<b><i>2021 Purchasers</i></b>&#8221;) that provided for the resale of the shares of Common Stock underlying the Series B Preferred Stock and the shares of Common Stock underlying the Common Stock purchase warrants issued in the 2021 Private Placement (the &#8220;<b><i>2021 Warrants</i></b>&#8221;), which, as a result of our warrant reprice transaction of previously issued Common Stock purchase warrants held by the Selling Stockholders and other warrant holders that was completed on September 9, 2022 (the &#8220;<b><i>2022 Warrant Reprice Transaction</i></b>&#8221;), were amended and repriced and are referred to as the &#8220;<b><i>2021 Amended Warrants</i></b>.&#8221;&#xa0;Pursuant to the terms of the Series B Registration Rights Agreement, we initially registered, on behalf of the 2021 Purchasers, the shares of Common Stock underlying the Series B Preferred Stock for resale on an initial registration statement on Form S-1 (the &#8220;<b><i>Initial Series B Registration Statement</i></b>&#8221;) and also registered for resale on a separate registration statement on Form S-1 the shares of Common stock underlying the 2021 Warrants. We also filed (i) an additional registration statement on Form S-1, on behalf of the 2021 Purchasers, that registered for resale the additional shares of Common Stock that became issuable upon conversion of the Series B Preferred Stock as a result of an anti-dilution adjustment to the conversion price of the Series B Preferred Stock that occurred as a result of the completion of the 2022 Private Placement and the 2022 Warrant Reprice Transaction &#xa0;and (ii) an additional registration statement on Form S-1, on behalf of the 2021 Purchasers, to register for resale the additional shares of Common Stock that became issuable upon conversion of the Series B Preferred Stock as a result of an anti-dilution adjustment to the conversion price of the Series B Preferred Stock that occurred as a result of entering into the transactions contemplated by the 2023 Private Placement, in which we issued the Debentures and the 2023 Warrants at an effective price per share that was lower than the conversion price at such time of the Series B Preferred Stock. The Series B Registration Rights Agreement provides for payment of liquidated damages to the 2021 Purchasers that are a party to the agreement in the event we are not able to perform our obligations with respect to registering the Common Stock. In addition, pursuant to the Series B Registration Rights Agreement, we also agreed, among other things, to indemnify the 2021 Purchasers, their officers, directors, members, employees and agents, successors and assigns under the registration statement from certain liabilities and pay all fees and expenses (excluding any legal fees of the 2021 Purchaser(s), and any underwriting discounts and selling commissions) incident to our obligations under the Series B Registration Rights Agreement. For additional information regarding the Series B Registration Rights Agreement, see a copy of the Series B Registration Rights Agreement that is filed as an exhibit to our Annual Report and is incorporated into this prospectus by reference.&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>Series C Non-Voting Convertible Preferred Stock</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On November 18, 2022, we closed the 2022 Private Placement and issued and sold pursuant to the terms of the Securities Purchase Agreement, dated September 9, 2022 (the&#xa0;&#8220;<b><i>2022 Securities Purchase Agreement</i></b>&#8221;) &#xa0;units consisting of (i) 3,250 shares of Series C Preferred Stock, (ii) short-term Series A-1 warrants to purchase Common Stock (&#8220;<b><i>Series A-2 Short-Term Warrants</i></b>&#8221;), which are exercisable for 515,876 shares of Common Stock and (iii) long-term Series A-2 warrants to purchase Common Stock (&#8220;<b><i>Series A-1 Long-Term Warrants</i></b>&#8221; and, together with the Short-Term Warrants, the &#8220;<b><i>2022 Warrants</i></b>&#8221;), which are exercisable for 515,876 shares of Common Stock. At the time of issuance, all of the Series C Preferred Stock were convertible into shares of Common Stock at the election of the holders of the Series C Preferred Stock, subject to the beneficial ownership limitation described below. Of the 3,250 shares of Series C Preferred Stock originally issued and sold in the 2022 Private Placement, 1,097 of these shares remain outstanding as of the date of this prospectus. In accordance with the Series C Certificate of Designation, the stated value of each share of the Series C Preferred Stock is $1,000 with a current per share conversion price of $1.30 into 770 shares of Common Stock, or an aggregate of 844,690 shares of Common Stock upon conversion of all outstanding Series C Preferred Stock. The current conversion price of the Series C Preferred Stock reflects an anti-dilution adjustment that occurred pursuant to the Series C Certificate of Designation as a result of entering into the transactions contemplated by the 2023 Private Placement, in which we issued the Debentures and the 2023 Warrants at an effective price per share that was lower than the conversion price at such time of the Series C Preferred Stock. The following is a summary of the terms of the Series C Preferred Stock, which is qualified in its entirety by the Series C Certificate of Designation that is filed as an exhibit to our Annual Report and is incorporated into this prospectus by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Rank</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Series C Preferred Stock ranks as to dividends or distributions of assets upon our liquidation, dissolution or winding up, whether voluntarily or involuntarily, as follows:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">on par with our Common Stock and our Series B Preferred Stock;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">senior to any class or series of our capital stock hereafter created specifically ranking by its terms junior to the Series C Preferred Stock; and</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">junior to any class or series of our capital stock hereafter created specifically ranking by its terms senior to the Series C Preferred Stock.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Conversion Limitation</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Series C Preferred Stock is subject to a limitation upon conversion of the Series C Preferred Stock to the extent that, after giving effect to such conversion, the holder of such Series C Preferred Stock (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates), would beneficially own Common Stock in excess of the Beneficial Ownership Limitation (or 4.99% or 9.99% of the outstanding Common Stock) as set forth in the Series C Certificate of Designation. Any holder may increase or decrease such percentage to any other percentage not in excess of 9.99% of the total number of shares of Common Stock then issued and outstanding provided that such increase in percentage shall not be effective until sixty-one days after notice to us.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Liquidation Preference</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the event of our liquidation, dissolution or winding up, holders of Series C Preferred Stock are entitled to receive the same amount as a holder of Common Stock.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Voting Rights</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The holders of shares of the Series C Preferred Stock generally will have no voting rights, except as required by law, and except that the consent of the majority of holders of the outstanding Series C Preferred Stock would be required to: (i) alter or change adversely the powers, preferences or rights given to the Series C Preferred Stock or alter or amend the Series C Certificate of Designation, (ii)&#xa0;amend the Certificate of Incorporation or other charter documents in any manner that adversely affects any rights of the holders of the Series C Preferred Stock, (iii) increase the number of authorized shares of Series C Preferred Stock, and (iv) enter into any agreement with respect to any of the foregoing.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
15
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Dividends</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Holders of the Series C Preferred Stock will be entitled to receive, and the Company will be required to pay, dividends on shares of the Series C Preferred Stock equal (on an as if converted to Common Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. The Series C Preferred Stock will not be entitled to any other dividends.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Dilution Protection</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the event the Company, at any time after the closing date of the 2022 Private Placement and while at least one share of Series C Preferred Stock is outstanding: (i) pays a stock dividend or otherwise make a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon conversion of the Series C Preferred Stock or payment of a dividend on the Series C Preferred Stock); (ii) subdivides outstanding shares of Common Stock into a larger number of shares; (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares; or (iv) issues by reclassification of shares of Common Stock any shares of capital stock of the Company, then in each case the conversion price of the Series C Preferred Stock will be adjusted as provided in the Series C Certificate of Designation. Any adjustment made pursuant to the Series C Certificate of Designation will become effective immediately after the effective date of the applicable event described in subsections (i)&#xa0;through (iv) above. In addition, if the Company at any time while the Series C Preferred Stock is outstanding, but prior to the Ratchet Termination Date (as defined in the Series C Certificate of Designation) sells or grants any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other disposition), any Common Stock or any securities of the Company or any of its subsidiaries that would entitle the holder thereof to acquire Common Stock at an effective price per share that is lower than the then conversion price of the Series C Preferred Stock, then the conversion price of the Series C Preferred Stock will be reduced to such lower price, which is referred to as a &#8220;full-ratchet&#8221; anti-dilution protection. This full-ratchet anti-dilution protection is subject to termination as provided in the Series C Certificate of Designation upon the earlier of: (a) the Common Stock achieving an average trading price of 250% of the conversion price during any 10 days during a 30-consecutive trading day period and (b) 75% of the Series C Preferred Stock issued on the original issue date has been converted. The holders of Series C Preferred Stock will not have any preemptive rights as a result of their ownership of Series C Preferred Stock.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Redemption</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We are not obligated to redeem or repurchase any shares of Series C Preferred Stock. Shares of Series C Preferred Stock are not otherwise entitled to any redemption rights, or mandatory sinking fund or analogous fund provisions.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Listing</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There is no established public trading market for the Series C Preferred Stock, and the Series C Preferred Stock has not been listed on any national securities exchange or trading system.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Fundamental Transactions</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If, at any time that shares of Series C Preferred Stock were outstanding, we effected a merger, a sale of substantially all assets or engage in another type of change of control transaction, as described in the Series C Certificate of Designation and referred to as a &#8220;Fundamental Transaction&#8221;, then a holder of Series C Preferred Stock would have the right to receive, upon any subsequent conversion of a share of Series C Preferred Stock (in lieu of shares of Common Stock) for each issuable conversion share, the same kind and amount of securities, cash or property as such holder would have been entitled to receive upon the occurrence of such fundamental transaction if such holder had been, immediately prior to such fundamental transaction, the holder of Common Stock. In connection with a Fundamental Transaction, the holders of Series C Preferred Stock may instead receive in exchange for their shares of Series C Preferred Stock a security of the successor entity evidenced by a written instrument substantially similar in form and substance to the Series C Preferred Stock, which is convertible for a corresponding number of shares of capital stock of such successor entity equivalent to the shares of Common Stock upon conversion of the Series C Preferred Stock and with a conversion price consistent with the conversion price of the Series C Preferred Stock then currently in effect. If we are not the surviving entity in any such fundamental transaction, then it shall cause any successor entity to assume in writing all of the obligations of the Company under the Series C Certificate of Designation, the 2022 Securities Purchase Agreement, the 2022&#xa0;Warrants and the Series C Registration Rights Agreement in accordance with the provisions of the Series C Certificate of Designation.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Series C Registration Rights Agreement</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In connection with the 2022 Private Placement, we entered into a Registration Rights Agreement, dated November 18, 2022 (the &#8220;<b><i>Series C Registration Rights Agreement</i></b>&#8221;), with investors (the &#8220;<b><i>2022 Purchasers</i></b>&#8221;) that provided for the resale of the shares of Common Stock underlying the Series C Preferred Stock and the 2022 Warrants.&#xa0;Pursuant to the terms of the Series C Registration Rights Agreement, we initially registered, on behalf of the 2022 Purchasers, the shares of Common Stock underlying the Series C Preferred Stock and the 2022 Warrants for resale on an initial registration statement on Form S-1. We also filed an additional registration statement on Form S-1, on behalf of the 2022 Purchasers, to register for resale the additional shares of Common Stock that became issuable upon conversion of the Series C Preferred Stock as a result of an anti-dilution adjustment to the conversion price of the Series C Preferred Stock that occurred as a result of entering into the 2023 Private Placement, in which we issued new securities entitling the holders thereof to acquire Common Stock at an effective price per share that is lower than the conversion price of the Series C Preferred Stock. The Series C Registration Rights Agreement provides for payment of liquidated damages to the 2022 Purchasers that are a party to the agreement in the event we are not able to perform our obligations with respect to registering the Common Stock. In addition, pursuant to the Series C Registration Rights Agreement, we also agreed to, among other things, indemnify the 2022 Purchasers, their officers, directors, members, employees and agents, successors and assigns under the registration statement from certain liabilities and pay all fees and expenses (excluding any legal fees of the 2022 Purchaser(s), and any underwriting discounts and selling commissions) incident to our obligations under the Series C Registration Rights Agreement. For additional information regarding the Series C Registration Rights Agreement, see a copy of the Series C Registration Rights Agreement that is filed as an exhibit to our Annual Report and is incorporated into this prospectus by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
16
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>2023 Securities and the 2023 Private Placement </b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><i>2023 Securities Issued in the 2023 Private Placement</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Debentures</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Debentures issued in the 2023 Private Placement have a term of 18 months from the date of the 2023 Private Placement Closing with a maturity date of November 1, 2024. The Debentures were issued at a 10% discount to the Selling Stockholders in the 2023 Private Placement, which resulted in us receiving in gross proceeds of $3.0 million. The Debentures are secured obligations of our Company and DERMAdoctor pursuant to the terms of the Security Agreement whereby the holders of the Debentures were granted a security interest, a lien upon and a right of set-off against all of our Company&#8217;s and DERMAdoctor&#8217;s assets as collateral security for the complete, timely payment, performance and discharge of the obligations under the Debentures. Additionally, DERMAdoctor executed a Subsidiary Guarantee, pursuant to which DERMAdoctor is a guarantor of the Company&#8217;s obligations owed to the Debenture holders.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The Debentures are convertible by the holder, in whole or in part, into shares of Common Stock at a conversion price equal to $1.30 per share, subject to limitations upon conversion, including until such time as the Stockholder Approval is obtained by the Company. As of the date of this prospectus, the aggregate number of shares of Common Stock issuable upon conversion or redemption of the Debentures is 2,538,464 Conversion Shares, which number of shares will be subject to reduction for conversions and redemptions of the Debentures and to customary antidilution adjustments. Until the Stockholder Approval, the Debenture holders may convert their Debentures only up to their pro rata share of an aggregate of 438,669 shares of Common Stock, which is 19.99% of outstanding shares of Common Stock immediately prior to the 2023 Private Placement Closing. The Debentures are subject to another limitation upon conversion into shares of Common Stock to the extent that, after giving effect to such conversion, the holder of a Debenture (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates), would beneficially own in excess of 4.99% or 9.99% of the outstanding Common Stock. For additional information regarding the conversion, redemption and other terms, conditions and obligations relating to the rights and obligations of the Debentures, see &#8220;Prospectus Summary &#8212; The 2023 Private Placement and the Shares &#8212; The Debentures.&#8221;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>2023 Warrants</i></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The 2023 Warrants have an exercise price equal to $1.30, subject to customary anti-dilution adjustments as provided in the 2023 Warrants. The 2023 Warrants, however, will not be exercisable into Warrant Shares unless and until Stockholder Approval is received. After Stockholder Approval, the Long-Term Warrants will be exercisable for a period of five (5) years thereafter and the Short-Term Warrants will be exercisable for a period of two (2) years thereafter. The 2023 Warrants will be exercisable for an aggregate of 5,076,928 Warrant Shares. The 2023 Warrants prohibit the exercise of such 2023 Warrants to the extent that, after giving effect to such exercise, the holder of such 2023 Warrant (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates), would beneficially own in excess of 4.99% or 9.99% of the outstanding Common Stock. The 2023 Warrants do not have any preemptive rights or a preference upon any liquidation, dissolution or winding-up of the Company.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The 2023 Warrants do not have any preemptive rights or a preference upon any liquidation, dissolution or winding-up of NovaBay.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><i>2023 Registration Rights Agreement </i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In connection with the 2023 Private Placement Closing, the Company entered into the 2023 Registration Rights Agreement with the Selling Stockholders to register the Conversion Shares and the Warrant Shares. Pursuant to the terms of the 2023 Registration Rights Agreement, the Company agreed to file this registration statement with the Commission covering the resale of the Conversion Shares and the Warrant Shares no later than 30 days after the 2023 Private Placement Closing and to use best efforts to have the registration statement declared effective as promptly as practical thereafter, and in any event no later than sixty (60) days (or ninety (90) days in certain circumstances) after the date of the Private Placement Closing. The Company&#8217;s failure to satisfy certain conditions and deadlines described in the 2023 Registration Rights Agreement may subject it to payment of certain liquidated damages.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">For additional information about the terms of the 2023 Securities that we issued in the 2023 Private Placement please see the forms of such securities filed as exhibits to our Annual Report, which &#xa0;are incorporated into this prospectus by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Common Stock Warrants</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><i>2022 Warrant Reprice Transaction and Reprice Warrants</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On September 9, 2022, we completed the 2022 Warrant Reprice Transaction. In connection with this transaction, the Company entered into Reprice Letter Agreements (&#8220;<b><i>Reprice Letter Agreements</i></b>&#8221;) with certain holders of Common Stock purchase warrants that were issued as part of our prior warrant reprice transaction that closed on July 23, 2020 (the &#8220;<b><i>2020 Warrants</i></b>&#8221;) and with all of the holders of the 2021 Warrants. The Reprice Letter Agreements provided for the 2020 Warrants and the 2021 Warrants held by Participants to be amended to reduce their respective exercise price to $6.30 (reflecting the adjustment as a result of our Reverse Stock Split) (the &#8220;<b><i>Reduced Exercise Price</i></b>&#8221;) and, in the case of the 2021 Warrants, extend the term of those warrants until September 11, 2028. The 2020 Warrants and the 2021 Warrants as so amended are referred to as the &#8220;<b><i>2020 Amended Warrants</i></b>&#8221; and the &#8220;<b><i>2021 Amended Warrants</i></b>&#8221;.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">As part of the 2022 Warrant Reprice Transaction and pursuant to the Reprice Letter Agreements, certain participants elected to make a cash exercise of a portion or all of their respective 2021 Amended Warrants and 2020 Amended Warrants (the &#8220;<b><i>Initial Exercise</i></b>&#8221;). In connection with the Initial Exercise, the Company, in a private placement, for those participants that made an Initial Exercise each of them received a newly issued Common Stock purchase warrant that provided for the purchase of a number of shares of Common Stock equal to 100% of the shares of Common Stock received by such participant in their Initial Exercise (the &#8220;<b><i>Reprice Warrants</i></b>&#8221;). After issuance, the Reprice Warrants were exercisable for an aggregate of 327,860 shares of Common Stock at an exercise price equal to $6.30, which number of underlying shares and exercise price reflect the adjustment for the Reverse Stock Split and are subject to potential future adjustment. The Reprice Warrants are exercisable until they expire on September 11, 2028. The terms of the Reprice Warrants provide for a restriction upon exercise to the extent that, after giving effect to such exercise, the holder of the Reprice Warrant (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates), would beneficially own in excess of 4.99% or 9.99% of outstanding Common Stock. The Reprice Warrants do not have any preemptive rights or a preference upon any liquidation, dissolution or winding-up of the Company.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In connection with the 2023 Private Placement, the exercise price of the Reprice Warrants and the 2021 Amended Warrants held by the Selling Stockholders were reduced to $1.50 per share as discussed below.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
17
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><i>Warrant Amendments in the 2023 Private Placement </i></b>&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">As a condition to the closing of the 2023 Private Placement, each of the Selling Stockholders entered into a Warrant Amendment Agreement with the Company that provided for the Reprice Warrants, the 2022 Warrants and the 2021 Amended Warrants held by each Selling Stockholder to be amended to reduce the exercise price of their Reprice Warrants as well as their 2022 Warrants and 2021 Amended Warrants from $6.30 per share to $1.50 per share, which became effective as of the closing of the 2023 Private Placement. In addition, the Company entered into additional Warrant Amendment Agreements with one other existing investor that hold previously issued Common Stock purchase warrants, which was a condition for Mr. Fu and Pioneer Pharma (Hong Kong) Company Ltd. to enter into and deliver certain voting commitment letters to the Company.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><i>Aggregate Outstanding Warrants</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">As of May 24, 2023, we had outstanding Common Stock purchase warrants (including the 2023 Warrants and other Common Stock warrants separately described above) to purchase an aggregate of 7,382,447 shares of Common Stock at a weighted average exercise price of $2.18 per share. With the exception of the 2023 Warrants, all such outstanding Common Stock purchase warrants are currently exercisable. The 2023 Warrants will not be exercisable unless and until we obtain the Stockholder Approval.</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Anti-Takeover Effects of Provisions of our Certificate of Incorporation and Bylaws and Delaware Law</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Our Certificate of Incorporation provides that the Board of Directors is divided into three classes with staggered three-year terms. Only one class of directors is elected at each annual meeting of stockholders, with the other classes continuing for the remainder of their respective three-year terms. Because holders of Common Stock do not have cumulative voting rights in the election of directors, stockholders holding a majority of the shares of Common Stock outstanding are able to elect all of our directors. The Board of Directors is able to elect a director to fill a vacancy created by the expansion of the Board of Directors or due to the resignation or departure of an existing board member. Our Certificate of Incorporation and Bylaws also provide that all stockholder actions must be effected at a duly called meeting of stockholders and not by written consent, and that only the Board of Directors pursuant to a resolution adopted by a majority of the total number of authorized directors may call a special meeting of stockholders. In addition, our Bylaws include a requirement for the advance notice of nominations for election to the Board of Directors or for proposing matters that can be acted upon at a stockholders&#8217; meeting. Our Certificate of Incorporation provides for the ability of the Board of Directors to issue, without stockholder approval, up to 5,000,000 shares of preferred stock with terms set by the Board of Directors, which rights could be senior to those of our Common Stock. The Certificate of Incorporation and Bylaws also provide that approval of at least 66-2/3% of the shares entitled to vote at an election of directors will be required to adopt, amend or repeal the Bylaws, or repeal the provisions of our Certificate of Incorporation regarding the election of directors and the inability of stockholders to take action by written consent in lieu of a meeting.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The foregoing provisions make it difficult for holders of Common Stock to replace the Board of Directors. In addition, the authorization of undesignated preferred stock makes it possible for the Board of Directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change control of NovaBay.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Section 203 of the Delaware General Corporation Law</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We are subject to the provisions of Section 203 of the Delaware General Corporation Law regulating corporate takeovers. This section prevents some Delaware corporations from engaging, under some circumstances, in a business combination, which includes a merger or sale of at least 10% of the corporation&#8217;s assets with any interested stockholder, meaning a stockholder who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, did own 15% or more of the corporation&#8217;s outstanding voting stock, unless:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the transaction is approved by the Board of Directors prior to the time that the interested stockholder became an interested stockholder;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">upon consummation of the transaction which resulted in the stockholder&#8217;s becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced; or</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">at or subsequent to such time that the stockholder became an interested stockholder, the business combination is approved by the Board of Directors and authorized at an annual or special meeting of stockholders by at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">A Delaware corporation may &#8220;opt out&#8221; of these provisions with an express provision in its original certificate of incorporation or an express provision in its certificate of incorporation or bylaws resulting from a stockholders&#8217; amendment approved by at least a majority of the outstanding voting shares. We do not plan to &#8220;opt out&#8221; of these provisions. The statute could prohibit or delay mergers or other takeover or change in control attempts and, accordingly, may discourage attempts to acquire us.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Transfer Agent and Registrar</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Computershare Shareholder Services, Inc., located in Providence, Rhode Island, Providence County, is the transfer agent and registrar for our Common Stock and preferred stock in the United States and Computershare Investor Services, Inc., located in Toronto, Ontario, Canada, is the co-transfer agent and registrar for our Common Stock in Canada.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Listing on the NYSE American</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Common Stock is listed on the NYSE American under the symbol &#8220;NBY.&#8221;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
18

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SELLING STOCKHOLDERS</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The shares of Common Stock being offered by the Selling Stockholders in this prospectus are those issuable to the Selling Stockholders upon the conversion or redemption of the Debentures and the exercise of the 2023 Warrants that we issued in the 2023 Private Placement, which is described in this prospectus and documents incorporated by reference into this prospectus. The table below lists the Selling Stockholders and other information regarding the beneficial ownership (as determined under Section 13(d) of the Exchange Act and the rules and regulations thereunder) of the shares of Common Stock by each of the Selling Stockholders. These rules generally provide that a person is the beneficial owner of securities if such person has or shares the power to vote or direct the voting thereof, or to dispose or direct the disposition thereof, or has the right to acquire such powers within 60 days.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Until Stockholder Approval occurs, the Debenture holders may convert their Debentures only up to their pro rata share of an aggregate of 438,669 shares of Common Stock, which was 19.99% of outstanding shares of Common Stock immediately prior to the 2023 Private Placement Closing. Further, until Stockholder Approval occurs, the 2023 Warrants will not be exercisable into Warrant Shares. The Debentures and 2023 Warrants are subject to another limitation upon conversion into shares of Common Stock to the extent that, after giving effect to such conversion, the holder of such Debenture or 2023 Warrant (together with the holder&#8217;s affiliates, and any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates), would beneficially own in excess of 4.99% or 9.99% of the outstanding Common Stock. The 2023 Warrants do not have any preemptive rights or a preference upon any liquidation, dissolution or winding-up of the Company.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In accordance with the terms of the 2023 Registration Rights Agreement with the Selling Stockholders, this prospectus generally covers the resale of the sum of the number of shares of Common Stock initially issuable to the Selling Stockholders upon conversion of the Debentures and the exercise of the 2023 Warrants and based on the assumption that Stockholder Approval is received and that all of the Debentures are converted and all of the 2023 Warrants are exercised in full, without regard to any limitations on conversion and/or exercise contained in the Debentures or the 2023 Warrants as of May 24, 2023. Because the conversion price of the Debentures and the exercise price of the underlying shares of the 2023 Warrants may be adjusted, as the case may be, upon the occurrence of certain as provided in the Debentures and the 2023 Warrants, the number of shares of Common Stock that will actually be issued upon conversion or redemption of the Debentures or exercise of the 2023 Warrants in the future may be more or less than the number of shares being offered by this prospectus.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The name of each Selling Stockholder is set forth in the first column in the table below. The second column of the table lists the number of shares of Common Stock beneficially owned by each Selling Stockholder, based on its ownership of the shares of Common Stock, as of May 24, 2023, which assumes the full conversion of the Debentures, the shares of Series B Preferred Stock and Series C Preferred Stock and/or exercise of the 2023 Warrants, the Reprice Warrants, the 2022 Warrants and the 2021 Amended Warrants that are in each case held by the Selling Stockholders on that date, without regard to any applicable ownership limitations on the conversion and/or exercise of such securities. The third column lists the shares of Common Stock being offered by this prospectus by the Selling Stockholders. The fourth column assumes the sale of all of the Shares offered by each Selling Stockholder pursuant to this prospectus, but does not assume the sale of any other securities listed in the table below that each Selling Stockholder may beneficially own.</div>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Percentage ownership is based on 4,209,534 shares of Common Stock outstanding as of May 24, 2023. The Selling Stockholders may sell all, some or none of their Shares in this offering that are received upon exercise of their Reprice Warrants. For additional information, see the section entitled &#8220;Plan of Distribution.&#8221; This information in the table and the footnotes is based upon our review of public filings, our stockholder, option holder and warrant holder registers and information furnished to us by the Selling Stockholders. Based on this information, we believe that none of the Selling Stockholders are broker-dealers or affiliates of broker-dealers.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tbody><tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares of Common Stock Owned</b><br />
			<b>After this Offering(2)(3)</b></b></div>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 52%; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name of Selling Stockholder</b></div>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares of</b><br />
			<b>Common Stock</b></b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Owned Prior to</b><br />
			<b>this Offering(1)</b></b></div>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares of</b><br />
			<b>Common Stock</b><br />
			<b>Being Offered</b></b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>by this</b><br />
			<b>Prospectus(2)</b></b></div>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Number</b></b></div>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Percentage</b></b></div>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Altium Growth Fund, LP(4)</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,183,863</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,903,848</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,280,015</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">27.2</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</div>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Alpha Capital Anstalt(5)</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,661,263</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,903,848</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,757,415</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">31.1</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</div>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Armistice Capital, LLC(6)</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,598,770</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,903,848</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">694,922</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">10.2</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</div>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Bigger Capital Fund, LP(7)</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,103,776</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">951,924</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,151,852</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">18.2</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</div>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">District 2 Capital Fund LP(8)</div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,911,220</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">951,924</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">959,296</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">15.7</td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</div>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total Number of Shares</b></div>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>15,458,892</b></td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>7,615,392</b></td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><b>7,843,500</b></td>
			<td style="nowrap: true; width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#xa0;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b>&#xa0;</b></td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="text-align: left; height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 3pt auto 3pt 0" />
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(1)</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Includes 100% of the shares of Common Stock issuable upon conversion of the Debentures, Series B Preferred Stock and the Series C Preferred Stock at the current conversion price and the exercise of the Reprice Warrants, the 2021 Amended Warrants, the 2022 Warrants and the 2023 Warrants as well as any other shares of Common Stock held as of May 24, 2022.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
19
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(2)</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">This column represents the maximum number of shares of Common Stock that may be issued to each Selling Stockholder upon conversion of the Debentures and exercise of the 2023 Warrants and are being offered by the Selling Stockholders in this prospectus. Pursuant to the Debentures and each of the 2023 Warrants, a Selling Stockholder may not convert its Debentures or exercise its 2023 Warrants for shares of Common Stock if as a result of such exercise such Selling Stockholder, its affiliates and any other person whose beneficial ownership of shares of Common Stock would be aggregated with the Selling Stockholder&#8217;s for purposes of Section 13(d) of the Exchange Act, would beneficially own more than 4.99% of our Common Stock (or 9.99% if such Selling Stockholder elected for this limitation to apply or provided not less than 61 days&#8217; prior notice to us of an increase to 9.99%). The full conversion of the Debentures and the exercise of the 2023 Warrants are also subject to the Company obtaining the Stockholder Approval.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(3)</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Assumes, for each Selling Stockholder, the conversion in full of the Debentures, Series B Preferred Stock and Series C Preferred Stock held by such Selling Stockholder and the exercise of all Reprice Warrants, the 2021 Amended Warrants, the 2022 Warrants and the 2023 Warrants and the sale of all Shares offered by this prospectus.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(4)</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Altium Growth Fund, LP&#8217;s ownership as of May 24, 2023 includes an aggregate of: (1) 1,386,000 shares of Common Stock issuable upon conversion of its 1,800 shares of Series B Preferred Stock; (2) 634,616 shares of Common Stock issuable upon conversion of its Debentures; (3) 214,286 shares of Common Stock underlying its 2021 Amended Warrants; (4) 71,429 shares of Common Stock underlying its Reprice Warrants; (5) 1,269,232 shares of Common Stock underlying its 2023 Warrants; and (6) 608,300 shares of Common Stock. Altium Capital Management, LP, the investment manager of Altium Growth Fund, LP, has voting and investment power over these securities. Jacob Gottlieb is the managing member of Altium Capital Growth GP, LLC, which is the general partner of Altium Growth Fund, LP. Each of Altium Growth Fund, LP and Jacob Gottlieb disclaims beneficial ownership over these shares.</div>
			</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(5)</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Alpha Capital Anstalt&#8217;s ownership as of May 24, 2023 includes an aggregate of: (1) 2,471,700 shares of Common Stock issuable upon conversion of its 3,210 shares of Series B Preferred Stock; (2) 634,616 shares of Common Stock issuable upon conversion of its Debentures; (3) 71,429 shares of Common Stock underlying its Reprice Warrants; (4) 214,286 shares of Common Stock underlying its 2021 Amended Warrants; and (5) 1,269,232 shares of Common Stock underlying its 2023 Warrants. Nicola Feuerstein, Director of Alpha Capital Anstalt, has sole voting and dispositive power over the Company&#8217;s securities held by Alpha Capital Anstalt.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(6)</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The securities are directly held by Armistice Capital Master Fund Ltd, a Cayman Islands exempted Company (the &#8220;<b><i>Master</i></b> <b><i>Fund</i></b>&#8221;), and may be deemed to be beneficially owned by Armistice Capital, LLC (&#8220;Armistice Capital&#8221;), as the investment manager of the Master Fund; and (ii) Steven Boyd, as the Managing Member of Armistice Capital. As of May 24, 2023, this includes an aggregate of: (1) 634,616 shares of Common Stock issuable upon conversion of its Debentures; (2) 60,000 shares of Common Stock underlying its Reprice Warrants; (3) 634,922 shares of Common Stock underlying its 2022 Warrants; and (4) 1,269,232 shares of Common Stock underlying its 2023 Warrants. Armistice Capital, LLC and Steven Boyd share voting and dispositive power both with the following address: 510 Madison Avenue, 7th Floor, New York, New York 10022.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(7)</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">Bigger Capital Fund, LP&#8217;s ownership as of May 24, 2023 includes an aggregate of: (1) 616,000 shares of Common Stock issuable upon conversion of its 800 shares of Series B Preferred Stock; (2) 305,690 shares of Common Stock issuable upon conversion of its 397 shares of Series C Preferred Stock; (3) 317,308 shares of Common Stock issuable upon conversion of its Debentures; (4) 158,732 shares of Common Stock underlying its 2022 Warrants; (5) 17,858 shares of Common Stock underlying its Reprice Warrants; (6) 53,572 shares of Common Stock underlying its 2021 Amended Warrants; and (7) 634,616 shares of Common Stock underlying its 2023 Warrants. Mr. Michael Bigger is a managing partner of Bigger Capital GP, LLC, which is the general partner of Bigger Capital Fund, LP, and has sole voting and investment power over the Company&#8217;s securities. Bigger Capital GP, LLC and Mr. Bigger may deemed to beneficially own the shares beneficially held by Bigger Capital Fund, LP.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
20
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">(8)</div>
			</td>
			<td style="width: auto;">
			<div style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">District 2 Capital Fund LP's (&#8220;District 2 CF&#8221;) ownership as of May 24, 2023 includes an aggregate of: (1) 654,500 shares of Common Stock issuable upon conversion of its 850 shares of Series B Preferred Stock; (2) 154,000 shares of Common Stock issuable upon conversion of its 200 shares of Series C Preferred Stock; (3) 317,308 shares of Common Stock issuable upon conversion of its Debentures; (4) 79,366 shares of Common Stock underlying its 2022 Warrants; (5) 17,858 shares of Common Stock underlying its Reprice Warrants; (6) 53,572 shares of Common Stock underlying its 2021 Amended Warrants; and (7) 634,616 shares of Common Stock underlying its 2023 Warrants. Bigger Capital Fund GP, LLC (&#8220;Bigger GP&#8221;) is a general partner of Bigger Capital Fund, LP (&#8220;Bigger Capital&#8221;) and District 2 Capital LP (&#8220;District 2&#8221;) is the investment manager of District 2 CF. Michael Bigger is the managing member of Bigger GP and District and District 2 Holdings LLC (&#8220;District 2 Holdings&#8221;), which is the managing member of District 2 GP LLC (&#8220;District 2 GP&#8221;), the general partner of District 2 CF. Therefore, Mr. Bigger, District 2, District 2 Holdings and District 2 CF may be deemed to be the beneficial owner, and have the shared power to dispose of or direct the disposition, of the shares reported as beneficially owned by District 2 CF and Mr. Bigger and Bigger GP may be deemed to be the beneficial owner, and have the shared power to dispose of or direct the disposition, of the shares reported as beneficially owned by Bigger Capital and District 2 CF.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Relationships with the Selling Stockholders</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Based upon information provided by the Selling Stockholders, except as set forth below, none of the Selling Stockholders nor any of their affiliates, officers, directors or principal equity holders has had any positions or office or has had any material relationship with us within the past three years.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Altium Growth Fund, LP, Alpha Capital Anstalt, Bigger Capital Fund, LP and District 2 Capital Fund LP, participated in the 2021 Private Placement and all such Selling Stockholders currently own shares of Series B Preferred Stock and 2021 Amended Warrants.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">As part of the 2022 Warrant Reprice Transaction, Altium Growth Fund, LP, Alpha Capital Anstalt, Bigger Capital Fund, LP and District 2 Capital Fund LP own 2021 Amended Warrants, and each of the Selling Stockholders own Reprice Warrants.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Armistice Capital Master Fund Ltd., Bigger Capital Fund, LP and District 2 Capital Fund LP, participated in the 2022 Private Placement and all such Selling Stockholders currently hold shares of Series C Preferred Stock and 2022 Warrants.</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Altium Growth Fund, LP, Alpha Capital Anstalt, Armistice Capital Master Fund Ltd., Bigger Capital Fund, LP and District 2 Capital Fund LP participated in the 2023 Private Placement and all such Selling Stockholders (i) currently holds Debentures and 2023 Warrants and (ii) entered into a Warrant Amendment Agreement with the Company that provided for their respective Reprice Warrants, 2022 Warrants and/or 2021 Amended Warrants to be amended to reduce the exercise price from $6.30 per share to $1.50 per share.<b>&#xa0;</b></div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
21

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PLAN OF DISTRIBUTION</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Each Selling Stockholder of the securities and any of their pledgees, assignees and successors-in-interest may, from time to time, sell, transfer or otherwise dispose of any or all of shares of Common Stock covered by this prospectus on the NYSE American or any other stock exchange, market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed prices, at prevailing market prices at the time of sale, at prices related to the prevailing market price, at varying prices determined at the time of sale or at negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling securities:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">block trades in which the broker-dealer will attempt to sell the Shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">purchases by a broker-dealer as principal and resale by the broker-dealer for its account;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">an exchange distribution in accordance with the rules of the applicable exchange;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">privately negotiated transactions;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">settlement of short sales, to the extent permitted by law;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">through the writing or settlement of options or other hedging transactions, whether through an option exchange or otherwise;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">in transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">a combination of any such methods of sale; or</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">any other method permitted pursuant to applicable law.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if available, rather than under this prospectus.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Broker-dealers engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for us to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar effect and (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities with respect to the Common Stock for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the Common Stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
22

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>LEGAL MATTERS</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Certain legal matters with respect to the validity of the issuance of the securities offered hereby will be passed upon by our counsel, Squire Patton Boggs (US) LLP, Washington, DC.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>EXPERTS</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The consolidated financial statements of NovaBay Pharmaceuticals, Inc. as of December 31, 2022 and 2021 and for the years then ended, incorporated by reference in this prospectus, have been audited by WithumSmith+Brown, PC, an independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>WHERE YOU CAN FIND MORE INFORMATION</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:26pt;">We have filed with the SEC a registration statement on Form S-1 with respect to the Shares of Common Stock being sold in this offering. This prospectus constitutes a part of that registration statement. This prospectus does not contain all the information set forth in the registration statement and the exhibits and schedules to the registration statement, because some parts have been omitted in accordance with the rules and regulations of the SEC. For further information with respect to us and our Common Stock being sold in this offering, you should refer to the registration statement and the exhibits and schedules filed as part of the registration statement. Statements contained in this prospectus regarding the contents of any agreement, contract or other document referred to herein are not necessarily complete&#894; reference is made in each instance to the copy of the contract or document filed as an exhibit to the registration statement. Each statement is qualified by reference to the exhibit.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:26pt;">The SEC maintains an Internet site that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. The SEC&#8217;s website address is www.sec.gov.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:26pt;">We file annual, quarterly and current reports, proxy statements and other information with the SEC. We make these filings available on our website <span style="text-decoration: underline;">http://www.novabay.com/investors/sec-filings</span>. Our website and the information contained on, or that can be accessed through, our website will not be deemed to be incorporated by reference in, and are not considered part of, this prospectus. You should not rely on our website or any such information in making your decision whether to purchase shares of our Common Stock. You can also review these documents on the SEC&#8217;s website, as described above.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">You should consider the incorporated information as if we reproduced it in this prospectus. The SEC allows us to &#8220;incorporate by reference&#8221; the information we file with the SEC into this prospectus. This permits us to disclose important information to you by referring you to other documents that we filed separately with the SEC. Any information referred to in this way is considered part of this prospectus. The information incorporated by reference is an important part of this prospectus, and information that we file later with the SEC will automatically update and supersede this information. This prospectus omits certain information contained in the registration statement, as permitted by the SEC. You should refer to the registration statement, including the exhibits, for further information about us and the securities we may offer pursuant to this prospectus. Statements in this prospectus regarding the provisions of certain documents filed with, or incorporated by reference in, the registration statement are not necessarily complete and each statement is qualified in all respects by that reference. We incorporate by reference the following documents that have been filed with the SEC:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001389545/000143774923008843/nby20221231_10k.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline;">March 31, 2023</span></a>, as amended on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1389545/000143774923011647/nby20230422_10ka.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline;">April 28, 2023</span></a>;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Our Quarterly Report on Form 10-Q, filed with the SEC on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1389545/000143774923013945/nby20230331_10q.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline;">May 11, 2023</span></a>;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">our Current Reports on Form 8-K,&#xa0;filed with the SEC on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001389545/000143774923001446/nby20230120_8k.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline;">January 20, 2023</span></a>, <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1389545/000143774923013945/nby20230331_10q.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline;">April 27, 2023</span></a>, and <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0001389545/000143774923011990/nby20230501_8k.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline;">May 2, 2023</span></a>;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">our Definitive Proxy Statement on Schedule 14A filed with the SEC on <a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1389545/000143774923015017/nby20230515_def14a.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline;">May 18,2023</span></a>; and</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the description of our Common Stock in our registration statement on Form 8-A, as filed with the SEC on&#xa0;<a href="http://www.sec.gov/Archives/edgar/data/1389545/000119312507191730/d8a12b.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline;">August 29, 2007</span></a>, as updated by our Current Report on Form 8-K filed with the SEC on&#xa0;<a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774911004362/novabay_8k-062711.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline;">June 29, 2010</span></a>, and including any amendments or reports filed for the purposes of updating this description, including <a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923008843/ex_485491.htm" style="-sec-extract:exhibit;"><span style="text-decoration: underline;">Exhibit 4.1</span></a>&#xa0;or our Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 31, 2023, as amended on April 28, 2023.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
23
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Any information in any of the foregoing documents will automatically be deemed to be modified or superseded to the extent that information in this prospectus modifies or replaces such information. We also incorporate by reference any future filings made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination of the offering of the securities made by this prospectus, including those made after the date of the initial filing of the registration statement of which this prospectus is a part and prior to effectiveness of such registration statement. Information in such future filings updates and supplements the information provided in this prospectus. Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document we previously filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed document modify or replace such earlier statements.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Notwithstanding the foregoing, unless specifically stated to the contrary, information that we furnish (and that is not deemed &#8220;filed&#8221; with the SEC) under Items 2.02 and 7.01 of any Current Report on Form 8-K, including the related exhibits under Item 9.01, is not incorporated by reference into this prospectus or the registration statement of which this prospectus is a part.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will provide, upon written or oral request, without charge to each person, including any beneficial owner, to whom a copy of this prospectus is delivered, a copy of any or all of the information incorporated herein by reference (exclusive of exhibits to such documents unless such exhibits are specifically incorporated by reference herein). You may request in writing or orally a copy of these filings, at no cost, by writing or telephoning us at the following address:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">NovaBay Pharmaceuticals, Inc.</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">2000 Powell Street, Suite 1550</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">Emeryville, California 94608</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">(510) 899-8800</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">Attention: Corporate Secretary</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
24

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><img alt="nby20230525_s1img002.jpg" src="nby20230525_s1img002.jpg" style="width:372;height:81;" /></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>7,615,392 Shares</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>of</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Common Stock</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>PROSPECTUS</b></div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#xa0;</div>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto" />
<div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b> </b>&#xa0;<b>, 2023</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</div>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PART II</b><br />
<b>INFORMATION NOT REQUIRED IN PROSPECTUS</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 13. Other Expenses of Issuance and Distribution.</b>&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth all costs and expenses to be paid by us in connection with this registration statement and the listing of our Common Stock. All amounts shown are estimates except for the SEC registration fee.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;">

		<tbody><tr style="vertical-align: bottom;">
			<td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td colspan="2" style="text-align: center; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Amount</b></b></div>
			</td>
			<td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman; font-size: 10pt; width: 85%;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">SEC registration fee</div>
			</td>
			<td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">572</td>
			<td style="nowrap: true; width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounting fees and expenses</div>
			</td>
			<td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">12,000</td>
			<td style="nowrap: true; width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Legal fees and expenses</div>
			</td>
			<td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">50,000</td>
			<td style="nowrap: true; width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Transfer agent and registrar fees and expenses</div>
			</td>
			<td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#xa0;</td>
			<td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,000</td>
			<td style="nowrap: true; width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#xa0;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);">
			<td style="font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Total expenses</div>
			</td>
			<td style="width: 1%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td style="width: 12%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">64,572</td>
			<td style="nowrap: true; width: 1%; font-family: Times New Roman; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 14. Indemnification of Directors and Officers.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s amended and restated certificate of incorporation provides that the liability of the directors for monetary damages shall be eliminated to the fullest extent under applicable law. If the Delaware General Corporation Law is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Company shall be eliminated to the fullest extent permitted by the Delaware General Corporation Law, as so amended. Under the Delaware General Corporation Law, no director will be personally liable to the Company or the Company&#8217;s stockholders for monetary damages for breach of fiduciary duty as a director, except for liability:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">for any breach of the duty of loyalty to the Company or the Company&#8217;s stockholders;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">for acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">for unlawful payment of dividends or unlawful stock repurchases or redemptions under Section 174 of the Delaware General Corporation Law; and</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">for any transaction from which the director derived an improper personal benefit.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company&#8217;s amended and restated bylaws provide that:</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the Company is required to indemnify the Company&#8217;s directors and executive officers to the fullest extent not prohibited by Delaware law, subject to limited exceptions;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the Company may indemnify the Company&#8217;s other employees and agents as set forth in the Delaware General Corporation Law;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the Company is required to advance expenses to the Company&#8217;s directors and executive officers as incurred in connection with legal proceedings against them for which they may be indemnified, against an undertaking by the indemnified party to repay such advances if it is ultimately determined that the indemnified party is not entitled to indemnification; and</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 18pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9679;</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the rights conferred in the amended and restated bylaws are not exclusive.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The information provided above is a summary of relevant provisions of our amended and restated certificate of incorporation, amended and restated bylaws and certain provisions of the Delaware General Corporation Law. We urge you to read the full text of these documents, forms of which have been filed with the SEC, as well as the referenced provisions of the Delaware General Corporation Law because they are the legal documents and provisions that will govern matters of indemnification with respect to our directors and officers.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
II-1

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company has entered into indemnification agreements with each of the Company&#8217;s directors and executive officers that require the Company to indemnify these persons all direct and indirect costs of any type or nature whatsoever, including attorney&#8217;s fees, witness fees, and other out-of-pocket costs of whatever nature, incurred by the director or officer in any action or proceeding, whether actual, pending or threatened, subject to certain limitations, to which any of these people may be made a party by reason of the fact that he or she is or was a director or an executive officer of the Company or is or was serving or at any time serves at the request of the Company as a director, officer, employee or other agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company has purchased insurance on behalf of any person who is or was a director or officer of the Company against any loss arising from any claim asserted against him or her and incurred by him or her in any such capacity, subject to certain exclusions.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 15. Recent Sales of Unregistered Securities.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">During the last three years and to date in the current fiscal year, we sold the following unregistered securities, which have been adjusted to reflect the Company&#8217;s reverse stock split at a 1-for-35 ratio that became effective on November 15, 2022 (without accounting for fractional rounding):</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:30.1%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Capital Raise</b></div>
			</td>
			<td style="vertical-align:bottom;width:0.9%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:6.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b># of</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Shares,</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Units or</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Warrants</b></div>
			</td>
			<td style="vertical-align:bottom;width:0.9%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Date</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:30.1%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:7.9%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:30.1%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Issuance of warrants exercisable for an aggregate of 197,102 shares of Common Stock at an exercise price of $57.75 per share to certain domestic and foreign investors as partial consideration for the exercise of certain warrants then held by such investors with the exercise of such warrants providing aggregate proceeds of $6,829,580</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">197,102</div>
			</td>
			<td style="vertical-align:middle;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:7.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">July 20, 2020</div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:30.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:middle;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:7.9%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:30.1%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Issuance of warrants exercisable for an aggregate of 429 shares of Common Stock at an exercise price of $23.513 per share as consideration for certain services pursuant to that certain Services Agreement, dated May 13, 2020 with TLF Bio Innovation Lab, LLC</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">429</div>
			</td>
			<td style="vertical-align:middle;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:7.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">January 15, 2021</div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:30.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:middle;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:7.9%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:30.1%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Sale of (i) an aggregate of 15,000 shares of Series B non-voting convertible preferred stock that are convertible into an aggregate of 1,071,429 shares of Common Stock and (ii) Common Stock warrants exercisable for 1,071,429 shares of Common Stock for an aggregate purchase price of $15,000,000</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2,142,858</div>
			</td>
			<td style="vertical-align:middle;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:7.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">November 2, 2021</div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:30.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:middle;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:7.9%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:30.1%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Issuance of warrants exercisable for an aggregate of 327,860 shares of Common Stock at an exercise price of $6.30 per share to certain domestic investors as partial consideration for the exercise of certain warrants held by such investors with the exercise of such warrants providing aggregate proceeds of approximately $2,065,500</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">327,860</div>
			</td>
			<td style="vertical-align:middle;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:7.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">September 9, 2022</div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:30.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:middle;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:7.9%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:30.1%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Issuance and sale of units consisting of an aggregate of (i) 3,250 Series C Non-Voting Convertible Preferred Stock, par value $0.01 per share, convertible into an aggregate of 516,750 shares of Common Stock, (ii) short-term Series A-1 warrants to purchase an aggregate of 515,876 shares Common Stock, and (iii) long-term Series A-2 warrants to purchase an aggregate of 515,876 shares Common Stock for an aggregate purchase price of $3,250,000</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,548,502</div>
			</td>
			<td style="vertical-align:middle;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:7.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">November 18, 2022</div>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:30.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">&#xa0;</td>
			<td style="vertical-align:middle;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:7.9%;">&#xa0;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:30.1%;">
			<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Issuance and sale of an aggregate of (i) $3.3 million aggregate principal amount of Original Issue Discount Senior Secured Convertible Debentures Due November 1, 2024, which may be converted or redeemed into up to an aggregate of 2,538,464 shares of Common Stock, (ii) long-term Series B-1 warrants to purchase Common Stock, which are exercisable for up to an aggregate of 2,538,464 shares of Common Stock, and (iii) short-term Series B-2 warrants to purchase Common Stock, which are exercisable for up to an aggregate of 2,538,464 shares of Common Stock, for an aggregate purchase price of $3,000,000</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:6.5%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">7,615,392</div>
			</td>
			<td style="vertical-align:middle;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:middle;width:7.9%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">May 1, 2023</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
II-2
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 36pt;">Ladenburg acted as placement agent in connection with each of the private placements described above, except as relates to the private placement of warrants to TLF Bio Innovation Lab, LLC. No other underwriters were involved in the foregoing sales of securities.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The securities described above were issued pursuant to the exemption from the registration requirements of the Securities Act afforded by Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder, as a transaction to an accredited investor not involving a public offering. The recipients of securities in all such transactions represented their intention to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the stock certificates and option agreements issued in such transactions. All recipients had adequate access, through their relationships with us, to information about us.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 16. Exhibits and Financial Statement Schedules.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">(a)&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;The following exhibits are filed as part of this Registration Statement:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="3" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Exhibit</b></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; border-top: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Exhibit Description</b></div>
			</td>
			<td colspan="4" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 35%; border-top: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Incorporated by Reference</b></div>
			</td>
			<td style="vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; border-top: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Filed</b></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Herewith</b></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Form</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>File</b></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Exhibit/</b></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Form 8-K Item</b></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Reference</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Filing Date</b></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/0001389545/000143774921022779/ex_286899.htm" style="-sec-extract:exhibit;">Membership Unit Purchase Agreement dated September 27, 2021, by and among the Company, DERMAdoctor, the Founders and the Sellers (as defined therein)</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-3678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/28/2021</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774918005177/ex_107885.htm" style="-sec-extract:exhibit;">Amended and Restated Certificate of Incorporation of NovaBay Pharmaceuticals, Inc.</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/21/2018</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774918011215/ex_115851.htm" style="-sec-extract:exhibit;">Amendment to the Amended and Restated Certificate of Incorporation, dated June 4, 2018&#xa0;of NovaBay Pharmaceuticals, Inc.</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">6/04/2018</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.3</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774920011939/ex_188182.htm" style="-sec-extract:exhibit;">Amendment to the Amended and Restated Certificate of Incorporation, as amended, dated May 27, 2020</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">5/28/2020</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.4</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/0001389545/000143774921013167/ex_252546.htm" style="-sec-extract:exhibit;">Amendment to the Amended and Restated Certificate of Incorporation, as amended, dated May 24, 2021</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">5/24/2021</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.5</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922002101/ex_330469.htm" style="-sec-extract:exhibit;">Amendment to the Amended and Restated Certificate of Incorporation, as amended, dated January 31, 2022</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2/1/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.6</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774919016569/ex_154773.htm" style="-sec-extract:exhibit;">Certificate of Designation&#xa0;for the Series B Preferred Stock</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/1/2021</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.7</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922027767/ex_448350.htm" style="-sec-extract:exhibit;">Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, dated November 14, 2022</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/18/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.8</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922027767/ex_448351.htm" style="-sec-extract:exhibit;">Certificate of Designation for Series C Preferred Stock, dated November 17, 2022</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/18/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.9</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922007543/ex_351428.htm" style="-sec-extract:exhibit;">Amended and Restated Bylaws</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3.7</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/29/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923008843/ex_485491.htm" style="-sec-extract:exhibit;">Description of Securities</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/31/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774920011168/ex_186813.htm" style="-sec-extract:exhibit;">Form of Warrant pursuant to the Services Agreement with TLF Bio Innovation Lab, LLC, dated May 13, 2020</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">5/18/2020</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.3</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774920015464/ex_194651.htm" style="-sec-extract:exhibit;">Form of July 2020 Warrant</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">7/21/2020</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.4</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422213.htm" style="-sec-extract:exhibit;">Form of Amended July 2020 Warrant</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.5</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422214.htm" style="-sec-extract:exhibit;">Form of Amended November 2021&#xa0;Warrant</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.6</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422215.htm" style="-sec-extract:exhibit;">Form of September 2022 Warrant&#xa0;(2020 Participants)</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.3</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.7</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422216.htm" style="-sec-extract:exhibit;">Form of September 2022 Warrant&#xa0;(2021 Participants)</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.4</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.8</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422217.htm" style="-sec-extract:exhibit;">Form of Series A-1 Long-Term&#xa0;Warrant</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.5</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
II-3
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<table cellpadding="3" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: top; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.9</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422218.htm" style="-sec-extract:exhibit;">Form of Series A-2 Short-Term&#xa0;Warrant</a></div>
			</td>
			<td style="border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.6</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: middle; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.10</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508269.htm" style="-sec-extract:exhibit;">Form of Original Issue Discount Secured Senior Convertible Debenture</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.11</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508270.htm" style="-sec-extract:exhibit;">Form of Series B-1 Long-Term Common Stock Warrant</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.12</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508271.htm" style="-sec-extract:exhibit;">Form of Series B-2 Short-Term Common Stock Warrant</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.3</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.13</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508272.htm" style="-sec-extract:exhibit;">Form of Warrant Amendment Agreement</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4.4</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">5.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="ex_527859.htm" style="-sec-extract:exhibit;">Opinion of Squire Patton Boggs (US) LLP</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">S-1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">333-269083</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">5.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">X</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508273.htm" style="-sec-extract:exhibit;">Form of Securities Purchase Agreement*</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508274.htm" style="-sec-extract:exhibit;">Form of Security Agreement*</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.3</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508275.htm" style="-sec-extract:exhibit;">Form of Subsidiary Guarantee</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.3</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.4</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508276.htm" style="-sec-extract:exhibit;">Form of Voting Commitment</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.4</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.5</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508277.htm" style="-sec-extract:exhibit;">Form of Registration Rights Agreement</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.5</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.6+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922007543/ex_346224.htm" style="-sec-extract:exhibit;">Director and Officer Indemnity Agreement</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/29/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.7+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774917001041/ex99-1.htm" style="-sec-extract:exhibit;">NovaBay&#xa0;Pharmaceuticals, Inc. 2007 Omnibus Incentive Plan&#xa0;(as amended and restated)</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">S-8</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">333-215680</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">99.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">1/24/2017</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.8+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774917010557/ex99-1.htm" style="-sec-extract:exhibit;">NovaBay&#xa0;Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">S-8</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">333-218469</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">99.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">6/02/2017</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.9+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774917010557/ex99-2.htm" style="-sec-extract:exhibit;">NovaBay&#xa0;Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan (Form Agreements to the 2017 Omnibus Incentive Plan)</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">S-8</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">333-218469</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">99.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">6/02/2017</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.10+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774920001861/ex_171553.htm" style="-sec-extract:exhibit;">Executive Employment Agreement (Employment Agreement of Justin M. Hall)</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2/6/2020</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.11+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922001821/ex_325549.htm" style="-sec-extract:exhibit;">First Amendment to the Executive Employment Agreement with Justin M. Hall, dated January 26, 2022</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.6</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">1/28/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.12+*</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774921011142/ex_245260.htm" style="-sec-extract:exhibit;">Performance Restricted Stock Unit Award Agreement with Mr. Justin Hall</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10-Q</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">5/6/2021</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.13+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774920009347/ex_184393.htm" style="-sec-extract:exhibit;">Executive Employment Agreement (Employment Agreement of Andrew D. Jones)</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.8</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">5/5/2020</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.14+*</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774921011142/ex_245261.htm" style="-sec-extract:exhibit;">Performance Restricted Stock Unit Award Agreement with Mr. Andrew Jones</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10-Q</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">5/6/2021</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.15+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774921026234/ex_306146.htm" style="-sec-extract:exhibit;">Executive Employment Agreement with Dr. Audrey Kunin, dated November 5, 2021</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/12/2021</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.16+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774921026234/ex_306148.htm" style="-sec-extract:exhibit;">Side Letter with Dr. Audrey Kunin, dated November 5, 2021</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.3</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/12/2021</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.17+*</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774921026234/ex_306149.htm" style="-sec-extract:exhibit;">Performance Restricted Stock Unit Award Agreement with Dr. Audrey Kunin</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.4</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/12/2021</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.18+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774921026234/ex_306147.htm" style="-sec-extract:exhibit;">Executive Employment Agreement with Dr. Jeff Kunin, dated November 5, 2021</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/12/2021</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.19+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774920024160/ex_214825.htm" style="-sec-extract:exhibit;">Consulting Agreement between the Company and Eric Wu, dated November 17, 2020</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/18/2020</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.20+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923008843/ex_485490.htm" style="-sec-extract:exhibit;">2023 Non-Employee Director Compensation Plan</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.15</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/31/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.21</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774916038133/ex10-1.htm" style="-sec-extract:exhibit;">Office Lease (between the Company and KBSIII Towers at Emeryville, LLC)</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8/26/2016</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.22</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922001821/ex_325548.htm" style="-sec-extract:exhibit;">First Amendment to Office Lease by and between the Company and KBSIII Towers at Emeryville, LLC, dated January 24, 2022</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">1/28/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.23*</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774912002793/ex10-18.htm" style="-sec-extract:exhibit;">International Distribution Agreement (by and between the Company and Pioneer Pharma Co. Ltd.)</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.18</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/27/2012</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.24</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774921012360/ex_249745.htm" style="-sec-extract:exhibit;">At the Market Offering Agreement between the Company and Ladenburg Thalmann &amp; Co. Inc., dated May 14, 2021</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">1.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">5/14/2021</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.25</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774920009821/ex_185106.htm" style="-sec-extract:exhibit;">Paycheck Protection Program Promissory Note and Agreement, dated May 3, 2020, between the Company and Wells Fargo Bank, N.A.</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10-Q</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.28</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">5/7/2020</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.26</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774920015464/ex_194652.htm" style="-sec-extract:exhibit;">Form of Exercise Agreement with Holders of 2019 Domestic Warrants</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">7/21/2020</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
II-4
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<table cellpadding="3" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: top; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.27</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774920015464/ex_194653.htm" style="-sec-extract:exhibit;">Form of Exercise Agreement with Holders of 2019 Foreign Warrants</a></div>
			</td>
			<td style="border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: top; width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-top: 1px solid black;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">7/21/2020</div>
			</td>
			<td style="border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: top; width: 9%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.28</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774920015464/ex_194654.htm" style="-sec-extract:exhibit;">Form of Reprice Agreement with Ladenburg</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.3</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">7/21/2020</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.29</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774921024705/ex_300009.htm" style="-sec-extract:exhibit;">Form of Securities Purchase Agreement, dated October 29, 2021</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">1.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/01/2021</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.30</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774921024705/ex_300012.htm" style="-sec-extract:exhibit;">Form of Registration Rights Agreement, dated October 29, 2021</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">11/01/2021</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.31*</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422219.htm" style="-sec-extract:exhibit;">Form of 2020 Reprice Letter Agreement, dated September 9, 2022</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.32*</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422220.htm" style="-sec-extract:exhibit;">Form of 2021 Reprice Letter Agreement, dated September 9, 2022</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.33*</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422221.htm" style="-sec-extract:exhibit;">Form of Securities Purchase Agreement, dated September 9, 2022</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.3</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.34</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422222.htm" style="-sec-extract:exhibit;">Form of Registration Rights Agreement</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.4</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.35</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422223.htm" style="-sec-extract:exhibit;">Form of Participant Voting Commitment</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.5</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.36</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422224.htm" style="-sec-extract:exhibit;">Form of Additional Voting Commitment</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.6</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.37</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922022258/ex_422225.htm" style="-sec-extract:exhibit;">Form of Leak-Out Agreement</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.7</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">9/13/2022</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.38+</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923008843/ex_486069.htm" style="-sec-extract:exhibit;">Consulting Agreement between the Company and Andrew Jones, dated February 15, 2023</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.33</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/31/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.39</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508273.htm" style="-sec-extract:exhibit;">Form of Securities Purchase Agreement*</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.40</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508274.htm" style="-sec-extract:exhibit;">Form of Security Agreement*</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.41</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508275.htm" style="-sec-extract:exhibit;">Form of Subsidiary Guarantee</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.3</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.42</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508276.htm" style="-sec-extract:exhibit;">Form of Voting Commitment</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.4</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.43</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923011416/ex_508277.htm" style="-sec-extract:exhibit;">Form of Registration Rights Agreement</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">8-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10.5</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">4/27/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">21</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774923008843/ex_485489.htm" style="-sec-extract:exhibit;">Subsidiaries of NovaBay Pharmaceuticals, Inc.</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">10-K</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">001-33678</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">21</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">3/31/2023</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">23.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="ex_527988.htm" style="-sec-extract:exhibit;">Consent of WithumSmith+Brown, PC</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">X</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">23.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="http://www.sec.gov/Archives/edgar/data/1389545/000143774922029932/ex_456732.htm" style="-sec-extract:exhibit;">Consent of Squire Patton Boggs (US) LLP (included in Exhibit 5.1)</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">S-1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">333-269083</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">23.2</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">X</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">24.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="#poa" style="-sec-extract:exhibit;">Power of Attorney (included on the signature page to this registration statement)</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">S-1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">333-269083</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">24.1</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&#xa0;</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; text-align: center;">X</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">104</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">The Cover Page Interactive Data File, formatted in Inline XBRL (included within the Inline XBRL document)</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">X</div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">107</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 38%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="ex_526764.htm" style="-sec-extract:exhibit;">Calculation of Filing Fees Tables</a></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 11%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 10%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 9%; border-left: 1px solid black; border-right: 1px solid black; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">X</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">+</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Indicates a management contract or compensatory plan or arrangement.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">*</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Certain confidential portions of this exhibit were omitted by means of marking such portions with brackets because the confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(b)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Financial Statement Schedules</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Financial statement schedules have been omitted, as the information required to be set forth therein is included in the consolidated financial statements or notes thereto appearing in the prospectus made part of this registration statement.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
II-5

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>ITEM 17. Undertakings.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(a)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The undersigned registrant hereby undertakes:</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(i)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(ii)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221;&#xa0;table in the effective registration statement;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(iii)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>provided, however</i>, that subparagraphs (i), (ii) and (iii) do not apply if the information required to be included in a post-effective amendment by those subparagraphs is contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(2)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(3)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(4)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 72pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(i)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 72pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(ii)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; and</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 72pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(iii)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness; provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
II-6
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(5)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 72pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(i)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 72pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(ii)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 72pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(iii)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 72pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(iv)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#xa0;</td>
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(6)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">That, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(b)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
II-7

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Emeryville, State of California, on May 31, 2023.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:23.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:17.6%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>NOVABAY PHARMACEUTICALS, INC.</b></div>
			</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.1%;">&#xa0;</td>
			<td style="vertical-align:bottom;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.1%;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/&#xa0;Justin M. Hall</div>
			</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Justin M. Hall</div>
			</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:23.1%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Executive Officer and General Counsel</div>
			</td>
			<td style="vertical-align:top;width:5.6%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
II-8

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Each of the undersigned officers and directors does hereby constitute and appoint Justin M. Hall and Tommy Law, and each of them, or their substitute or substitutes, as his or her true and lawful attorneys-in-fact and agents, with full power and authority to do any and all acts and things and to execute and file or cause to be filed any and all instruments, documents or exhibits which said attorneys and agents, or any one of them, determine may be necessary or advisable or required to enable said corporation to comply with the Securities Act of 1933, as amended, and any rules or regulations or requirements of the Securities and Exchange Commission in connection with this registration statement. Without limiting the generality of the foregoing power and authority, the powers granted include the power and authority to sign the names of the undersigned officers and directors in the capacities indicated below to this registration statement, to any and all amendments, both pre-effective and post-effective, and supplements to this registration statement and to any and all instruments, documents or exhibits filed as part of or in conjunction with this registration statement or amendments or supplements thereof, with the powers of substitution and revocation, and each of the undersigned hereby ratifies and confirms all that said attorneys and agents, or any one of them, or their substitute or substitutes, shall lawfully do or cause to be done by virtue hereof. In witness whereof, each of the undersigned has executed this Power of Attorney as of the dates indicated below.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons in the capacities and on the dates indicated.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">Signature</span></b></div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">Title</span></b></div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline;">Date</span></b></div>
			</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Justin M. Hall</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Chief Executive Officer, General Counsel and Director</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">May 31, 2023</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Justin M. Hall</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(principal executive officer)</i></div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Tommy Law</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Interim Chief Financial Officer</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">May 31, 2023</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tommy Law</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(principal financial and accounting officer)</i></div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Paul E. Freiman, Ph.D.</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Chairman</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">May 31, 2023</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Paul E. Freiman, Ph.D.</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Dr. Audrey Kunin</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Director</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">May 31, 2023</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dr. Audrey Kunin</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Julie Garlikov</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Director</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">May 31, 2023</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Julie Garlikov</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Swan Sit</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Director</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">May 31, 2023</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Swan Sit</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Mijia (Bob) Wu</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Director</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">May 31, 2023</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mijia (Bob) Wu</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Yenyou (Jeff) Zheng, Ph.D.</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Director</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">May 31, 2023</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Yenyou (Jeff) Zheng, Ph.D.</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Yongxiang (Sean) Zheng</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Director</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">May 31, 2023</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:16.2%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Yongxiang (Sean) Zheng</div>
			</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td style="vertical-align:top;width:16.2%;">&#xa0;</td>
			<td style="vertical-align:top;width:0.9%;">&#xa0;</td>
			<td colspan="2" style="vertical-align:top;width:12%;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
II-9
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex_527859.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html><head>
	<title>ex_527859.htm</title>

	<!-- Generated by ThunderDome Portal - 5/31/2023 1:11:20 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin: 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 5.1</b></font></p>

<p style="margin: 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:37.4%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img src="ex_527859img001.jpg" style="width:199;height:73;" alt="ex_527859img001.jpg"></p>
			</td>
			<td style="vertical-align:top;width:16%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Squire Patton Boggs (US) LLP</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2550 M Street, NW<br>
			Washington, D.C. 20037</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">O&nbsp;&nbsp;&nbsp;&nbsp;+1 202 457 6000</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">F&nbsp;&nbsp;&nbsp;&nbsp;+1 202 457 6315</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">squirepattonboggs.com</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">May 31, 2023</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board of Directors<br>
NovaBay Pharmaceuticals, Inc.<br>
2000 Powell Street, Suite 1150<br>
Emeryville, CA 94608</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Re:</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Registration Statement on Form S-1</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dear Ladies and Gentlemen:&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have acted as counsel to NovaBay Pharmaceuticals, Inc., a Delaware corporation (the &#8220;<b><i>Company</i></b>&#8221;), in connection with its filing on the date hereof of a Registration Statement on Form S-1 (the &#8220;<b><i>Registration Statement</i></b>&#8221;) with the Securities and Exchange Commission (the &#8220;<b><i>Commission</i></b>&#8221;) under the Securities Act of 1933, as amended (the&nbsp;&#8220;<b><i>Securities Act</i></b>&#8221;), on May 31, 2023. The Registration Statement relates to the registration for resale from time to time, on a delayed or continuous basis, by the selling stockholders named therein (the &#8220;<b><i>Selling Stockholders</i></b>&#8221;) and as provided in the Registration Statement, of up to 7,615,392 shares (the &#8220;<b><i>Shares</i></b>&#8221;) of the Company&#8217;s common stock, par value $0.01 per share (the &#8220;<b><i>Common Stock</i></b>&#8221;), issuable upon: (i) conversion of our Original Issue Discount Senior Secured Convertible Debentures Due November 1, 2024 (the &#8220;<b><i>Debentures</i></b>&#8221;), (ii) the exercise of our outstanding long-term Series B-1 warrants to purchase Common Stock exercisable for a five-year period (&#8220;<b><i>Long-Term Warrants</i></b>&#8221;), and (iii) the exercise of our outstanding short-term Series B-2 warrants to purchase Common Stock exercisable for a two-year period (&#8220;<b><i>Short-Term</i></b> <b><i>Warrants</i></b>&#8221; and, together with the Long-Term Warrants, the &#8220;<b><i>Warrants</i></b>&#8221;). The Debentures and the Warrants are collectively referred to herein as the &#8220;<b><i>Securities</i></b>&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Securities were originally sold to accredited investors in a private placement offering that was consummated on May 1, 2023, pursuant to a Securities Purchase Agreement, dated April 27, 2023, by and between the Company and each of the Selling Stockholders (the &#8220;<b><i>Purchase</i></b> <b><i>Agreement</i></b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In connection with our representation of the Company, and as a basis for the opinion hereinafter set forth, we have examined and relied upon originals or copies certified or otherwise identified to our satisfaction, of such documents, resolutions, certificates, records and other instruments as we have deemed necessary or appropriate as a basis for the opinion set forth herein, including (i) the Registration Statement, (ii) the Purchase Agreement, (iii) the Registration Rights Agreement, dated as of April 27, 2023 (the &#8220;<b><i>Registration Rights</i></b> <b><i>Agreement</i></b>&#8221;), by and among the Company and each of the Selling Stockholders; (iv) the Debentures, (v) the Warrants, and (vi) certain minutes and unanimous written consents of the board of directors of the Company and a certificate of the Secretary of the Company with respect to the approval of certain resolutions by the board of directors of the Company (collectively, the&nbsp;&#8220;<b><i>Resolutions</i></b>&#8221;). In addition, we have also reviewed and investigated such questions of law as we have considered necessary and appropriate for the purposes of our opinion set forth below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Board of Directors</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">May 31, 2023</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Page&nbsp;2</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Squire Patton Boggs (US) LLP</b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In rendering our opinion set forth below, we have assumed without independent investigation or verification: (i) the authenticity and completeness of all agreements, instruments, corporate records, certificates, questionnaires and other documents submitted to us as originals, (ii) the genuineness of all signatures, (iii) the conformity to authentic originals of all agreements, instruments, corporate records, certificates, questionnaires and other documents submitted to us as certified, conformed or photostatic copies and the authenticity of the originals of such latter documents and (iv) the legal capacity for all purposes relevant hereto of all natural persons and entities (other than the Company) executing all agreements, instruments, corporate records, certificates, questionnaires and other documents submitted to us. We have also assumed, with respect to all parties to the Purchase Agreement, Registration Rights Agreement, and other agreements, records, certificates, questionnaires, documents and instruments relevant hereto, other than the Company, that (i) such parties had the requisite power and authority (corporate or otherwise) to execute, deliver and perform all obligations pursuant to such agreements, records, certificates, questionnaires, documents or instruments, (ii) such agreements, records, certificates, questionnaires, documents or instruments have been duly authorized by all requisite action (corporate or otherwise), executed and delivered by such parties, (iii) such agreements, records, certificates, questionnaires, documents or instruments are the valid, binding and enforceable obligations of such parties, (iv) the Selling Stockholders properly convert their Debentures into Common Stock or the Debentures are properly redeemed, in each case in accordance with the terms of the Debentures; (v) the Selling Stockholders properly exercise their Warrants in accordance with the terms of the Warrants; and (vi) none of the agreements, corporate records, certificates, questionnaires, documents or instruments we reviewed and that were submitted to us have been amended or terminated orally or in writing except as has been disclosed to us in writing. Additionally, we have assumed that the Shares issuable upon conversion, redemption or exercise, as the case may be, of the Securities, will continue to be validly authorized on the dates the Shares are issued upon conversion, redemption or exercise, as the case may be, and that the Company will continue to reserve and have available the requisite number of shares of Common Stock upon proper conversion, redemption or exercise, as the case may be, of the Securities. As to all questions of fact material to our opinion expressed herein, and as to materiality of any fact or other matter referred to herein, we have relied upon, and have made no independent investigation of, representations and certificates of officers and representatives of the Company and the information provided by the Selling Stockholders and of public officials.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Based on and subject to the foregoing, and in reliance thereon, and subject to the assumptions, limitations, qualifications and exceptions set forth herein, we are of the opinion that the Shares have been duly authorized by the Company, and when issued and delivered upon (i) conversion or redemption of the Debentures in the manner contemplated by the Debentures, the Registration Statement and the Resolutions, and (ii)&nbsp;exercise of the Warrants in the manner contemplated by the Warrants, the Registration Statement and the Resolutions, will be validly issued, fully paid and non-assessable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The foregoing opinion is limited to the substantive laws of the State of Delaware that are relevant to the subject matter of the opinion, and given on the basis of the law and the facts existing as of the date hereof. We do not express any opinion herein concerning the laws of any other state, country or jurisdiction. We express no opinion as to (i) compliance with any federal or state securities laws, including the securities laws of the State of Delaware, or (ii) the securities laws of any other country or jurisdiction. Our opinion is based on applicable constitutions, statutes, regulations and judicial decisions that are in effect on the date hereof, and we do not opine with respect to any law, regulation, rule, judicial decision, governmental policy or otherwise which may be enacted or adopted after the date hereof, or if we become aware of any fact or circumstance that might change any opinion after the date hereof. Accordingly, we assume no obligation to revise, update or supplement the opinion rendered herein should any such changes occur after the date hereof or to advise you of any such changes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We hereby consent to the filing of this opinion letter with the Commission as an exhibit to the Registration Statement and to the reference to our firm under the caption &#8220;Legal Matters&#8221; in the prospectus constituting a part of the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Very truly yours,</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: small-caps; margin: 0pt;">/s/ Squire Patton Boggs (US) LLP</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Squire Patton Boggs (US) LLP</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ex_527988.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html><head>
	<title>HTML Editor</title>

	<meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; padding:0in .1in;">
<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;"><b>Exhibit 23.1</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">We consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Form S-1 of our report dated March 31, 2023, relating to the consolidated financial statements of NovaBay Pharmaceuticals, Inc. (the &#8220;Company&#8221;), included in its Annual Report on Form 10-K for the year ended December 31, 2022, which included an explanatory paragraph related to substantial doubt about the Company&#8217;s ability to continue as a going concern. We also consent to the reference to us under the caption &#8220;Experts&#8221; in this Registration Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">/s/ WithumSmith+Brown, PC</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">San Francisco, California</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">May 31, 2023</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ex_526764.htm
<DESCRIPTION>EXHIBIT FILING FEES
<TEXT>
<html><head>
	<title>ex_526764.htm</title>

	<!-- Generated by ThunderDome Portal - 5/25/2023 11:36:22 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b>Exhibit 107</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Calculation of Filing Fee Table</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;S-1</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&nbsp;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Form Type)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;NovaBay Pharmaceuticals, Inc.</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u><u>&#8239;</u></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact Name of Registrant as Specified in its Charter)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>Table 1: Newly Registered Securities</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: bottom; width: 1.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Security</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Type</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 4.8%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Security</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Class Title(1)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.6%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Fee</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Calculation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">or Carry</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Forward Rule</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.5%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Amount</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Registered(1)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.4%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Proposed</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Maximum</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Offering</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Price Per</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Share</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.5%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Maximum</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Aggregate</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Offering</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Price(2)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.3%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Fee Rate</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.6%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Amount of</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Registration</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Fee</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 1.9%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Equity</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 4.8%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Common Stock, par value $0.01 per share(3)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.6%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">457(c)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.5%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">7,615,392</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.4%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0.68</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.5%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$5,192,935.80</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.3%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">0.00011020</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.6%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$572.26</p>
			</td>
		</tr>
		<tr>
			<td colspan="5" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 14.2%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total Offering Amounts:</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$5,192,935.80</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.3%;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.6%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$572.26</p>
			</td>
		</tr>
		<tr>
			<td colspan="7" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 19%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total Fees Previously Paid:</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.6%; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr>
			<td colspan="7" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 19%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Total Fee Offsets:</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.6%; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>
		<tr>
			<td colspan="7" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 19%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Net Fee Due:</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 2.6%; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#8212;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The 7,615,392 shares of our common stock, par value $0.01 (&#8220;<i>Common Stock</i>&#8221;), being registered hereunder are being registered for sale or other distribution by the Selling Stockholders named in the prospectus that is part of this registration statement. Under Rule 416 of the Securities Act of 1933, as amended (the &#8220;<i>Securities Act</i>&#8221;), the shares being registered include such indeterminate number of shares of Common Stock as may be issuable with respect to the shares being registered in this registration statement as a result of any stock splits, stock dividends or other similar events.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The proposed maximum offering price per share and the proposed maximum aggregate offering price have been estimated solely for the purpose of calculating the amount of the registration fee in accordance with Rule 457(c) under the Securities Act, using the average of the high and low prices of our Common Stock as reported on the NYSE American on May 25, 2023, a date within five business days prior to the filing of this Registration Statement.&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Consists of 7,615,392 shares of Common Stock issuable upon: (i) conversion of our Original Issue Discount Senior Secured Convertible Debentures Due November 1, 2024, (ii) the exercise of our outstanding long-term Series B-1 warrants to purchase Common Stock exercisable for a five-year period, and (iii) the exercise of our outstanding short-term Series B-2 warrants to purchase Common Stock exercisable for a two-year period.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>nby-20230531.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/31/2023 8:44:05 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:nby="http://www.nby.com/20230531" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.nby.com/20230531">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nby-20230531_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nby-20230531_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nby-20230531_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.nby.com/20230531/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="nby_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>nby-20230531_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/31/2023 8:44:05 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.nby.com/20230531/role/statement-document-and-entity-information" xlink:href="nby-20230531.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.nby.com/20230531/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>nby-20230531_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/31/2023 8:44:05 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFilerCategory-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Filer Category</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xlink:type="locator"/>
<link:label xlink:label="dei_EntitySmallBusiness-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Small Business</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>nby-20230531_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 5/31/2023 8:44:05 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.nby.com/20230531/role/statement-document-and-entity-information" xlink:href="nby-20230531.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.nby.com/20230531/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex_527859img001.jpg
<TEXT>
begin 644 ex_527859img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !) ,<# 2(  A$! Q$!_\0
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M4(+=@\=C;Q^7 S#HS#J2*[M8U15"@ *,*!P /2EW*>AZC(]Z:)%8D*P)4X8
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M!DKGD#Z4 <;\/O (\"P7\8OWNOM<HD)9<;3BH?$/PZ&O>.M,\2G47B:Q9"L
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>%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>nby20230525_s1img001.jpg
<TEXT>
begin 644 nby20230525_s1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !% 30# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WZFLP52Q(
M '))[4^J.K_\@:^_Z]Y/_0332N[";LAHU?3B,B_M2#_TU7_&I(M0LYW\N&Y@
MD?\ NI(":^5K2WC^RQ'8,E>:T]-NI-'U6UU&S^6>W<. #]X=U/U%>J\K?*VI
M'E_VG'GY6CZ@XZU0?5].BE:.6_M4D4X9&F4$'WYIFCZK;:UI<%_:MNBE7(!Z
MJ>X/N*^=_%,,;^-M>)0$_;7Y/X5QX;#>VFX-VL=>(Q*I04]SZ/M]0LKIREM=
MP3,!DB-PQ _"J>KZRFF+#&$\V[N7\JW@'5VQG\ !R37D_P ((T3QC=E5 _T'
MG'^^*M>,_$4FG?$/49%),MKI@M[7)XC>0Y9A[XJI8-QK.FG>R)6*3H^TV+^M
M^*$T:]8:IXAO;F^Q_P >&F*L<,7L6()_,US-[\4+XC$3S6R^LEP"?Y5SGACP
MQJGB_4Y+73R8[>)LW=_)\P0GG _O-7M>A_#'POHJ*QT];^Z ^:YO!YC,?8'@
M?@*U<Z-'2UV9*G6K:MV1Y WQ"\132;H-:O%P?^6:!Q_*N@T7XS:E9W"Q:S%!
M?V_1I80(YE]RIX;Z#%>U1V=M"NR*VAC'HD8 K/U'PUHNK1F+4-*LYU/7?",_
MGUK&6(I3T<#>%"<-I-B:!XHTGQ-:FXTJ[68+PZ$;70^C*>16WU%>3ZQ\*I]*
MNEUGP1J,^GZC",K;2R%XI!_=R>WL<BNB\$^.D\1F;3-0MS8:[9_+=6C\9/\
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M_ FHL[VL5=;FE1FJ%MJVG7DGEVM_;3OC.V*56./H*L2SQV\32S2)'&@RSN<
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MHQM'4U]+Z'ID&BZ+9Z9; "*VB$:X[XZG\Z\F^%NC_;O$,FI,N8+%-J'UD;_
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3 "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>nby20230525_s1img002.jpg
<TEXT>
begin 644 nby20230525_s1img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !1 70# 2(  A$! Q$!_\0
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M?Q-KUOX;T*?4KC+>7A8XQUDD/"J/J:\^U_Q#9^&GAGOH(;_Q1/$'.\92W4]
M/0#I[U-.DZC0JE50W.^MO&&CW<?F023LA&0WV=P/U%-F\:Z#;_ZZ[*?6-O\
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MK2%!>U]G-F52JU3YXG:)\2_"$CA%UJ(%C@95AS^5=6K J&!R#R#7RL\&^)E
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MH!DLQ]*^E?"FCKH/A?3M, PT$*A_]X\M^IKE_ WPUB\-7/\ :>I3B]U9EP'
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%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140041574843408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>May 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">NOVABAY PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">68-0454536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">2000 Powell Street, Suite 1150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Emeryville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">94608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">899-8800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity, Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity, Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0001389545<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>nby20230525_s1_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nby-20230531.xsd" xlink:type="simple"/>
    <context id="d202310K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001389545</identifier>
        </entity>
        <period>
            <startDate>2023-05-31</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d202310K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d202310K">0001389545</dei:EntityCentralIndexKey>
    <dei:EntitySmallBusiness contextRef="d202310K">true</dei:EntitySmallBusiness>
    <dei:DocumentType contextRef="d202310K">S-1</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="d202310K">NOVABAY PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d202310K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="d202310K">68-0454536</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d202310K">2000 Powell Street, Suite 1150</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d202310K">Emeryville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d202310K">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d202310K">94608</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d202310K">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d202310K">899-8800</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="d202310K">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="d202310K">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="d202310K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M;%!+ 0(4 Q0    ( !V&OU:47L&,[P   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( !V&OU:97)PC$ 8  )PG
M   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ '8:_5H\/)<RA P  EPP  !@              ("!#@@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( !V&OU:?H!OPL0(  .(,
M   -              "  >4+  !X;"]S='EL97,N>&UL4$L! A0#%     @
M'8:_5I>*NQS     $P(   L              ( !P0X  %]R96QS+RYR96QS
M4$L! A0#%     @ '8:_5CJJHN=  0  / (   \              ( !J@\
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( !V&OU8D'INBK0   /@!   :
M              "  1<1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( !V&OU9ED'F2&0$  ,\#   3              "  ?P1  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  $83      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>15</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="nby20230525_s1.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nby.com/20230531/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1" original="nby20230525_s1.htm">nby20230525_s1.htm</File>
    <File>ex_526764.htm</File>
    <File>ex_527859.htm</File>
    <File>ex_527988.htm</File>
    <File>nby-20230531.xsd</File>
    <File>nby-20230531_def.xml</File>
    <File>nby-20230531_lab.xml</File>
    <File>nby-20230531_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>nby20230525_s1img001.jpg</File>
    <File>nby20230525_s1img002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="16">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "nby20230525_s1.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 16
   },
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "nby-20230531_def.xml"
     ]
    },
    "inline": {
     "local": [
      "nby20230525_s1.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nby-20230531_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nby-20230531_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "nby-20230531.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 19,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 15,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "nby",
   "nsuri": "http://www.nby.com/20230531",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "nby20230525_s1.htm",
      "contextRef": "d202310K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.nby.com/20230531/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "nby20230525_s1.htm",
      "contextRef": "d202310K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity, Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity, Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.nby.com/20230531/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001437749-23-016284-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-23-016284-xbrl.zip
M4$L#!!0    ( !V&OU;I"CWHL@<  .DZ   -    97A?-3(V-S8T+FAT;>U;
M6V_;-A1^7G[%F=>+ UBV)<>YV(Z!-$V+86MJQ-[#G@9:HBUN$JF1E!/OU^^0
MDGQ+FW1-HCJK@2"R*(KG]IU/AQ35"W4<]7LA)4%_[X>>9CJB?7KS1]L[/#H\
MJ./57B-KW/L!K__H./"><BJ)I@&,YS *4QY0^5;$% 9":A*! ^V&AW]-KP6N
MVVD==CP/!A_ <?J]F&H"?DBDHOJTDNJ)<US)6SF)Z6EE(F1,M!-037W-!*^
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M])%<4&:JR83K>SX >/\?D8["CV :[=(DY2PH[\D(L-AYR827.,&>J=@]"$O
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M<44>[O!QL^?EEGDX\Z5I[&8*7U)/-9R?]%\^5" M9#(>F+)CXZ^KM7!H&?F
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M&ZH$#/$B[1MRG6MK+;&#[0#]]SL[+R200EJD:9_JE^?Q/7<^7ZX'1T])3!Y
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MV)$%FV$K4#X0F(LJM.\"'U7]$.2W]KBZ=R&/JUB.+G)DQ3N01U7\2(Z<C&W
M8ZDM(5/L2BRDC:J:GMQ:E2FXG"&JV58C>P.6+ 21*]#&E*3@[\B/TY4B)O[I
M&-Z\@(1JA6K]=ZDVW613JY=O_WE@(A1+N:CAD*5T6NZ=8]N=J*%J,0"^?9;Y
M$"[==*N0#;OV<A+#C/O),BF9U%).F/LR<.X3+O0C8?O[UGL7DY79YJESF/M[
M=*PJ/!_D>C@5V7-XY1#E6 7[/$A.25)H(X_8V)[\]M"$M[T(8T-O+14'MG<+
MI>H.:SJ4]EDQUMMEFVE0P(W*>OT9_%E$F.BR5^"1OD:3TX9T!8E,C2]2?F *
M\B"KCD3*C3;(T0]%CS1_O0$I9"X<ZEJ=T1GB$27%8I,I_7AD-%PS<='4C2<E
MZZ<])0:C*D_(4!+DI&)S=\DD*(BZNG^"%%LC_<XX!?LLJ*ROR2KU3,9A+#AF
MXA%'IO[FE96Z$LQ"U7-%>(+>69&B;>#*T&(A%/6FXB!TF0]\"ES/%WD?+D@'
M9DSP90<">RX*'54J)KG(=:4F(^($:1D(.%I)04I+ U$JYCJ4M+/BH WQHAO(
M41>^ALG/B8^S:$2X-6)[ZDN%RX)95ZPD/<KRHT1  UG:9R\<[%O%^6D'@;0X
M7KVHZ^66-3LYM:5R8\"K*S,KSO4&TC<X3ZR)^9-G*QSD5SU9Z<C-)SZ$N?TG
M+FOE1W+RCE9[2A2U6JD4>7,),=AIRH?-IWK2H5?#)][G\!8F3[QRFVHI_TA.
MMB!K#\OZNB95T%QB;.Z:8I-K6SW9Z4,L,/TKG.9>)><5?R0W&<#:4Y.P(TG?
MU'5PKJ^FQ.085EE>U'!K<X(M"3'M/C 3FQ!5IT"O*XJL_IX;G8)]%E3W@$6V
MA_8GP(CU!L96<N@CEBV8RI^Q*#ZD"9NX+[&Z!D7LJ'CN?PDIX1VY[HR!+ZT#
MWUA5:M)GD.H:\9H4I:P-#':S?U#0F(HC,(@PI7_,8GDW$YL>K^54E8I !JFN
M"&A2E+(V$ &S?U#0F(HC\! 1/@[9^"N'N9AT()IB9I\&N=6E(F%$K"L:*3E*
MV-&*OH&,Y!L+!SI666;:$6&!>KKSA>*Q(27&_0?F(H-1=1+69$BQU=IXLU>P
MUX2*!T)'DG),NRP@BV_$/@HL=:6&P!9675__%2W2O$@2-_#%M]D(A?W9R</&
M2?3DUOW[1V'RO\KRD_\!4$L#!!0    ( !V&OU;L(*4XR ,  !@B   4
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MTI%7P(#I1_PW&,)JTW-B.!0#DFU4\\5UE'L5KR\I@=A;YRFM_@G<0\F$5T3
M1:2C OH";RR6V44&ZPY+1(OV#GK"FPR7N4_BNOHY\$(1!Q/\D)%6%R5E6D)3
M00[OC<LL+]$%!.^=E["'V[T=CZ*KZ@$)!P/:<?0(^M[@6@P^TQ/#-([36QQ5
M/_W2\?[YC_T7V[N/Q L^]V:9+8A43 >LI]HFE(<BI&:0V*V]1!DC2'BK</V:
M6[&[N=9?;]T-WQO'(LA%VV:0I!7#"%P[F=F'+%>'3(ICBO!$D,48AF0.:LMK
M.!6B5'8M\H0D,6P_:6((/."/Q899P4"%WTDZ<>[Z8-JNK[;[L6UWN-KN![+=
M28@^%(%!R+PO\/QG[_9:D-\7%\F*JB!ZB*%!((/! %1>#F!&0LA0#W9^BP&_
M&\X?<HQ]A5XR,4ZS LD I+$QR0ETD<!FX=BOO"O0=(IK]6L'B$/0T$(QC!*Z
MB'*D ;3W;79?M0V0?NZ]4H_-?*!U>/I!I%CY<,M8U9-1PH>CM]G?V%3TJJ,A
M@<)_O#3XX*-%1E$8QD)VLO]=W+V5]7M/='5@D<T[))N%'-2+CODN=MUF:E\_
M2D4]=S[%;]V61[,ATEW]M^6C_*^*B^(8?>*L>,-<I=G$%1U%6W8H'WCVYB-<
M%HX==7K>EGJ'=Q_QD;N0-^.YOAD/^;I;\HWY*CKNIVG<A_FF<"]]F9G H_=^
M%L5^VVG_)M*XOY>_)U$>*PGL%Y; GBY)JI7@A9#K8%T\<Y+FHXN;6L!4V:9[
MH ?0J3%%P[JR=!WD'EQC [S%DI3TXS)GO04Z!24:;6J8C$X*C,=Y9:2:8E_Q
M!#NG/"I4B!*8<HJJR$V4D[Z2!,D@"F)4<S"8&!_.93 GQCND-U'(-KL+P5&[
M+]:"];7-];6WZTK]J*K83U+]?=U_<UG;-9$)V%FR<N33S/=HB<[+P;4T]6?T
M;XZ)!Z-@@A;K1 S@1L H6]@%LEA3%D+-1X![%]=))[^&PTU**6C)PS(C7=P8
M7FZO(^A7YC< \XHG;-O \0;%U$%SR]B>8+=%7PPPZ=B,*B(M'K1"3#=G LPE
M">VM';00#\[?S&1JWXT.*^L8Y-2"20_T831%W9B<!U%8&95/BQX*F-$(+N*Y
M_*'?A8X'&,C\KV=GO[S]32O,?)MXI 9[MA[L83->11'&K^#*J;;U[O)<-V:1
MN"?]?)[50>W=Z^$&L*_FEZC:>V>_?/STH3:+ZC]_?WV=J8[/#GXYWGA[?GSP
MV\;!N\OC\Y=>$-\&D_R5-"%P8G=E,*_@-/&L-L=?7@%;BS$W_!]=^C]X+QA\
M!NY:)N%&]:=GE,=568)?C]Q+@.OXU0MP>7KX'M%#IBW!+"KR&F3D>_2-C^$6
MT5!FU-LI]I*&>/?KD[DW[@C,,(<;3O7%._*/X9#VZAFQR2C1N"G()HC/P%6#
MC*@H<[0.XCU'MY? LYR$BA>RG2OL>)?D_8MCOJ_2P>?K- ;BR4F&"5VM8@O8
M++Z%O"&ON ^;[+-NZETX'SFR>#0.V#E)Y>8B;N0<&38?%>KY/(VC042,S'ZU
M7TZ:;R('ABN_DG-SBQR;9L#O8C0/.JAE\V/D>P5(&L#Y<!<?B6>_$<C@J?_M
MS:;8BT]O_WU\> FG'%-VS]X?8\JH[QT=8,+OAX,_K(SSA[YD]4B/L_/3BS.8
M^Z>+MHNPN<AWK=:,@-+C@N G+"@4^+K;[77^'%\!.\\&4W^V;\^M[MXK>9GL
M[K]B.)/EV*XE)HO9(4$O_-W>CK^UO^E=7 >9("\*LD*2VX [/[4@H3JWST!L
M)[DZE7<,,EW?&]9C@'S4!HNVNTU#F,@+3FC9544(65V2V13O+.E8NI M7E@M
M*J_2&K8EGX/=?!V]<3T-"O\;SHJ@MTB$+\<X=+/].6^_HT'ZP=7$Q_0F> N7
M\QD\,0H&HB1#"L@])\F@HT/OURJME?66_&IOMV+Z[VF937] #JKQD'3X5I[5
M!J+:W 9\ &@+?6\<9-Y-$)?"^ZG;Z?;PJN75<BP6'QW3()$U+R.?IFI//ES?
MH-.@&ZX<IR  KD78>W(#FR:I R;LG8)J$&&HS0D\+;RC*">5'V29)()YD4@#
M]')(+Q81-G<D^D!')6[I$;P"JR+(4<XWWK9CZ.:-YBC7(A@7VRU$-HARH4:6
ME@49'9#BXC2YVD#]"P:4H1CS=J/GW089*K1T@$"! V$K%Q4&HYJD1:#X(9#8
M;L3&1,"R2Y-(E83>8S^7V,_OLO'F@%'V@D'/,>K\.LV*VK WOVK8Q6TZ9=07
MU,^T8>.@?>CPBCWO6F)MSM=ODC*AA+6M!TO=%DE0P#I\57F+8NU AHI9\HTG
M'B%!96Q%0O$3Y=*\I6\C5]=Z?U)1CI=J42TUXQ8%]U0>8;34 %/&%0T& UC;
MJ*!+X48 M\E8],=LI1NTA8SC0,>ERH@ZLN_<PBX E\C+T8A<9 R@Q*L@15K'
M :>OSV339ZKIYMFQ[2R!/9$S=1 .KC)!+_MDLPF] QAQ[&V^X+[I+D02ZXOB
M5HA$&70HL ._%\'@VIB1FO<5#9ZG,XW0' -J4O[O@NA:!2[R&JJ+7 ^"+S]Y
MA3N'9*\*/H0<@P\2[$1H0E :YJ]SE%GSYIH%]'AUY5IVS76?3.VCN:EL,;P5
M'HF!1'(P$4LK=DP9:!'FEDA)13_KIJ,G=<Q/RZQJ;JC2T0!NVXQQ'>O"79@*
M5MA'(DB4M;9E_6^C.+:T?30R6"'4W%>'%^6RK0TTGO";V%9&T7R9/60KD%>=
M @K(5N'65;JO3D8.?IR)FX#P3\D3(@ID8 .A?R<Y&;KC$Y?AUXFX2HN(S@$_
MV\%X0WLPEJD)#6FB(C4O("(_*;K\73#1((%E8B H7!-(!O9L($282[V% A\7
MX7X=[]?T5MQ@T![*J=3F(,BO*Y)54Z"8TJ*/O(C&JL9)[>F!&B%;_%4".4BN
MJ_LCJG'VVO%.7&.AIN3;(5^SV&,L\EQ_;P8U>P&GSIP%KO9#31=@'V5%/)8#
M;7KD"R64\CUF&U+6!,BS19%%_9(C]G@M(F1!=!)QD+B?>8TU>(H<J"?\89#F
MV*KX,A9)+N7 H1"MK+Z=QSVI8X7LOB+\ QO$.&65K +ZU1\7Q]X!N=.!K9O(
MYWPRZJ>Q8E,?W_[14<(^$D@<Y(4,+E7Y1IJNTWJ?"B6S*T4%% )!(=W=,6?E
M26W*'VF)REL)PG0F@K!^.?ET;H/Q.(8MZ=/*ZGLK+^%K%JSQ!."#;.>!TP 2
ME'>;L:'>>F4 RSLL47SO"[B8A#>![EEL[W@@D9W0G_@2'"7<NXHY_R:-;_"X
M>=<@J'FA0#F-D JB_'/'>\LMAF(0D4JJ8Z]3V4.S39_ZE],W8T.E(%*TAXU+
MAS"PM>L '<XB'P ?@7D:$AT$8SK>6EXD"?,<7O;>!0-42BQ)$GY!0AP'5\+;
M=1BO[L_O>G_Q Q]%I$/EY_ N)13:+AWV-IF8:X B1P+,5;SA'#>X$<S'8=-A
M!(^,@QPO-KJ>2:X;P*_!@"/I0[Q$!Q/7AGD'1/T@P^4P+>;T\K+%4*0,PQ<H
MZA\(9T1&*)0,X?9X1%OMLHTC?Z[D<%9=@$H[7?T7_\M7TOU</ZN BU7 Q0,(
MN&CQOUT>O'U_C+#$AZ<?+X\_7K;Z:[_K.7KPF4 &]G%SL[.S4)2R]6JG=R](
MH&<@35G;[@X15Z-I'N'LJK^VV=T&'KRU!__9V5E7DUA@N;YK?DX_+650XIF^
M1+\2U?->]FCS6W9F9X<V92EWQFR'=X'.A&RQ8/E[WI:MQWI@JLK7P]F0W<=Z
M3BXPTAI4GX]I0=Z=("-%_5V:W<*?&^_3]#,;^F30X6*[YN%DE$1%&^<Y9,YG
M;UX\+BK_Q,;3,VE:_2Y+MO>XZ/ #NU<PWJ!N'_PNR[?_N"CN*,*DF"3TSC 8
M=[&[[CLNV3)3W)D&3JT&E'V'E4,XWT=%;61L'2O?R6$PC@JUCM]G 3<?%^VY
M0QF_Q\(],CYW%E.* 08*LMLPPIC$[[!PFX^,XMZ#:!=['X*B^%ZDAL$\CXG4
MCK^,H?OE6:MEIJ[?*84'_9:'<#[?12"(?$#'WXD)=5F:=5QFFCNIU@&"JQ5&
M$T2)IXK)4>3)N2IC^F/6]+YSY;^+&P2]%7.[06J#>H!^#)=3XMY=FP_7A8J
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M/1KH^E_-0?F<78<_H^V!JS88""/I)QABFK<%3T0SL>>K)>QYU !9B<.*?25
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M7\QVX%W!59+1M2-=>2K\1.6 "$X=#C!;F(IF4]Q:'-Q*1P#]JA/S$+Q$E[_
MF)<_TPQ#?9HX&?-XN5#2T+T6Z4OR\01QP3>LC,4QP384<^\(4DMU" T(%2*9
M)0'3[:TZ(8?%_#Y*LO+S.^FL&$(=;P43R;"[,!V4["&+.,X?Z"+AX-&B$5.4
MTQ.MH4$-0SW#3^C+KAKMYLR[;[K.R8UQL^Y19 Q;V'$0P16F(^&VDQPD,\3T
M)<]C \%"7*7S1)X^IA-HI04_.>[SZ]??:+X*]L#?+0Z  6F^;:Q/YDV#$.B?
M L$X(3=]CADU)EH!&JY(D/T@C_)U)F#M2J,+%JOS4,*$R6 >%"7QSW$0A<T!
M5;&:0#)E&")L5NHL5E.9F*,5=MY-8YGU;$$C:NN^5O%[E?B]K57\WB..W_LJ
M;ZG.EGUJ;/MWYKK(1-(^O!<4BC6'<,MS>+X.PJBFGK3:%+TY)%'=::%P;>H\
MS,I@5M(I9D0 ,PV*-)M4<YK)!!/$Z55:YHTLYZ>TGZ2=YRC3/S5*OKSF@!C4
M:@Q> P:;P5\#K\@"TCYD8+["/)@2.EK7!)K1D+D)AH3."JX-B+3+"@+:[\6@
MS#A/&)0G5F&P9SF8? )OC9X:@1ZI,,&S+"TX .NI$6O%=G2+$C G%5$F%QL8
M28V*LKP@['#*I:)LL7E2@#D/!]J,0?TK*)M,A\U.DR4M-9W5[S$9/$V^B-)B
MB6./@L^"?K1R]IL!-;9TB^ZI!@J<EE=1\B\H9D;^A?_<!#&ND7608$P*J;+%
M)KQ&06(^(Z#=I%&H$I;"M.P7OF7M515$JS=; RV>S2!EOK#'0\Z/@ /,%-:E
MZ2 O^[RR>4N2?\TQP/X7("RT/]<,XTKG9ZA >'W-@ ' V$&&Q6<S&<++?L4<
M0WC7%^@[!V*/'9WC/,E60(LE(^\43,X@4 'TK9!Y]N(WW)_D^TE\G;PX"'()
MA[5P$#1O/*7?XSGEJ$/M)5C4#V*BG.$HA.*KPIK5B&#;;,>#C6-GV('Y7;$$
MBK(=PS8.Z$@P/S&Y!'A$RG[./#:70=.@BUQ=\W8%_?1&<)R^!"CTU2IP4RKW
MW[BX*+D1VHQ@>)Q8B1JN'D*5DS$?FA6H7Z$_C&K [JY4N.]$5F(@@X"21,EA
MWGPR,P F1!!^E6$!9Z+,09I'IHAUC2:7@(;&.:Y C %.A-K5,W>.0>G9V"PM
M'X7_3MP\3JZ=863MBZH25LA=* 5CV^.(W0K<_I33)3-16?9Z(@O&U6K2X9-B
MTB!4%"Y'*NO4=?*K+7K ^*A^W=FD!,6^D F-H78"\[BHC5<ZQ%>*#6@=1;4\
MK+F'9U&<_@87$"\X&7$_+.-X(PN*P;4H9(A]+;/!](V6&0Q>MEYI?;;F1&?<
M.IW7\!4,B"\B.J=878]F#3?VEW5'^!_5J>8<4[@-148N62F \M:$9<:_3T!W
M9R>G^LK;ZFZ0F5\6/%(OPD.J9C42$$M6Z!\08>[]M+73Z7:]-;9XI3&"7DEG
MU75 0R&963-A.K"4GM*69^)78[^MM51IV!8SQFN?T4CL>RY'4"QYL43_5;GH
M_$!8@2CD4ZW0NJQ<EG6M%*AEP-#>D5Y Y?BF2MYJ+78DT 2>.&OU7M6\T]CJ
MB4S"T01P+JY0F.(MO\!L*)J@G8,@\QO4P#+[C5R_P5^+3 .:"^1Q3K-EB1@<
M\40]J1,OYD'99K!=F0IFW5:E[!BV;D30P_PT+]4KDAXFZ]Z+G9_G.+PT"IN,
MM&67;:7SN%8ELH;&TW @K#72GZ*L6HUK5DC5D]!C0)M[!P2#/C"4UZQ$F2?G
M #D95F4?CCF9;0FC/)XJRH0%&Q[ @4%YWT?I6QY9E!2*()%(\2@_RI0%U)R2
MJX A"X)$(B),QO26LCX,-9A!87:KA@NUP$7$N9_NZ[2%-.3-*H4%.W:A?9%(
M$M*@#ED-J,[G^Y!D-Y1W_RIK.9+H]9Q#!0:=R8/;M&Q75M8-"JHN(V;U(XMP
M: _2YRB110+X^L-VM0#HHRISS:@3*?!"T'@5L+5<$FO:Q.I<X2!:$I#IE5+5
MI6:&U@98NZV]40HZ.PBI?=^-GSVMJ7I@7M5W==),L@N\%JIH(!RW[A('GC'$
MNEH%CB-C$I>VO2B;Y_@%:D.T[QJFBP%I=)@*,D.0<#!@(T#@W6:(:)O0$#)R
MX==.I)(<8$SL0<0\;'["%.J8(\G.3E4G4P:"H*"_/65=R14;5PT<5G30G)*Q
MK,CQS)^U/-OZ)#.NZQJ K'6C0P>^2DU@O41#8FDY XAMJ'S(>+?S3F8W,K"4
MIQTI'C&#H#&G4:KF@Z!4GH_Z(A*WRU'^@W:1*DABCC5*C'2HV-5Q5%6!4@.=
MS9T,3Q+7A=$>SY0>>J ",OQJ@Q7AD4.BS+-:8*1F=69IY,[8;Y;YF<=(LO(Z
MVU[G[977>>5UKDC.\YW499*C[Q%)QB%*M.NA+$/CV52YX<'T1?;)HAIZIX,B
M):R:?0:K\=:@$UZ;"BC#(EMGEQ6C<4=PY>4$ +?F0GOH:=:>M> ]:,N!06ZW
MU?FVJ[RJV,_$IIROF1EP#7-9#5J6H0WT0HI(?EU)1].7[%@9@"M2;SI<'&Y"
M%=7F%8MC"F"U<=6,P4AU7:W>$^14_CL6TCU\(<8%XR$QB6VZ9S\5A,*Q(%0'
MK%+NCMXR%<IJ.II[Q57QOOK*=V1/?!+.:GX.-WC$C/.&V$ZZVIDR3XF04*_[
M D2OH85]81\)_RYH?,BXDW1H*$A0X=^TV,_@PSL4Y2\V>H[]FM-NYRQ92*"6
M9O[UD<%%-PX(]G".D3D7)G<M3.5\=3R, L)Q,!('Q5U7:E;-[GN^?0N*EJF2
M'\OTUYKK$U Y*-2LJT6\%]%0JDP#)]J"7:3H^RMT%!BG1CMR("E)CF -UXW7
M8TOITV%I^&1JZ)GOLGV&3I_HUI%$01 ZB6)]EL&3[&H"-C9@-'>UB@Y('O*R
M*E Z=1,5;D"@*O3/7-X\O'1J[KPFL)-,B"-;Y8Q5J04A3U<LI7#"17<<Y0Z@
M4="[ RPK(A>Q1FDR P(O-$2U8$6;J$SW$57#9[323U2%/EJ1D>6%JM!96G@]
M8Z'N%FE8KXQ;O-6Y/_N>(]9*@V\!JT4D:.#/HP1$X=8K#_T/0U"T!=<8TLC3
M(Y(F,'<'2"^="$DZL,!)0<#4TFHAO\Y1/\\M T0+<R" :8725:]W,0[8[CQ4
MO8DO8Y&@9WU-?%%1)VCGH"H?_)B3K:SEZR8!E\:D["@,S*L0OW(I>@'C',%Q
MP<VD]!8TS&FP*'NG'0:6J1O5059H\[$H00KBAQ'E+VN6U9BQ\[D09 4;3Q:3
MC;ROPL5:'!%K/I7O1ZF6CTN%K2'''JZ08[\%.;:W9U74K4+'M@E-=0C4.ONN
MZ2Q3K:I\:;D5-X=M@'Z;VF1#$>!6R@3C(Z657-9S0UE\WO+1*JK0B6"I-5H[
MA*D:->FR<"" Y04U>(D-SE#).<.+$0QU3:>=WHZ_]V*W/?I/5<MVHF=^];A[
MWGML;]JPL6_?@>O@F/"BP)Q?OR =[\ 4QE1AOVB.]VW?0BN"Y_<#.7;0VQV!
M',]='WTNC&,G[BG51Y<3RK66W 0MQNM63MO$6%8NT5FPQH=W!VOL*!#_HV&-
M][:W_=W].P U;A89(Z5B3CSCYDH8/.-I6F!%FVL1X:=MV!/5 %LV:W$,65=A
MHT4Q9*?NSP^2E9=%(%NAQ_X($"P'MUFAQRXS(J%$&EPA$KJ=XFZ];(YR;>D"
MN+)-;,V[P!:\I\)T*UJ_:U)ZP*?@/A%KFVC-=X58NSI9JY-UWT._3RS<UJK7
MCQ4+=[I$O$+#G4L1^&HTW&93WP<-M]G/"@WW&]!PIQD?5FBX*S3<%1KN=T'#
M=51L6Z'AKM!P%[S%+;IR D<VJ<P Y!(<P:(HN?[=P^0Z/'SRVOS^8+DN!]P4
ML-SIGB_T3<LH1?WB_2'F3O=1+ Z?V][60\;17=IDJIU5,M4C3J9:H2Q/N]5^
MG8^+:4"=5L3EPDI(->@["\,O-WM^I/#++4NL]*1EQ&!>@3PNBTID';8VM$>,
M;&1T( /N-B7$<0Z01Z?]J@WDL0J%]+2A'FW6N*A=KYKV8(-G)E-?7']U]ZB0
MK^X3%?+57<)"-H M*@>*[5X60.0\V3_M5^8<\)"S#8-SPD-.#6^2 _I1Z)#,
M.V=#1%;!+*8B/LYB0;X'[,-@S>";YQ)-[]*"R3O"*=FX9_/OQOHC!I6TT22K
MFV+,\,B)*^"2'"&X +;DC\*3=&C/Q9QXDNUG>0J>I!6,^" 0(:>R"C<B9+#>
ME(SG0(2$MC=WNMK[T%C\;T.,))-(WP7XY^(6="?+N:D <(F%38P.<=CG P*<
M(L#?!11@JT?Y24B[JS(:WU1&PQ%RW2BCX?:*K,IH?">WWJJ,QJ)E-%K,WU,9
M_*J,Q@IX]0< K[9DRBTU\.KTS*3O +S:YFR\8^!51XS2"GAUZ8!7F[OT#<"K
M#M'E?H%7IV6F+3_PJF,Y[Q9XU1&N^#B!5V>GZ\[.YS?/\:UH<C7KPL]TX(]%
MT5>GVB ?L @P+W+FC/5<)D%H*9$SG9GR7XF<V0#K<.#D+;)MBZ)F;OY0U$PW
M_]7+JI'UY@=,G+$H"P(F;GX;8.*<T_L6&,4ZZ.#=(-9MWBMBG6/9[AJQSG4O
M+X18MP <00)LRM:\2096E&)03K^+NV#19:@%:GP'B+K-API1-P]GL2#JX&TW
M2ET#HJ[!9!X/1-WF?4#4S=BHQ2'J9NY\*T3=K!/TF&$WEC;H=7<5]/I0@E[O
M/+F:  7I[K8TT0I 4#-([-$A";H0%NMK<E('G'>LS IF42N'&*FI$:=6"K,.
MLK9@N!HE#%QGC>,'2+/#J[2WYX$$55SG+*3@B[6H3E<CAS( 5-KQX&IG^ZAZ
MU>C8I&)OL]!K#?66?7><_@F7+BS.SUI,,6*AHXS!U-DITRCK%;P692Y-P*Q=
M8%9P3A<YE[U$T+FM3M>#O8QE:$P5VPR+<^*I16]?U5PG@68XM PXW-'Q^8>#
M,$59<BX8SXDEI]RB=B+C.6O9/_5EH\@L<OQHNW1$=I <\[+1.Y$H9P<^Q)X0
M<BL4&R#U@C0;H&%:V2&M69CLY^ILS/?L1:)2$3&"QV7&YSG1Y@I51L(G-Q<%
MP4]X=Z0N059#[ -W_!H#0ET&42-VFA7H> =:K$28*7O)Q1>,Y*&%N5!19!/O
MES*@]1)5M8/IQ'Z=D.*N^.DTJYEC]0I42."6_2R5(:K=6QJSYO+PIZ &^%DA
M=ZG8I[%@-#%25_U9H* .'P+G=,!;C"6I%?@*"*A!0\CKIA+?,Y'',I%<@P_*
M>B060_(.QJBD4Z 7$ =J>(W ;"#:65B=OE3*%:#ES/SY=D-/9D?2-%D(=+OI
M[VSM^=N[VYX%H\$Q/(J!-OI708K6&E*\(O6"!]\,(9<>7S4(%R,C@3#U!D!*
M*4$SHK7)86R" _^)]J!MV7WWZ2,/H*0UJ?!;O:=)C-'R\NQ&Y%WU0-6S',!U
M>-%M6+'=W?U61%+MDNMI-(1YXM)=SM39]Z[[DK+0/J1C?PKFQ[1S=7=X'X&U
M,P\-W:,"<;$84,<"!A![[:QS:XHUD>#@XW/<FBSD9%U#F8";F-I+3>A#\['&
M(62KBG1/G!G#QH5$2Z75VGQ%M-9"C]IMR(1DOV'=V=*[L;H0M1I8!>-^\LNB
M*4S[:V24LT(D%\Z[O7*C5Z\2E^,B=P6L5[KM>(V1(.;'+68=^=4<2@LIG5BI
M*GDD3T*9Q,@Y\'RP#-$F,LCHE!!D!.*P[7=<$R3>),[6<-L#%;\.9WZ(OHRU
MG75O(@+E!6%F;@YO T1^KI:+V]1;VVPV[%C%]O9JU^R.WWVQZ^]O[M46U-4F
M+(ZTXUX+0R@JH*7Z[*)7FFK."6!E-_VTKK7F)H3IK*P$IAIM*C=Q>'. [FR4
MXYHBME*K7.SRA^S"1^!%;X.GM@,5\^UT7]/*6CM'*,\4M<:O!,!58GOTR]-W
MP"IQX3 =VE$6W%--^]578OWRF1H7,WM<U8EI[S4Y)=D2T.(XUO,YU+Y:6-<;
MXV2O1@;-.R%,F2#K'8<Q;'5MA+PYS+Y2>\>PQ[[("[P\082@!38!V.X9A9A6
MC=MJ BU8*@-V%4_X;[P.!T%LB12^@MP@PJ!(A>H4".O/6]OMKO-4,*LUB1*L
MT;"VK[Z$]Y43?A!E@W+$\;;YNC5SV_@]0_^NFP:' <B<&<5,Y##M?#@QW56U
MMU $84Q9[HV ^CF('$T;2O!E+[85&6*B#.H1(D^,;SO9TA2U/.B#V--RN"VO
M':<DB_E\+>.8@34%'PGL+#<1UZ91'9P@(Q-R9VB",C));#)TH#R ((4?YF*M
MF+",@OW(KN,6T61ZS5WD.>K[>AVP1[4Z7UW!KU$SCROXZ7KH]8A2US([DUGH
M0#:R89PRCFKRO2CP-M(,/Z\5CFM]KA%-3"-0-X+E59Q12E[R.,M#FY,W1GD+
MV5(]K8 ]M2#K'\+'?Y=PM6]NT<IVW5'1W=8"=5;"B$F<J+E(:U7"\79N7\U&
M>'6E>SM6I6<9I$1,;IVS &'ZH[&R*O1--7OE$A'2J2!C(U'$J9FQT("UB\ZI
M-5D<3(ES5I1M+3X6U_U<HM_POETP^DUS-<\ECL2QZO0,.W4MJZ_N+P*B<:VE
MSR:34%^,_%1JDXLT<.D3U&.G_YXV%\Q<7,QI2_4ZXLU6RQ=T4\R!?&%*T43G
MF[U9;SZNF_+KF.*!.?/S,#\.9:VI2:UGT-=<:6R?)RKOR)LN<;PH_=&V[04>
MBD+2/F$80O6X.?>81NBD&\<9.I'I >H,U4]/"Z\77OW%"K^G\X9F&!84QR9L
MA5D1'JO*@A ?)4PFT''J37..*<]_I W)T'XB;DW=R:F\WG/GFQB0'USPF;YH
M;97'P,D962IZF'V99&?-5W(CV,O&5%U<SBW/F!UB@[HI2FI3I#%,"T?=T[I5
M>FOSA;^WVUI;4F8.M+DJ=LE54?>K6_DLN='5:XW(ZZ%^-ZA]<EP(;&&NNH/'
M*5J]<3V');EB35/5N](<E=JBE,H'/\'H=$R=2)-6CE_1GQI-2V*3W@0,6H+?
MC8M:+\!=6>P=@WAL-OOI]OK&#JQ,]DMN#_6K'JU*6E'SJ-H25>-F4V)KJTV4
M^)^%//93K[-C!4TQJFT^*',4Y;D8\BK7P<YU>+'*=7C:N0X@BZA[A8Z?!OZ?
M8A@TPLH\XWX"_/$@YU!.-LWJ%%/I;Y@:C.[;<K";R=72Q!O;Y?(@*1.-6T*N
MLV$+@&%!SDR#=XQZFG'!?3=$F>-V0 Y/\#_RB>80W<.C;  V4E@IL(W[0<FU
M,OVXXM11D(SS;&(M0;351F89[Z?LHDQ.1:!IB>+\A3'2=&X^;RNN-,HY-U%:
MYG.J3#I$]C:HTBR2QH>LX[TK:5G/X#L!79_!,HT";^U7S%/]#?ZSKF?VO@@[
MN*;"KK>!WJ$85C#3*K*LZ4+IFBS_QZ1/ZZB61REGN?CL@5;*3BV1=V71=K%3
M.&X?@HFWN4VJV1;9LQ'%J4U9<-B!+0CN1JB<%:%:+6:@?L\%:/8<V6R<G(31
MO%[!$:[KVB_\K;U-?WO[Q=2H_UL2DK!%B0K;Y(@_;79Z>X93=;S?%6OGLD=6
M>'PMX@_-2J13+K!6E-N@,8<LW;DU&LX12=B(&KP5,J>@-?[=>>@K].$FM'EH
M]#Y+?/;?'& 8YV7P66"\@W<L:R7!CIU54(8H?6E:=29<S;>3.+B5:4T"_L3=
M>A_<+A6WJ*_B=_9YS5HV#3VAJX.]38., C^/%& "!K"&D8JGI=L(;F!6&82\
MA.$ 75W1!4X_;F"T*)N(.MXIYF'@+2T+Z@X-%@,VK<S!T#])20%[PT="%%*@
MR"TISS>RFZS&)8>!8(914A)VK ;4&0518BQ$5?-Q<Z!O!8-\M?G0;)/*H!R5
M&) /?U:JL6F@C5A: >SI^I6I4#^,46W78)MB5K4Y%:GM$KR#.K,S_72/S)?<
M>UI[6[\D8Y9 G/1N@D&0#":ZMK&T,8@O((G8@#..#K <1ZD-?)F%%$G52-$@
M7.HD'"VY]:DA!N@ REGDU"-DB#([,AY*'-OK[4D\4F\$Q\=4$E6IJ2%Z+[%H
MLPC;:(^Z(X8^T>!_LIB> I9%[)M$%KAS+(KM.B&S:*KCU]-QH8 %Z]10+[9J
M57PS)XE2H0@#E"M0MQ^AFA2.]"+74-<D4767*G;H(+RAE$Y97!5:35*%$L_8
M-9KHY:Z[R6(H@2Y981@%4LHE9W*0D#I$V\+VR$*5@I&CER95-;DYB*0"KT,3
M(626R13BA?&3EL#<!D.&*H2D(_8YNVS'[W:[^#_KW(ZU;S.7R.[(M63Y[T(=
MI&;7.K>9N<E %5>T:X:G[+.1*;TU0_ WG!>5L( DILKX[.YN;#[?JOM[;/Q1
M8']".4=<3,]9RXOHW9<U&QF.7' LH!R?7_MVO)@X4$V_<H]+:>Y PH8@\EHH
M:4$>2GZ[>>P]"R<VT"2Y+,+&CZH IZM"VKM$KMVH@/5&"":,;\#CUW:U<CD3
MM!.TG N'Z4"Q05VX!YUM?,V(L'$ <3PY#@CX3JZA5&><?_<QEA>^KHUB_"EV
M+5-F:'1^H]%8A+(V,(-+\;V'M6H*],I0:A.#UBI0YB4,Q?\^&L"%/)N;W2V3
MO2BE]U^X_BW0BCG:2R;1_\!R#G:!E@9+_(IE1"Y9RJQ2'6)*' ^5L5S6CY$%
MF<B"1E:W'*L_Z;8MKBOMB00]3H'^C.U SU="L66$1+_,,3PZE^7 I,-1YEBS
M*))KX',JAR2CX/7MU+-KPNAQU($L.*PL,0 :ZC@K3(*1"!(6Q.UK_O8Z]6ON
M7N/&5=!PZ4#ZC]-;W(>,)092 E!)XJRY2M)W*.SJ.C!Z]Z@HFKXDX+J0W,.]
M'?('C]),3)NSK2-(1I5S\CK;'5[^\(-3D*+!OK!_/>L^\]#%-$9>GESIS_DX
M&*C/+L=?1;OMCK] -W__V]__]K?713\-)V]>%]H=1\ 3( DK;;E(Q_0P/AO6
MV]ZK#+@(IS]'/WZMNZNNZ,^QC/N[+_;5.F+7[0.$NS#]U@%^C<W6:9=X]H:T
M%AMG/I?2I=$A7=J1?4Q,[026T9QG1#HD".G5]8!C\>#?#$D'_F7*>4[T^2,-
MW2V+MCHVWYDJ'_"!4L >.:(VV$9M^Y0U4;%(XC3'05\25,)15EQKNQ2G'#NL
M-A::6WC/U$VS;QS'+56U8!7V0:].!=U@5&H!BW:N#O'J$#^&0QQ0I4VK,(V*
M:JS>=8M<<'Q,78+TG'<NB;'&GLAV'&F"Q\%.-R62O5*Q@>(VW0#1-PMU4$";
M+&IPE*A8W*T%IN6>9N<N6,#2^WAFN'-:J.K J8N1/5B&4J?C K=")4SPYN05
M!5*J2&C9ST2>FY_P%HG(N"$K70ZJ9K>H8G;CJ.K61F:]VV?3)-]@Y,E!?=)M
M_PUT0(A-Y9H8FU9T%S'*Q&_0KZ5O9QP'9+V>>^78Z$JZ6B&DN4=#EI"G(X:-
M8!4V-R8CI63C-]+PPPG$9/N15J&<LW>X!@N,%Z$0<5L909,<XOI)"^^^7)XD
MX.]C,:*$E"&EFBAX*I5+G3TUTQ!&!97H0*'0+4K\EU?'A<AN(C*VG"2#CN_%
MZ4!F$+-OG4I9^=[Y=1H*[R2/B=;,+]XA@K1B,DMNI#-<]$ ONDK^9Y=.W1W!
MN4(U^ZF423\E44&E$K0II3J/$Q7 -642EVD&"YCZWFE2P"+"'X=!$H2!'O$
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M=.8^+M5.16'%6?$!#VJ<:FV]TC#FM1O+/R<OG. 135Q)H]6M&'5C]='44X]
MX732@A6J=2KUN=M1U10I1 %?'TW'?%1]$V]NI2Q,&;7&]#4=/(IIJ$*M\I1!
M3%9 SUG$J.-W0"T"T\:PW\R^V]-^<8/ MD0OZ@M([\-'C45TX,D-6+W_EUO*
M%TPU>\3;E:U.FYA>X"P:=E6[4@>+XN]I*KDA8@=RV[3&_AR<GIJG;,7VK9)_
M6^T/6)PO%.<K5L\X"'%>4/UC$]+<J#1 DK6_79K7*X:^-VG^4B'<V)!"(%'\
M4HE>U3Y9?=<VM0\BA&D'PG(JVGOJ7.HJP59 !%(<^ZXMTC(Y[G+Z)')".3J7
MQL23:O,2@>_"%S&L+:T<7#$%_P#DH.H %A$LVEYD;U][FE!OOLX R$/LUZ)"
MW0/L?@=?3>&UVK5O [OX>)H<3] 8%5EM3I!55&\:+.]IO94/^>G<HM*>FOP0
M'QE]I+K5G,I6I,HR.\".D&29[8DY7<>*ZR)H)^KM,U^GWN,O0&_X36KB2DA9
MUBF((O$D'.V=.TT: 7Z,8-C'!(;E7PQ0LJ"AF6I?LTC);%+JHQ*I+3I^+)?Z
M=3FBKK&&F#;RTK[Q8FD_9]_)/)+LD.IXO%"V]UP LK$=>.C:MOM,5P\&,"S_
M!ZT)*OJC"3?"T"[@R:&H:&T$O[;K>A5BPW^XWI?D-Q1YQ^U<99&_4.2OF+-\
M ")_3M;U)L OR*27&#+6,6/4:\U*J_OM*+O;GGW5C/54RK:ZWJ[4:YV-2%N4
M<LU.I;V.C#/R9HYVI=.<.YSEXKIUJC7KE69[C2',Q>CMI<IHL<S^Z,%_5G]D
M"EM3A&FACS"V8J3L$#G"7=E^,8?@):PH OMS#3 +L'YUSO#H@3A+]37"F#2&
MR7D#4_%,F>\B+#9G+L>L6 XY:L>H<=0.1^T<%Q)9,?'X )#(_.SIO_GQ<2U]
MT8?HJ/8BD-)L8!C_-X.4YNH@18=7O0 /&45X:#<@I=VMU%MKZ/0R8Y0"G1MK
M]XA*U36_W,842C!F=322?U+.-D$S*>"7U(W)M^DQS+=G9!BK"(7-\2;%4\V.
M*3? 7UT;Y;&?6:6"[Q/C2P;&%;PW=3.\>\YCDPVHS(.#N7D_C 3PD^O!"3Z!
M:974597":>7WXT.A@0J'D'=U1;CS221H;Z" )MPEK1$4'>%ZRAA'%\9F"NQH
MG U]]\3$]=#:9OIS;&+9H>8P*?Z9[.I!SR/'/3.[L!$@O/$4G5UU3:<DI3MA
M4\P?:D=_831C.L6W?(M1T$+^7=+$/-UF/ Z(7!!Y6]'$U[[ I"<\]048U04+
MVQ.V^UQ9WD_<P>[A&+L8-7M/HEF1!X#.Z14#Y9SR99@FX!AK E0N_AU:P52+
M'H9'UI$I0V C3J([Y(/PM_0E,$E #O 8+T48DBY"21^J^_O$])%#/2&TJ3"/
MHJ7Y[I"]WEDQ[;6S/(E_V0$ICY176,9NJ]W]\26X?^,#7":IY@7#S''*SH--
M<W"1.D=42/%;R$:!3%J+@QAO/>L)CP6WMMFGZ!T95@Z'X'FADGZ4Y:5L-<M/
M ?3(0FAZF'J*^>\5\9]/O)&*P8_/</&![ '^\LV^A&H[85ABK#E!QOEDED(6
MQ?OSY\GYS+:H LP&J7'I=:L0Q0M,+;F2+QFNW]NB,(LN9=%E@1?5C>M%XX5Z
M$3]9P685*4:#>91Y]+AY=#VMN#V6GL?1]6_BZ!/K-,?5?CZ3;S:SAX*AR+E&
M(\"<PQA2D#JGEU\\>D(.([9-1$%BE((;G\9E'B.>EE4U" S0F4U+FLD[.H?[
M"B&$,F:9ZF/X"P8:]D4V_TD^?^BY8^VOK6J]A@FF*F@([OBK7FVF/JKFJL(<
M(*C?H'_5T(_3 5KDS3QR@]><MNFW-Q>?M,\?M/?7]P]WU^_^>+C^_.F0K'Q:
M?M:KQA44NB)GG971N5,9_*[F9>]'=N=4Z&N45!Z9Z":V&#P*U!9 </!>H2X"
MH=D7ON]Z/KP-_D5QYU/E@(J4&@%,D9*6X2>J&MNN: &>I(;X8D^FK3^CJ$G9
MR.G5'DGE^>GJ?0Q$*<R1U%PI\#_]X_X*Y1[(,-/1(JNCK -#CQ J)[V"B_=%
M!'@-# Y/^-H0#O8V6AHIG1Z],?DU0AD(%\,0J'(/RDI2+4%R4/3)I>++'$\_
M\B: 7!]:7]$_@-(5UQ0%O7@R+=H:-1;Y9513A]81%P,>I&Z@K\F.*>4WF2V+
M'T-W !F15T_=F:I?5/ .6JY <\2C&UCT!GE;5;N86R<A](5<8H=NIV1^15M)
MV.A8!",7%.CS2#A$#_AALJP_L)V5 >J*D3+?''0%>VTYP U:SW._",]\S#*M
MS,Q.?V"E98"\Z6P@@$T\C)<#H EX:A)Z($U@K/[\D\KA!Z Q-VR:V(Z83WHV
MU0)");>0!YXMK+,6!)CF(JO4P=]DE92J&RO=/%).<"^4984B5QVQ&E8HP@=H
MZ/!.54N1KS?]E/</'JX4,VG:489QF>^8[TK!=Y$J\1'<FCEFR_"#8A\$;,I?
MG[T8S094,*K?AX-DP!S"'%(*#H'S7'1XPX-CX%F@653-H*6E6+'X%VPMDE/T
M$&8,9HQ2,(8R0MC3]-$]?99A2F=*+P6E^R((;.D[(2,AG!VDF:T2&</@-DI;
M0S-7$$A3H6T^,P<P!Y2" X*1YX:/$N \H_E4%I'/,H8[24)BR?0]$@-*)D@K
M!4PX$/1M]$PTF-.="<Y*6^N9AYB'2L%#&!N0MO1&])\Y1OO2&6^BLWYQ$D%L
M_3(U=$990PM+"R?5MC'&(.U#"O#"P)J$=N)CD0YU>=&4&8T9K12,9FI]=]RS
M'#.R\**GD/@A\@@JS^./H&B8Z)GH2T'T<<"!)/+46622:E20,DC!^>38ZU=L
M,M)E25#+G$$]S-/.Z'J2Y?111Z<4,24]:W<A[(#>:&1C163Y-I1:%-'BB4<T
M.$HY)N^3:"!^&'4XP 8/&(J!^U31X'*)KLWDGL*ZWGL/2MI)ZF$67 GGT7Q<
MTNN#=@XC%Q\%.37DUDB4YB<PS4U'?J(QF"P"52WW1GR:)_H"@RA!+8TMWX\.
M25B6%UTEOHI?FC>@$ZQM9DDUEG/0](/$Y1D%;B;A :3G8F*I)*^)KS@E*_98
MCD*&:2;&//*A%B=@XEV@4D&8R-,?F4$R5%:)8F'[9A1I1</L3],HF'IA6'3R
MPX88>)G6AXT%>LC$3"0KAU?#7R#%$K/[A^M/=Q>2I0S=T']4U82RKT^[=E,#
M,"EZ*9Q0&!'\-L!,EN7O>%5,=$VE*QS5:R4^E43=!'+1:A2B)J/SJ*B 1P5@
M%[(;!57*T.4BFX%\9>Z<%'/F$)">0_GQE@.S"<+8SH A!/AX)(70<Q3W$Z\F
M-KR"&42DXX+BI!G&@T+>B5-_X:\I!BF&8R%;L:RG".08J!*BL*VB6N/(5GV;
M(A7#0(5'RKOB051P'6Q7!AW*T,G\;)"M"XZ8T:+@^*(HBERE\^5S2FV<LN'$
MV_+2#<3OL>,-EI!)1?G!^]'M@.(T-4>YUQYF;'MR =2:3NF8C-@_*SD7OSPK
M.!?TR(BH++VM:[],J@C:@TFFIU0VU/0$)7 L<F4L:":F?HB-B.3[4XM_^JI$
MU5R2C>*,9XF0E&=D=_&H;(MK/\EDCBAJ-,=21;4Z5%$4@EQH(H6GJYHHZ63_
ML3 =V72L ,I)O9,5M-*.(Z$%R&'9NNN)(IQP.FE(H6!&TG=F[ERCQ0#J&EI!
M%,2LHCMFY6$$%R+<-"Y<@'CF.+^Y4&<>C%5]#8H"?K&J@JP;(0:S>2LP_H$K
M?$(25!4%O\%A!$)*(ZQ#8\;)+_ )#<$/8!'@396D\#(IKNBOBEQ^6B79Z4P6
M5Y'^_[R0?74\%FV!Y4=2=R A,9"D\+!3F#:,(O?%UXEP?-*KE-L4P^_X(2 3
M!R+II)<Y]\R0H]1+T;TC@K^PN_1^'.C8@2G,QQOFHXG"-QXFZ%<?P;'LD 'D
M8(Z!2^3( 0#V, *0T+,L;X;/2WT\GYY?$T7\*5)[\$6(R8SR$J!"92892 %+
MAFP*T[,M>4K!O#?2VE+=%Z=!**$#8LJU%Q_AD'41,F4("3<T]87IT6B1AIZP
M@Z6$&"9(7^_,'9Z1*$PZ^5%\'/;?DQ09'=\K\1,EW1(GC*/#6!B=J0K.$T&J
M>_$D[-E6/U,;)V<EF$=E6?,!AAX1=(%AVZ:G%CW)$323#F?I;@DH-'L"<R1P
M71=!$'=#0Y(LK/1-&L9A="^L%PW$=>QI["21.TDH# &OU4>),HA.Y:1BE):#
M@W(LD>084S8OGX)Y4V^TS6>I6-%L*@LNX&8IV4"7JSYKLZ.-TH+PB-.;QOT[
MH_&'CFKR**:I-<Y.Y-\AL!EY;JB!)[Y  8690=.RYBU$L](R?F9??I"F2:R-
M%QF*Y!G95W2I^F^^*J'U1YXX9.2>C'-]#%71IA2=9_N*II!!9%526Y>)$E3\
M-DL]$;D 9X0V@!'AAKX]39U155;5V/Q"!9)1>D9<DNW4KE1IDJ\6&8+2<Q,R
M@5F08=AR9<>$@1A&7>7OXBEK'RNJ"ZEZ-F(YX?1C/W]^CCG^62"5%7<G#493
M(Z3\8P489_NXQBT,BS>)S RT4VD]G9U38@\@L1[EH2DTG@1"4[)AVC*06=M%
M:B<C^21M5+4_A9PX[",NY<2*'IP5K0ECJE6?>XHA69+&P^-HH([2P)$] 1UA
MDVG1VZ(.RXFIT Q4\;-DWZ,DO=C6<Y(L;6\ZH]&D9F@;<S7#GDZBFTK"-C@)
M^T#D^YPD[)NK7RYNM(\7#[ =]X>4?;T+;789'6< V:*P"8((".=5Q1,\=D#I
MQI*UJ48Q<G&!*5<9OA3"B03X!*@P*N@('V/?;#S=^\*N:/?2!'<+ W"Q\\OC
MHZ^=_'%_JMU@>8X_37\$XB- /?'^\F#@QG$0PARRO_K?VZN[AU='\ ^$3!Q,
MBAU01%-B7"7 /"9+%]#T)_?)? =:_W9DPIOZ(J0H!D#UUTZ_JNJ8OQ=]6?"X
MKJO*)G$)0?PE E14GQ-_0\PW0 \9:$37F[B>J8)^J=X2@B4)!G/&XN088((:
M5;?\"3P:CN\!DHS^_LYSGX$U;B\KLN7[0$P$S3I];E#'195H114$+&]<F?'0
M145<,-=1(B1YO*$J[8/$-2.]9:EYR"\RTZEJ]VA17+[@TH*Z8%$\H4 #B0^R
M4ZHA/EK8+$H9(\T0SM6>$E-T%4X2YXCF)"_PH_P;M01DTL1%A3]8KFQ"KOSY
MZ]7=E?:/SW]HEQ>?T/_Y7OOX&3ZY_O3A\QUHV0,K<;)5F6/$=BYBX:%EJQ.S
MA+E7EX"U,^?PF".0GC_ Z[3[,[U0'=\7UQSI":I6@8:$2)*0-D;RUAYR<![9
MDMQ)>'Q)U9<T@SFCFGU$;$.'9Q&0,%5B==HJE1<O\^:<-+<?63U+.1S\_D@,
MZ/169.:-;Z[ U/LF%OCPW;&@R:1M5*X*:EJ8?9<_'D;>EJO+*FZ&-@P].J.E
MYY;?FU ^!L'-JAM3T:9NB![:T!Y(H;=XJLO629*9F:T8.F]#[Q,9K+90# J4
MD#)]1DXMO#12E'AVC1TE%?K*,Z5!3QYI!VX_'$MEI*H*DL.>E 7*?20?1V D
M!_"9K4Z((A#_^9=.M_%C6@V@^6- ZH".H6B0IWV,+0Z3&)ZFAQ$/(%X9,HG1
MXBU>:N5>2I8>AI 8WS(Z*D[IH<<>C"[9A7Q[4,)L#-2#%$3K>XW:P1%HJ2*_
MEQG+B*AS@(\&(_?K5"&)E+Q(X0+DI1FF2X@QVK;8%8M;K ET:7NN@XC-GF8D
MK@I/N+J,NX(]BQX-4;6+Q"U^?GZNPGFF^N@^O:J-_%/J*%AU)\2&G$#J7H"]
M5F@?(K]#;O>6[E9V^?\4TJ8EXT:&5 HJ;<="XR<(SVA7?O(GII.Q60Q$WY5\
M^H-J!0,R"P8_"H+)#^?GN'<.8/>>.:V")#F7[51<SS^''3U3[_OI'!_[MJI]
M3KTJ$JOIL2<RD?I?>(J084A8)HM*BQ$F)G=#)3-R.O8JRW[&X[T(YTI8'4E%
M5-#60*)W*<LK,V&9VC\2Y8'W>)A:FUM$96$D/)R>'9F+R4X\Q<MA9<F4FN1:
MN;&I+U7D+*_;Y!!P32BXQQ-/%E"IW-](],8ESPHX3]F4_;YG]5 \]]PG41*V
MFX.1KS]=?KZ[_7Q':!@+ %["4?SB^I/V_O/E'Q^O/CW<:^_^H=U=?0 H_>GR
MZM7@975&3U%TQ &*,5.,DZ9CD_QWSZC%@3.P2.@  SQF84PL_1&GNL^^\K6J
M()S4\S-\&07DY(7#LQ*7&41/46T%K\4/*+8^>BD&MU"4GC5&>8J^T_3#X0J$
MA=$X/,6E^'D65BG%]QR=+WP!LD)FV&<E[P7%3*2U: +'HJ5Z-J?2O9<7/,4K
MF14F<\4: 8)DFG,>69D! NF):9B YF776I9U"C'N-U"Z/IQ0,( L_8C.%#$0
MFFK2'3]X]ASCTL9$#MQB#;#P\$)"+)/(':_[/]9"]VE/5!KD5\B<5'0$ 8$9
M!M'!(V>*?1;DNJ*CQB(??>8@L!3^9YUNT:HE!)D<="LR/&J1PEMTT%EP.D@:
M#,Q!Y^HPJLYFOMP2,T@;I_[,R)0<GL\4A<PQ6W*PG#W3<X'(U+.;C=UE=.4S
M=E98QJ/-VT(,=D$H'6MLHQDT,ACIM;/?,Y9G:7.>M563Q"HP2<&#?C*U$7#"
MSV]2F%J=A\ZMK_\'F.'G\PO A19 ZW,Q -%P#E+7/*_5:GJ]TVTVFO1KH]YN
M-[I&O5;K=!KU<Z<WQ??J1EW_IU[[4AT%XY@4SQ"<PTSQR/Z#$GF(E59&_Q]-
M&$\TM[K"]S^=FV]IFE' \POF5C@Q76\UVFIB]5K#,'!BYF9G=C$!N:<9G9F9
M<>;UT8LL3D+%H>,A_+]C4\.L//OORH;E5#$OU[OP4<3+=1)2_]ZTD)IJ^JR(
M8D9F1BX%(Y-E2%D))1O[,1]WSGZOR*W8$>;0&XU6S,ZZ4?MG9\.0XS<3\)<W
M!6XN !W')IH4RF@7X2<X:&UZ=W2]VZW%,VK6](WO#O689U'+HK:\HO8]QF%;
ME!YS2ZZ8^W3XP+UR"&MZXV(G^ FX.#D+-?7F/P=BJ#<V?!HB"-6IY-D:A12S
M-K-V&5A;YJ&C.VP2Y8+,A)-8TL&W)'BH<W8QW\JC=G2!"%C&^GJWKAO-6EOO
MZNUZ[7S0,76CMV%8$C["NFA&%S5YK9VWZTAK_R *)\YBSS3TW-822.FG P,V
MZBWC7#F> <R<U5I&6]<WC#A#1ZBUT&LS&"WQ&U!(3M3"CQ),E,]>+4.JY MV
MM"(K/BVE-/!;?IK^T@Z)ER]5; T47__9Z#1A[3:[1%<JK*=1U5,+)#<:(Y*V
M:C?-&B'SEL>L(>\P>XIO,/,E^ZP/#\6I)\I#GDT^R=P[&IYY[C.FTM2C1)1X
MN$>86%,\M]R'J.ZUA\^7-Y;SI3@79\7,G&_06W,U%$[FD,($\OYL=/C%+0&1
ME<6CF_7=%?B+\\$Y8W<@W8>86!LYD =)=!\5[%:5<#*OSGM,U8,BZ8O=7/V9
M"!QR05+4S%P_)$YI&&(CUSA8BH(@,[(G[=F]%ZIZCEX_,4\K^*.//ZAHG-X\
M&9P69DIF<_BH\5ZFDD(4K5J0[T/C*:IRD_9D8Z0#76@. Q7/(=/V53H1'F1
M*LLY+HY:Q6^C5/_LHEMQ(#,JQ'A*<1D!1Y4+4_D#Q2&?U]F-E5D$V1V0N"/J
M,!D5U_%G(D3B[KA%H2A(OW[&ZQX':>5>MXQNB=:FN: 'LY@]XF#89]F,T9()
MQ 4*35*YGW7?4\K\O&"V@@R0(L[Q<Z$&46R''$,\0#6KA']4&1M5_R%Y2DF"
MQ5:3>I_< '<I*D23E765J'R JNTL:856:I!$26-DM#>M%(?:A)YC^2/M1 :3
M2 K & RUZRI4BK8J7:@HHII3E<=[#7OC:T:U)G.BVM6:'@6+ST?I^=B7J'=H
M'.B>/%OKPA,KT> 619@4%Z1XD71Y50079:(K65:1&5CY4DE8,$+X05+9!%2+
M]RB2E''*:Z_D#BD]D,A I2CXW6<'T_#A^N>1.UZ0A$ZG$\I4QTRZY+IL3]Z\
M)%XJIT[$5QB9C\8TN#VFN*@.7 (B(@XC611G8("TSO#<?(J4+S^5<6&RB!LM
M'?4O3)HDX*IBX'4ZJR$)F*9^N8X+7^*:]Z;I.P-AB\G(I8)A8=R?-XEE4H'N
MNX]3VDV(K1;]UU'R<D$>YWZ'9L!A0KMUGQ'LWP>>$+"5]R$&;.O-9FV_8[L:
M"V_Z!'P/#'^)(74NZ 53ZS9:M<Y^1W;2U&NG6J?;/>MT:GM>I0N4@=((<1G#
M=P#@G@A PQYUW8K&<1ZOB^M6)!.)QJ2O-:;<Q+)SC@[,=22-9/2O((%XN]X2
MQ7QOWOYDC4%KV<'/;V+ODM'\IZ_#Q[6:4?W7Y!&HP^LO_#K-"/6V\:.B@X[^
M(^[8H2QHV3:N][9=:>G-2KUKJ(SE57)9MI)SXP[W]NJTY^:0<GDV_IY$S!:9
M>%\H>HWF0LF+YI&#$+Z[XZW;N\_WMU>7#W^L5,5E1^,ZJ$4Z"OJ<F>A*:Y2>
M_,&HEQ)-96L*0;VW]U9#KN6_UOHK"NC;AR;?,\&\AK/,IES/I3FXED[Z(6RY
MN'O0KJ^)B7L>+1JFQ,?EH;1/GQ^TNZO__N/Z[NJ]=OU)6P_G'/#:S-0!>+CZ
MJ.GUJO:9DGJOHHKW[E"[CLHKHO?D?;IL;B(/=_/_(U[O;ZH.F!C*952F+S!N
MBLI7H6\!+>ZY!@72$SHQ+;+TAWY10P[R8BRIYV3#E\KY/5MCXP)=P*KEEC_"
M=E/H<Q!PQYA<T:K?5A3!A [<S.N&8@]%-=:.:U62<V@Y#WAKL1)8##5G.OE]
M>UQLSPT"=SP;&KOX?3/#D_,_DT\C=:U1.43->^R=U"H:_GNZ,,9V=R\$E891
M<S^_,1:&:ZTYH%FUO>H0%P7E;D4[P;\7Q&92U\3Z9DX(\9H+H6@_/>^9?5!A
M@/^QG# +L @NGU%K $ZN8Z!ALWGZ8O)5O->!\^V2(.E-'^K?O"T28RO%=.O?
MKTNDJ\2XK_W06<I_\_:OB]Y@?)\U91"NW<1;FVVCZ+V.^^R9DQ^TP M3*'@C
M\]PT53>;1-";H>J=4_)%JNYNOL71,5'T*@_=&A'K1J6&/M^CIN.-2N>=T_$-
M58IG$OYF.5PK 0D?MRA^P#:76!!+-D!697\)8WC'3=D;.&ILF0%6'N'6)7T1
M%&?QOY!WXO]4LN>#&X N.$I&64J8=2#,@1M2%ZPL9>X#OZ\^NE:CLF6HGV><
M^CJ,L^_DMFT:<AN8.R([B49]]+!)"+6&=54;KL]#^$YX?O7(3=DO:?\:%P".
MDB.E!E9I"EA.4BX@16(G@=2IA!I5AE$:3657U3CQ:Q"O]Y"Z?SL4BQDW:/5'
MIFQ')+"?FY/.C!B&MHV!V"I79:8-I&T^PP[+M[P7\!=:8'\1CL  ^,O4*&_,
M9TH62-ILJ[XD_P_3+Z(X4=EH.R[I&8U'17%3M[FXX"9%S\-;,K.-9UJ1S65F
MEL.,+TDUI:/^MZNOPDQ-TV4SEQUEW&CV5>V/N+';\EL=-QERW#=*3=Z>TNR2
M7G?19)3).T]=?KH%7B$MX(<]C_(38'V&UB#L6_1]".N'R;OQ8"II^WJ\QESJ
M,_5LQ>=<ZG/#Y2"&JGI[0J@DY4+)XK8[-6WX=7V6X%)(1\\&7"\E9I"^K'/A
MCBU?%J:6:8':H^L.M*&)+MBH>X/E/+DV-4-5R1O8^=#R^ZX#\E\VHM:^.-(%
M_&2Y=HSD0'DQTS#3E(9I0@<H&N >G.BF4>8K# WPM3,@;HHO(+V!:=AQNV/*
MRAZHKN)18JXJ/:#I[4:DIY9!/J[<Q4Q5*J9"](4-J?SH>.>YXSB?/#F=:D O
MUA.=?;$SAN=.XN;?IJWRHH.-U ABQF#&V/?05S;^]*:@+OS(S$-X[0=F F:"
M,C!!^GQ.P:#4\URU7Y)FXVGAJ7V0L2"+KZ(?!K).A;0ES['<X0D(&(DJ5$CS
M70S&;+2U^6'O7ZIK*1D;J= *&KD0T?%!A[FN=%R'U586LYILK0;'&MN=1H$
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M!1/L6LPKQ&ZS(S-\&.7IX*HM_VXC!Z5,VZ(_@0=6('YXP R*!Q0E/='V>.
MW(('RB%X(#L5>1HG<6IR@,V&V43Z(0T.'C#WE$L7[<S?'PF1H;1I:H6<>IPF
MM,GDN8*.>T4HO["]YE0;.)T:GR@M^JZ1)<BB4Z9&I[4_UHD'?LED':O\MIK$
M_:'E>,=;.(P'9%;]'Y/BRIOVO'O.GMKWSI%ZQ+$2<3 S07'H/>'\<9&"YHQ0
M;;'9P2UD[*:>3DBTUU-YO3P<C4?+QT;VBG:]6,8Y'!X0YL4#RO3)N)!N!)RM
M2^Y9,/HWU^>C.(0SC(O*_N(.'HAKW\XZ0U[?W^45J+#_%<>3:#_,)U4GI3>G
M&#=%*26R!/M0(<)H\&LI[4#>D8W^L?CCJ?W)4*?%08(QK3J]*CK6-+:F(QN%
ME<G$SCX7B@%NIVBZ:K$=L&GB#9]-K GF5O#N!0R-Z,H2US*A]CSJ,T#]\?+-
MC!E0_N&O73&]K<!1/R')KJ97C]I,GS;Y-;":I.O*WKL^7^9^18!+/ XM__[2
MST]R*,%')"EP='6&1)[4>CK=IF'#.=5/T'C59K F4-?@0GH+)N,=MB?L=!?[
MW2$J*G(Y&MCR(C\.K-#6LWU?:<C^DBX \<8H]6 /E4I4J55XVJ2!=$)/:U;V
M\4%]F!88CH"K\!85$"EH"RPY<*'\:JJ-9>3#BX#TA1M-56+G2\VIVMTYE=L_
M%U_X,I38+<\3]U=W%X^I'M=_6+\T^]0!*41B+17Z\H2S?)#/Y?C7336'6]F1
M\[@*I=.@XF^Q.)8 'N4Z=DUZJ[Q]'D,P3%^<OY7>(VAGC[8#W=T0H:M=$7NV
MD7L>NVJ1Q#!>>0-B6[EN5:$?DNZE.O]]8+_.-.F#JUS*(USL,:)B"V:ZJL"+
MX:E83LE^QB%(FD0/SK;^(W58=$%14AZ[S.JS^CH&HY[);YQ^(P5:5![HD"(B
M4KYG<R>O(675+>#GJ54C_V)\EZ;G:,]=G/:B5<+XY+Y4>/9DL[DUK>GG^CH\
MH/X)>[4W!WU75H$*Y&UHQK&>!CYX@>H>>?*C<OUDJ$-:>@=LO_V-=@-KE_T3
MW9^GX7_V^.A@*O@L/;439]2)IC5JJ!H6$H)_Z.)IR2!T1H[S[<4:F.VZE:#\
M*UOYI[3YGK><.*1#(_SE@Y9D)ZM'A7*?1DOU_N%_I#?LN9(Z,Q4(=6@DR3R9
M@MLB';.V_4.4;QU]W];FD,59[QI.,(DR<V$&W6"W[/,G\Y?*+-H]6P*LEKIT
M-EF,Z]1Z%J3+ZV6V[+%WIM=6\S:EZ'[OZH[6RE9 ,,+YA>K6WD,F:A1<)T1>
M2RWUW2=D ?L=^HTZ-'Z<MX[!),WLO^_OO3\H/#.JVY[& V%B4D&G2;P'].$*
MZ=;ZZ4DG');Z.K11MI$]Z;RC3?.4%VJQ';YT+':C=[Z^BH**W=&]H2'9KA)=
MTJTJ6#%\Q;YEP3VR.%XF*:OE\>$+V>W'G3>1XRP[7<4ZJ<>-W+$4V("28[\$
M[ZPE/AQ/+$]J*G_='V,;D]N43P@S 7:':!4?\AS /)*<K(<7TR2OO&A37V W
MQ5AEGR112IU"?M<Q+[AOK:%H6CRT_M8?+=*-@UJ5<)$9=*$A5,E;0BU!<;\V
MX^VHX ^0#[..ZMJ#MJ,*:ESKNW4<8^3N:!!LYWY\C>Y#;JM",.M/MGB'$05&
MAU&%.+0)YH=_"<%M-?<3ZUOQ$MA0,TP%3LNPI3'.0QU;NE/]-DD]M/?J5 YD
M\9K<D#LR<?G'U?)DAJG;9T;>%\].;=M]"U$7:U^,R[+?AOD(WRRZZ\?7(^G2
MF0F>:!:S99^;K:MGV%VZ+[I"SUL(KA6',WN78]MBC;[9&+PW10!D%\2&XVE=
MC)ZJZ\974_%#/%#YF<2'<,(8P5K-JJ*O>?$[R'ZZE@17[6\K%M")73FI$F4_
M6\X8T2W>]VQWWZ6SQ9IN?Q,^#03YV2[Q+3Q%A-W4Z?);Y@O*]SF<G>F+U3SG
M1HPD6^Y[S%A3-SKH<EO_:B.&KYM8F[V:#'M4/^O-85]C2_*3<K_V_)4"_UCM
M353D[8."6]8KSI##"NW3UF(*2S(5:U:"\[?;'!(3X!_SH\W>>7%G=6/\&DL\
M_'3'S[L<MF=6,)P!8H7Z"EVO.%?6W4]<>@AJ2\(-!95R?E%KT6WJ?[SS-<$N
M/^IWFI^@@_>/>AK27%8U TNM#=\7+,)1M@4(@*LN4K5A+Z;P3P7/*2+WLJE3
MW/[QUY"N^]?O<VM;D,QQW&CS17^%I,J-'D]S$O2?@:(MOISFY1':6H.)UA5J
MGW]_2=E?@YV%[@17USWA4]\",15D?$IMK#QH*0@<Y @0_!4(<<_>4K[*@ER%
M"#!=4=K%92N6V#.Q*^R=&B$6X>2_O76&_! F:QFVR8,VR<Q@)NQAA1'C^_RG
ML;>]A@_V&V0^ECP8L/[QC<_;Y+#%Z*_S+]CP[B>R-NC6RM$YRR*)K]&8:5VR
M2ZE=PK2Y\(:M4O26?$^+*_^^M99B+-;IX:7F]4S)\3PG54ZJ4!+S\2^&IY*
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MHODYJ#^0Q_]I;OX_&/[7_P)02P,$%     @ '8:_5D"0UA%3&0  8QH  !@
M  !N8GDR,#(S,#4R-5]S,6EM9S P,BYJ<&>MEW<PW/_W[]^K;1!66:(31(E>
M@RQ"U B"Z"UZV0BB;1"2($0-"1+!!MFL$D00T1-MB5Y7CT5T8=4E:_?G\YWO
M]W=G[MRY<^^=>U[S_.-USFM>,X_7Z\R9<\B3Y 6 Z9:>H1X  H& >^<+(,\
M-X$+-#1@&NH+8#"8EO8"W44HPT5Z^HN<+*P0*"\7/Q\O%P^/@+"TJ("@I! /
MC]@U<4E9.45%17Y15745>9BT@J+\/Y> :&EI+])?Y&!@X)"_S'-9_O_:R-\!
MY@N &2B8$B0(4#"#*)E!Y Z 'P! U*!_&?!O U%04E'3@"_0TM&?'ZAE BA
ME)045)34U%14Y]''YW& BIF:Y;*<%@VKF0M8,! J_S2]X(*0=M4/-O/A76$%
MUX?/:.G8+W%P<ET1$143OZJHI'Q-157MIHZNGKZ!X2V+NY96UC:V=F[N'IY>
MWCZ^0<$AH6&(1^$QL7'/XQ->)&:\>IV9E?WF;4YAT0?41W1Q2>F7ZIK:KW7?
MZAO:VCLZNS#=/3]'1L?&)["34].XQ:7EWRNK:^L;^+W]@\.C8\+)Z3]<(( 2
M]!_[7W(QGW-14%%14H'_X0)1A/US@)F*^K(<#8N6&=@ED%50_ND%J'9Z0=4/
M6B$%\UTVUX?#=.S"BK@K^'_0_D7V?P;V[/^)[+_!_@?7-'"1$G3^>93,@"9P
M?"I6^(3N7-Q(.P6'Z!<D@?5\]O'+HSL"]1F&KOM:+Q[*Y5H9$#H+CJI;R$"K
M&Q%N@ROM%^6H%K=&@WT4AM<JW-I(2J.PNUAZ]RN&?O@656LPN'6DP1RQ6/W:
MXU+OE9+ C(R&2XKUE2J-A.:B:=]+5IY=A]/S%O3RQ3^$RNV&6\1\PB>JX:AV
MKS >K'"I8J+<]T&ELO8)HW?9VNJUU_=^631)2BA88FOF&&>VN?)FK8;SXP:%
M3T%CX]&L\ D2]Q!ZK$)^WHE=!6,K#+N:5E*I@27>],*AGT>L76[%Z^#!U[O,
MYTQOJ /K.Q8FKXJ'2BWOS.Z4-[D4S6%6M(2W8MVO3<U"QBP\\14Q_J2&+?2$
M,AF@V_6SQG!M;_HWC3L)F+!S:-Q1?\+K\Y5+)JGV.]^H_IAP2CW+0&2MYO%X
MZ*<K*F2 Q4J%5&MG>AS8H/Y#0QAAN,+,Z\HQ>; /,CM)=[S2/-<\*VC_J"A'
M87CI7OM!)<CTN89"ANR.F[L"$:(B=5!J6(B8^5%'0QHU'I.B2Z[Z*NB-/%OF
M+1/'K6L^\]PMM][N.#52K%V>9R)TPHOG]-&(A)L>H<M733XDS)XR/;IY6&EE
M3?WP@D!RS*9#=>S[K0&4\$3L:S,#8X/.PE>*=RB&#74%V!-OCXP"A8FWAT!Z
MWOU!43)X=S[FT8*F;[59.(_7.NR"H)[3T60'I&08:\:MK;5U>8D^_:Z(B]'=
M['])IW::N"";$%+'>0*T8(GPZ%(KDI7;88YS7W@T--#)C0S0OS-5#X8/DP$*
M.U."0Q;_ 4T+D=/[-,__M\MAJ69?^'/OBHCV*,D1HBEE"U)\7PCSEC59/HIM
M*,;FEK3TB%+RZ\RA&C-=P6>)X@HWZ'5%O/L!*>C;(D6@QMSSZ;D#>@?T;X&?
M1SJ2@?2)05)3ZY'O(L V&^E(11CI3CO9)P-3*0$+D?5*!P29!9V3W(BHJ9Q\
M_@G/75(](YI)6*9'/A0Q:'8&7WM'/QE"S_%@>Q:F(! L-(3M>V=PG4,>J2TQ
MHG&)D#MC2@8NG"U%;7^92(W@VW1XF\II'&%SH/:0:"IQ% 3;MZ BI-D<_+U?
M3]QT_EY$DIB[E';B309.:3^56]XBO+(!"[SK8=3DFMQ5$<(TR*#?_!.JJ$<=
M>A*3!7]-8$MFB&X-WGY$C5PH'"]$N5$DV%1Z:FS:,7_%>ZL0GG?KU/1UJ.6A
MZ)>G3O5XI"D<25U.]#5:/Z85_[Y\^;K]26(_0:*H+?CO]N/L8"S+.\3D?@*V
M<@6.0=EJQTVLEILGE=@ZNT7_B&90;&70R;;VX3WZI.>THMM]<^W)0<4.W\?D
MBUYL_0A,A_-NZCJ]XCVEN;Y>O_OHCT<J5'\9:SMW[F8V5%<;Z-_TW+3X7.UA
MWS@##W5Y>>7M'63?V.=>M@ZXI/R'],_=P?>^DP2;;F*2<&\>N'_)ZC^4\GZ_
M_V?YY<O8H]43NCY"V*(M4:)RQJ9I^RSED0@F94#')%SV@+,"6=([%:$SX)$4
M@Q12C^]THAR*M/4>WF W>X'?<^BBZ([?_(6OH#? *B'C3L=;XXF&$H[>U\!^
M^8539[\*D;N5GKP2[_"5S]_C3>/^'/28A67*:W=XN<>\C$8OV5@@I[+ZUN&E
MUW"9(B_<4]J+BCT\5*G"L>HEB+_M=AHH$62QKQ'UV WVE/0&OKRR&(+9XMOM
MCVGM7+F=3=U]6=)G6A;Q2;M"@FG)X8*8(+?*KB+D@0]A0ZVD_+)6A+.7LH=Y
MV=V3Q= 7>)DV%A7=B4+J5!K+>,W,$-_OQ?<>0@2P/P=I"&]O< K%I&8>6,<<
MNI02M-M.)A\P;6=/5H)/K";[6-Z_2AK.)3AXU?D9VG6$5Z;!5 M]&5R*-PP9
M1H!^3BMARM'WI<Z[M3#>EYJUV%=/_Z+/RQ!>W>Y@4XV$*OX*F1;U^T & @):
M?]8260O(P -$PT_V!&ZX_\$+DI.LQAIQ,RR[3;'Y _*F4NKKL@B5HC7*$#K[
MLX+EN['2>UL!P*%JA?+?Q<&X3[\SQ/Z(- 9O'B&2Q#7>KCMD=TF%XFJY32'Z
M*^4E28/?]E[G850L5;:=(ORI^SL[K+*RPF@,'?0YY&0=D!:)@PPQL;A!<[UO
MR<8&1EG,ZC&D2WQI:2<T&SQDX+-FUZ?I2,?=K4_LRX[3[DO!51[Z8XF_"PCJ
MGV "_>4S&-%C=A;]50?/\@]SWN&YTWXG>OF2O'ADYM,U>#C"0<IJB=8W:+QC
M40PE7@[Y(*DD86PR]>!^A=NWN :87[I3-!Y-TGT'.24Y+\/3"2&?3%&(AHE.
MA[-4XFO$_O=(=^8=Q_BN $T<^Y>C9M-E> Z4]^)=UX$X1ZOV^OP;8"4TFA#F
M,"Y%/? .U1\(<FT<>T++"Y?3[U.M:&]O9?*/5$!)Y_E_O/FP8.JX!A6>BZUS
MLG2C'['VBH]/4349YWNNTP+%2])U/:;8$N.4?*\LP<NH=T.(MVJD<8HD S?7
M%11)\^&6?\GQTT0=[\"5)=FWNN)6WX+.R54LN]Y0]1DO6\2M=GL=1AERI3+U
M8)^;S?[94#<8?]$KYY3^?24KP0MWU(S%6F=Y=UC93C%I7I?C-?U<J8N?KPU\
MC] ^.AU0CB@O5'E6XO_VVP UXB0.G? [=;4Z>UY1NA,+>X0C Y#>92=GFGK^
MO38V:3+P<MUA&<FI&/<RX:!?6X>7VYOS#-XE]*A7L1_^6'B/=U#H1D?5SH#$
MU]W!]GZ+CH: ,:>=OVI@5R'#RR)ZE/7@]^5.$(C)M>)N1++.JK?.EO622.8W
M\$@M-;BD+3>J=L1; S84>5,FW2OLRRH)<;N1YTQAHJFLDQ^RTR3WL9P,',6&
MO033"IY$7!@,W'3(><Y8D6Q^5U4?3&WL$ "%:Q_8OJX:]S'-*M5X@;^4%(RD
M:_>7+E/HR&8TEZ_*[J%46:QJQ=TGW*B(KA'&G 5$[Y9:V%]+;6%OEXQYO)#4
MIX<AUIJHG"XVN;+8:GBT0S)_\$+",?3/T)9*HCM"D2;R=S,R[!36MS7O?!V7
MO-Q2_=+07WXGY4S7$TZ2&XZ4$6;>J',R&D1*6=*S@$?JG6/#ZY"%LS[RUW8D
ME_O<2&_K3">^:2:$(X\JTW:8+WC?3_?#\B0?^D]\0<6L5*P;N<-AYBG4EGSY
M9( ]4B#!L9:3XNFK-_Q$B<\U]:E' ]S%AG*WG^D(WUM(3I58]6?P-EZ$,$_[
M+%,R1D[M3UTBPM?6QLV5=(&KR<!U.IN?T#5#/<:E-NL\[WU#FXQ$L0J%3V*%
MB< _VMU)2JGK"G4Z0OZ5J^"SIIC65EELC$["\,E7D8%*S;.<;[:M2_.FJ,?*
MK [R!QK^'*W3C&1@$1+/Q7#=!$_=P,IMC^$=,CN.,GM.RFR_&3!L#,6KV@H%
MK+57\4JL;=JK^!.5_. P%US6N-G8,;5NY,DB \M2>_C6Z?V%DWO93_^J\2%3
M'BX$TOF,I+=<8^CQ39>8,SFNPUYZN- +>ZZ'N9TSLZL7C8,-/R(#62EDX'W.
MJKZ6(^1I-QF(W=$E Q7_\OVI)-*&\ZAXA>,/U<^SF/LOY[8T5%&ARRU _XZ>
M1!;!KV 6 6]_Z'U,I_6UZ;4>X>^:R5V2Y=22X)/"%LMK<'Y+OP=2CZR[:K*D
M^/6;M']([3R]STBC]8.X.0Z7<![:AND7SJZ'E=Y6J*#EO7LD-&LY@A0>:V0U
MAPU[GQ0^(@T'"6]UYNO-=AP73RM_JZ^NBWV0 W\S# V['A=BW4K79(]VY/"[
M7#<FM9^PPD*ELOV-[W 208G+FT@OB?8CQ'9@JY+M[3O"))V6CY4V+;LLCAX,
M',-R5*XF%CZ<XBM^$GLG_&F,0?A(S*9-B_!XZQ?%1^CG(OGK\=G^%(_7W6&
M9CFB=SY4_?E6&FA"-()3=%PR3&(:SE+;Z 4&EM-6G7#%,S^63"EXG[ U?[5U
M'=QMD=>TP__BF.E$V=MX7\7]N6R5CW\ZX!EE4&E.N&T4>6T4--B[ D(:=S7S
MF+R,TPEPF7F-ID%$4H]!,PVRE,464I,9&4);+N&I<OS;SWM2>_",<+0B)XRT
M'Y.(PK/JD#KPR:,ZW[Z.@?/S$\E A\3;[FD]@T%_NX,3*Y%$KU?B34H^-NX7
M!.,L,J /X5,:4!\&G_>#)3]1'BVOQ-,'?HR>YNS9VUNW-M5]?F&8M6&9<N-
M%#G2DOFE-K6MB]Y&3RB.0F:(;J7_ZC1=SD:(1TVEJ&4N)$5#4*M@ WQ[9&NQ
M>6PLZG"97]CI2?Z'O]9,9("9:#5@\\OVNT(;ZK- E$C]MLW/>9$)+K>_2Q$B
MBQI-5O'/14??XS60(N6_SU)LDTYBKC*JB-2@XU F:0HI<W'6;.:6]:Q?> /Q
ME!T*:D6(1-R;7+^Z%*TS:H_960<'1\7CM(!C%N+ ?LG%:+7C1S#=A6UERI"C
M?G'EY!@F\\DCRAQ\*W03OBC#,NLK5V 4>0$'+C'[-:/X.02Z^F?T]\VN'WI<
M UO1L0GG&3VJNXQ_J)E>J4OH)P."M<BS*/2>TLH\VWU$KV[/]VMP8DJX?E?T
M"9N4'!G0+"&FZ$F<[5&[:,ZY/V)Q$TI.7%<TI8!K"(]@[XQ62!8E-$I/U7D)
M_+56C"_H#-'@)SPM(?@;D09J1LL]DPU&P.G=FST<%5NFM<MG ZO(N".GT>-&
M=DR;/QO%-4>?6(CV+YQ#RMRGT\?$(VN#PH@P,9R)WN.R.GX.I9'H9;;S;OQQ
M;>"E[&RN+%1(=%#UP+>7C7X\$!=;EZC:OK.*KLG6LF^5'O5NQN/H827ZQ]KC
M;X53NG;5Y(_!NY5!>-$D2=CU]Y@2AS2% <KNV)#TA&[^L_!=?A'[;",;Z^!J
MM:XG8<)8.#Z44Z!Y=XPZ+2OKSYOM;ZZ?N\QB-]MD*E;U:#X4:)M662TM^B?Z
M"\_13]GHJ0GJKO!$O+*UYH/A>:H?^#/W)2.FZ,3XLR28@O*GV+;F62::+H/C
M[]>9HK4"H0*WA"T9.4(V!^T^Z8C?20Q$![J4#M1,O]YZI#115NY[]'MG)T2B
M$='MZFDN!-YC<WP<CW-*PE-B[*Q0A63 ?6T$U9.'R1.L8(/RD$)6UK?3'3E4
M;P4TIHGWIR1;&E\)FHUBISQO\*FS-3&BI.?P/EA8(2^XZYJ[R(S]_FJ;_HWH
MA*B0#7YZS66MZL'CWV1@J/\F7E]+K34N9^-*?W_,HPUP".GRB77ZK;HOG;W5
MH>J^-<T5G.%\SCAG)GY&./+^U4'6[\-JE0Y+O\_@S/)[AK#^MU?24:'J/:I*
M/(S"R8:YSU3*F.SZBQW:W1Z@T-]>ZCV)( -Q$9'I22&:Y1!(_L-;Z1N_:&N"
MV.(FJLY+@'UODN8L_R)\5/]6$6H=OY[C49Y\E2I KU@39-UHW8<MV?9519IJ
M(ZL_%DI!S6RYXJ!F-ZC/Q6>&YV_C.FI<-+*?NSJANF 4Q,W^4ARLNN/P&LE
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MNB+AW%"V87,F!L6M/^!+N#3:'GB@VZ=?OMEA6+DI25F,?&G"W2<FP,YA,4G
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M>%\U,C<X-3DN:'1M4$L! A0#%     @ '8:_5BADP/TD P  ' H   T
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M              "  98K  !N8GDR,#(S,#4R-5]S,2YH=&U02P$"% ,4
M"  =AK]6_RAF==@5  # %@  &               @ %$\P  ;F)Y,C R,S U
M,C5?<S%I;6<P,#$N:G!G4$L! A0#%     @ '8:_5D"0UA%3&0  8QH  !@
M             ( !4@D! &YB>3(P,C,P-3(U7W,Q:6UG,# R+FIP9U!+!08
1    "@ * ($"  #;(@$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
